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Abstract 
Genetic Code Expansion in Mammalian Cells 
Václav Beránek 
Proteins in nature are synthesized from a conservative set of 20 canonical amino acids, limiting 
the chemical space of biological systems. Over the last few decades, scientists have developed 
methods to expand the genetic code of living organisms, introducing new, non-canonical amino 
acids with diverse chemistries into proteins. These methods rely on engineering of the 
translational machinery often importing an aminoacyl-tRNA synthetase (aaRS)/tRNA pair that 
does not cross-react with the endogenous aaRS/tRNA pairs. This approach has allowed for co-
translational incorporation of a variety of non-canonical amino acids, including amino acids 
for photocrosslinking, biophysical probes, amino acids bearing post-translational modifications 
or bio-orthogonal chemical handles for protein labelling and imaging. These designer amino 
acids allow researchers to probe, image and control protein function in vivo with great precision 
and minimal perturbation. 
Cultured mammalian cells present an attractive model for studying human biology and disease. 
The first aaRS/tRNA pair used for genetic code expansion in mammalian cells was the 
Escherichia coli (Ec) tyrosyl-tRNA synthetase (TyrRS) and Bacillus stearothermophilus (Bs) 
tyrosyl-tRNA (tRNATyr), however, this pair was quickly supplanted by Methanosarcina 
barkeri (Mb) and Methanosarcina mazei (Mm) pyrrolysyl-tRNA synthetase/tRNA pairs 
(PylRS/tRNAPyl), which are easily engineered to incorporate a wide variety of useful non-
canonical amino acids. The developments in the genetic code expansion in mammalian cells 
have allowed researchers to study role of post-translational modifications, dissect signalling 
pathways, label and identify cell proteomes and identify protein-protein interactions directly in 
vivo.  
 
This thesis presents several key advances in, and applications of, genetic code expansion in 
mammalian cells. 
Chapter 1 introduces the relevant aspects of protein translation and summarises the progress in 
the field of genetic code expansion to date. 
Chapter 2 describes genetic encoding of phosphoserine and its non-hydrolyzable analogue in 
mammalian cells. The engineered phosphoseryl-tRNA synthetase/tRNA pair 
(SepRSv1.0/tRNAv1.0CUA) derived from Methanococcus mariplaudis and Methanocaldococcus 
janaschii (Mj) is shown to be orthogonal in mammalian cells. Subsequently, phosphoserine 
incorporation into a reporter protein is optimised by engineered translation elongation factor 1 
alpha, engineered eukaryotic release factor 1 and metabolic engineering of the mammalian cell 
line. Overall this approach achieves an order of magnitude improvement in protein yield over 
unoptimised system. Incorporation of non-hydrolysable phosphonate analogue of 
phosphoserine in an engineered cell line is subsequently demonstrated and used for synthetic 
activation of a protein kinase. 
Chapter 3 describes two methodological advances in the use of genetic code expansion for 
protein imaging. Firstly, we demonstrate the use of genetic code expansion for super-resolution 
microscopy. Secondly, we identify aberrantly extended endogenous proteins ending with the 
amber stop codon as a source of non-specific labelling. We then proceed to minimise this 
background by optimisation of the labelling protocol and use the resulting protocol for live-
cell imaging of a recently discovered microprotein. 
Chapter 4 experimentally demonstrates the orthogonality of a recently discovered 
PylRS/tRNAPyl pair from Methanomethylophilus alvus (Ma) in mammalian cells. We further 
demonstrate that this pair is mutually orthogonal to the widely used MmPylRS/tRNAPyl pair, 
establishing a new, orthogonal pair for genetic code expansion in mammalian cells. The two 
pairs are used to site-specifically direct two distinct amino acids into a reporter protein. 
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Chapter 1 Introduction 
1.1 Genetic Code 
The proteins of all living organisms known to date are synthesised from a limited set of building 
blocks - the 20 canonical amino acids. The field of genetic code expansion encompasses the 
efforts to create living organisms that incorporate additional amino acids, extending the 
chemical space of biology. 
According to the central dogma of biology, the information defining the amino acid sequence 
of proteins is encoded in deoxyribonucleic acid (DNA). DNA is a chain molecule comprised 
of four nucleotides (adenine (A), thymine (T), guanine (G) and cytosine (C)) linked by a 
covalent bond in an alternating sugar-phosphate backbone (Watson and Crick, 1953). The 
DNA nucleotide sequence is copied into messenger RNA (mRNA) (also comprised of four 
nucleotides with thymine replaced by uracil (U)) based on Watson-Crick base pair 
complementarity in the process of transcription. In the last step of the information flow, the 
mRNA sequence is used as a template for protein synthesis by the translation machinery. 
The set of rules that living organisms use to convert information from mRNA to proteins is 
know as the genetic code. The genetic code is constrained by the nature of the two polymers 
involved: while mRNA is a polymer chain of only four nucleotides, it encodes a polypeptide 
chain comprised of at least 20 various amino acids. Therefore, more than two nucleotides are 
needed to encode a single amino acid.  
Deciphering of the genetic code – the set of rules how four nucleotides code for 20 various 
amino acids – has been one of the major achievements in molecular biology. The efforts started 
in 1960 with the work of Tsugita and Fraenkel-Conrat who demonstrated that the genetic code 
is non-overlapping (Tsugita and Fraenkel-Conrat, 1960; Wittmann, 1961). Crick et al. 
subsequently established, through mutagenesis of the bacteriophage T4, that the genetic code 
uses non-punctuated triplets, or codons (Crick et al., 1961). In a set of experiments, Crick et al. 
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demonstrated that only triple insertions (rather than single or double) lead to wild type 
phenotype of the bacteriophage. 
In 1961, Nirenberg and Mattahei used cell-free protein synthesis experiment to show that 
polyuridine RNA leads to synthesis of polyphenylalanine (Nirenberg and Matthaei, 1961). In 
combination with the known triplet nature of the genetic code, the first decoded codon was 
therefore the triplet UUU coding for phenylalanine. Using analogous cell-free translation 
experiments combined with new approaches to synthesize polynucleotides of defined 
sequences, the remainder of the genetic code was deciphered over the following few years 
(Khorana et al., 1966). Because the 64 possible triplet codons (43 = 64) code only 20 different 
amino acids, the genetic code is redundant, i.e. several triplets can encode the same amino acid. 
In addition, three stop codons are present in the genetic code: UAA, UGA and UAG, which 
signal termination of translation. 
The genetic code is strikingly conserved across all branches of life. According to the ‘frozen 
accident’ hypothesis, the genetic code, once assigned, became too costly or deleterious to 
change (Crick, 1968). However, relatively shortly after this hypothesis, some exceptions to the 
genetic code in different organisms (Lozupone et al., 2001), and in mitochondrial genomes 
have been found (reviewed in (Knight et al., 2001)). The growing list of alternative genetic 
codes has recently been expanded by a report of stochastic decoding of a codon in yeast 
Ascoidea asiatica (Mühlhausen et al., 2018). Despite these notable exceptions the majority of 
nuclear genetic codes conform to the standard, near-universal genetic code (Figure 1.1). 
 
Figure 1.1 The near-universal genetic code. Taken from (adapted from Alberts et al., 2002). 
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1.1.1 Fidelity of the genetic code: tRNAs and aminoacyl-tRNA synthetases 
In the process of translation, the codon on the mRNA is paired with the particular amino acid 
inserted into the growing polypeptide chain via an adaptor molecule – the transfer RNA 
(tRNA). The tRNA is a short RNA molecule (typically less than 90 nucleotides long) that folds 
into a characteristic cloverleaf structure based on intra-molecular Watson-Crick base pairs 
(Sharp et al., 1985). The secondary structure forms three hairpin arms (D arm, anticodon arm 
and TΨC arm) and the acceptor (or aminoacyl) stem, which contains both the 5’-terminal 
phosphate group and the 3’-terminal CCA group (Figure 1.2). 
 
 
Figure 1.2.tRNA Structure. (a) The cloverleaf schematic showing Watson-Crick base 
pairing. (b) Tertiary structure of a typical tRNA molecule. (from (Hori, 2014)). 
 
For translation, the CCA group on the acceptor stem is aminoacylated by an aminoacyl-tRNA 
synthetase (aaRS) in two steps: 1. ATP dependent adenylation of the cognate amino acid, 
forming aminoacyl-AMP intermediate, and 2. linkage of the α-carboxylate to the tRNA via 
either the 2’-OH or 3’-OH of the tRNA 3’-ribose (Arnez and Moras, 1997; Ibba and Söll, 2000). 
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Once aminoacylated, the tRNA anti-codon is matched with the triplet codon of the mRNA 
inside the ribosome. 
The fidelity of the genetic code is maintained by strict specificity of the aminoacyl-tRNA 
synthetase (aaRS)/tRNA pairs: a unique tRNA has to be aminoacylated by only the 
corresponding amino acid. The high fidelity (with the error rate as low as 10-5 (Yamane and 
Hopfield, 1977)) is maintained by structural discrimination of both the amino acid substrate as 
well as the corresponding tRNA. On the tRNA, number of discriminating features, or identity 
elements, are present to ensure the stringency of the tRNA-synthetase selectivity. Most 
commonly these include the acceptor stem, the anticodon loop and the discriminator base (N73) 
(Ibba and Söll, 2000). In addition, crucial interactions can occur with specifically modified 
bases (Björk, 1995; Senger et al., 1997), in the variable arm (Hartz et al., 1990) or the D arm 
(Rasmussen et al., 2009). At the amino acid level, aaRSs have evolved several distinct features 
to prevent misacylation by the wrong amino acid. While some amino acids are sufficiently 
chemically distinct, for example cysteine, which is recognised via interaction with a Zn ion in 
the active site (Fersht and Dingwall, 1979; Newberry et al., 2002), some amino acids are very 
similar, for example tyrosine and phenylalanine, which differ by only a single hydroxyl group, 
or isoleucine and valine. To discriminate between the structurally similar amino acids, aaRSs 
use an additional editing domain, which proofreads the correct aminoacylation and hydrolyses 
the misactivated aminoacyl-adenylates (aa-AMPs) (reviewed in (Yadavalli and Ibba, 2012)). 
For example, a mutation in the editing domain of the isoleucyl-tRNA synthetase leads to 
misacylation rato of 1 in 150 (Fersht, 1977), while the wild type synthetase maintains accuracy 
of approximately 1 in 3000 (Loftfield and Vanderjagt, 1972). 
1.2 Translation 
The process of protein biosynthesis (translation) is mediated by ribosomes, large 
ribonucleoproteins composed of two subunits with many key components conserved across all 
domains of life. The ribosomes in prokaryotes consist of small (30S) and large (50S) subunit, 
which combine into the 70S ribosome, a 2.5-megadalton (MDa) structure. The eukaryotic 
ribosome is similarly composed of small (40S) and large (60S) subunits that form the 80S 
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ribosome with size between 3.5 and 4.5 MDa (Melnikov et al., 2012). The small subunit is 
responsible tor binding of the mRNA and – at its interface with the large subunit – forms the 
decoding centre where codon and anti-codon pairing occurs. The large subunit of the ribosome 
contains three tRNA binding sites on its interface side: the A site (which binds aminoacyl-
tRNA), the P site (which binds peptidyl-tRNA) and the E site (which binds free tRNA before 
exit). In addition, the large subunit contains the peptidyl transferase centre where the catalysis 
of peptide bond occurs. 
Canonically, the first translated codon is AUG, which is recognised by a dedicated initiator 
methionyl-tRNA (Met-tRNAi). In bacteria, the methionyl-tRNA is first formylated by 
formyltransferase resulting in formyl-methionyl-tRNA (fMet-tRNAi). 
1.2.1 Prokaryotic Translation 
In E. coli, translation starts through binding of the Shine-Dalgarno (SD) sequence on the 
mRNA to the complementary anti-SD sequence in the 16s ribosomal RNA (rRNA). Since the 
SD sequence is positioned just upstream of the start codon AUG, the 30S ribosomal subunit is 
recruited directly to the initiation region of the mRNA. In contrast to E. coli, other Gram-
negative phyla do not use SD recognition to initiate translation (Accetto and Avgustin, 2011), 
and leaderless mRNAs and mRNAs lacking SD are very common in bacterial genomes (Chang 
et al., 2006), therefore the conservation of this mechanism throughout the prokaryotic domains 
remains unclear.  
Three initiation factors are involved in translation initiation in E. coli: prokaryotic initiation 
factors 1,2, and 3 (IF1, IF2, and IF3). The IF3 and IF2 are the first proteins to bind to the 30S 
subunit, with subsequent binding of IF1, which enables the recruitment of the fMet-tRNAi and 
stabilization of the 30S initiation complex (Masuda et al., 2012; Milón et al., 2012). 
Interestingly, the interaction of 30S subunit with mRNA is independent of binding of the IF2 
and IF3 and can happen at any point before the binding of IF1 (Milón et al., 2012). Once 
formed, the 30S initiation complex with fMet-tRNAi is quickly bound by the 50S ribosomal 
subunit, forming the 70S initiation complex. The IF2 subsequently dissociates, allowing for 
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binding of the elongation factor thermally unstable (EF-Tu) and start of the elongation phase 
(Gualerzi and Pon, 2015).  
In elongation, aminoacylated tRNAs are delivered to the A-site of the ribosome by the EF-Tu 
in a ternary complex EF-Tu-GTP-aminoacyl-tRNA. The affinities of EF-Tu-GTP for the 
various aminoacylated tRNAs are very high (Kd ~ nM) (Louie and Jurnak, 1985) and, 
interestingly, span only 1 order of magnitude due to the thermodynamic compensation 
(LaRiviere et al., 2001). The thermodynamic compensation posits that the combined 
contribution of the tRNA and its cognate amino acid to EF-Tu binding add to the same level 
across all aminoacyl-tRNA species. This mechanism ensures appropriate level of different 
ainoacyl-tRNA-EF-Tu complexes available for protein synthesis and helps exclude 
misaminoacylated tRNAs, which are either bound too weakly or too strongly by the EF-Tu, 
from translation (Schrader et al., 2011; Schrader and Uhlenbeck, 2011). Once the correct 
anticodon is matched with the current codon in the A-site, EF-Tu in combination with the small 
ribosomal subunit triggers first hydrolysis of GTP and subsequently conformational switch of 
EF-Tu and its release (Stark et al., 1997). The free aminoacyl-tRNA can fully accommodate 
the A-site and formation of the peptide bond and simultaneous decaylation of the tRNA in the 
P-site can occur. After the bond formation, the ribosome translocates by a codon-sized step 
(approx. 10 Å) in a process catalysed by elongation factor G (EF-G), transferring the newly 
formed peptidyl-tRNA from A-site to P-site and the deacetylated tRNA from P-site to E-site 
(Achenbach and Nierhaus, 2015). This process completes one elongation step after which 
additional tRNAs are shuttled to the ribosome via the elongation factor until the ribosome 
encounters the first stop codon. 
The translation is terminated when one of the three stop codons (UAA, UGA or UAG) is 
positioned in the A-site. Unlike codons responsible for initiation and elongation, the stop 
codons are recognised by proteins called class I release factors (Capecchi, 1967; Vogel et al., 
1969). The two proteins responsible for termination in bacteria are release factor 1 and 2 (RF1 
and RF2). Interestingly, each of the two release factors responds to specific, yet overlapping 
set of stop codons: EF1 terminates at UAG and UAA while EF2 terminates at UGA and UAA 
(Ito et al., 1996; Nakamura et al., 1995). Upon binding of one of the release factors, the ester 
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bond joining the peptidyl moiety and terminal nucleotide of the tRNA in the A site is 
hydrolysed and the newly synthesized peptide is released (Korostelev, 2011). 
1.2.2  Eukaryotic translation 
Translation in eukaryotes is significantly more complex and involves a number of factors. The 
process starts with the preinitiation complex (PIC) binding to 5’ end of mRNA in a reaction 
promoted by initiation factors eIF1, eIF1A, eIF5 and eIF3. The PIC is composed of the small 
(40S) ribosomal subunit and the initiator methionyl-tRNA (Met-tRNAi) anchored together by 
GTP-bound form of eIF2. Binding of the PIC to the mRNA is facilitated by several additional 
eukaryotic initiation factors that recognise and bind the 5’-cap structure of the mRNA (eIF4E, 
eIF4G and eIF4A). After binding, the initiation complex scans the mRNA base-by-base until 
the first AUG is encountered and matched with the Met-tRNAi in the P decoding site of the 
ribosome (the sequence preceding the start codon is also involved and should conform to the 
Kozak consensus sequence (Kozak, 1987)). Matching of the AUG codon triggers hydrolysis of 
GTP in eIF2-GTP-Met-tRNAi complex, which releases eIF2-GDP and other eIFs and leads to 
recruitment of the large (60S) ribosomal subunit, forming the 80S initiation complex (Pestova 
et al., 2007). 
Similarly to prokaryotic elongation, aminoacyl-tRNAs are delivered to the 80S ribosome via 
the alpha subunit of the eukaryotic elongation factor 1 (eEF1α) in eEF1α-GTP-aminacyl-tRNA 
complex (Carvalho et al., 1984). Once correct match based on Watson-Crick base pairing 
between the mRNA codon in the A-site and the tRNA anticodon occurs, conformational change 
in the ribosome triggers GTP hydrolysis and dissociation of the eEF1α-GDP complex (Taylor 
et al., 2007). The sequences of eEF1α and EF-Tu are relatively homologous and (due to only 
limited structural data available (Andersen et al., 2000; Crepin et al., 2014)) most of the current 
knowledge relies on studies of EF-Tu. 
In eukaryotes, unlike in bacteria, a single release factor is responsible for recognition of all 
three stop codons (Brown et al., 2015; Frolova et al., 1994). The translation is terminated when 
the eukaryotic release factor 1 (eRF1) and the co-factor eukaryotic release factor 3 (eRF3) form 
eRF1-eRF3-GTP complex and bind to the stop codon in ribosomal A-site (Muhs et al., 2015; 
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Taylor et al., 2012).  Upon binding, GTP hydrolysis leads to dissociation of eRF3, bringing the 
GGQ motif of eRF1 close to the ester bond between the tRNA and the polypeptide leading to 
its hydrolysis triggering translation termination and subsequent dissociation of the ribosome 
through action of ABCE1 ATPase (Pisarev et al., 2010; Shoemaker and Green, 2011). 
1.3 Post-translational modifications 
The chemical space of proteins is expanded beyond the 20 canonical amino acids through a 
number of post-translational modifications (Walsh et al., 2005). Post-translational 
modifications are generally covalent, reversible, enzyme-mediated attachments of chemical 
groups to the side chains of the amino acids; however, they can also include proteolytic 
cleavage of functional parts of the protein, fluorescent protein maturation, or protein splicing. 
Currently, there are over 300 types of post-translational modifications known (Walsh, 2006). 
The major post-translational modifications include phosphorylation, glycosylation, 
ubiquitination, methylation, acetylation, alkylation, oxidation and less frequently 
succinylation, SUMOylation and citrullination (Figure 1.3). Collectively, over 260,000 of 
post-translationally modified sites have been experimentally discovered 
(www.phosphosite.org, (Doll and Burlingame, 2014)), with many playing critical role in both 
physiological (Deribe et al., 2010; Hsu et al., 2011; Humphrey et al., 2015) and pathological 
processes (Blume-Jensen and Hunter, 2001; Zhang et al., 2009). 
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Figure 1.3. Major types of post-translational modifications. The most common post-
translational modifications include pohosphorylation, acylation, alkylation, glycosylation and 
oxidation. Figure adapted from (Walsh et al., 2006). 
 
1.3.1 Lysine acetylation 
Acetylation was first discovered together with methylation through in vitro analysis of histones 
isolated from calf thymus (Allfrey et al., 1964) and has been postulated to regulate DNA 
transcription. The first enzyme responsible for installation of acetyl group from coenzyme A 
has been identified in 1996 in Tetrahymena (Brownell et al., 1996). Originally named histone 
acetyltransransferases, the enzymes were found to acylate wide variety of substrates and 
therefore subsequently renamed to lysine acetyltransferases (Allis et al., 2007; Drazic et al., 
2016).  
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1.3.2 Phosphorylation 
Perhaps the most studied post-translational modification is phosphorylation – the attachment 
of the phosphoryl group to the sidechain of one of the amino acids (Cohen, 2002). Currently, 
tens of thousands phosphosites have been experimentally reported in cultured cells (Humphrey 
et al., 2013; Lundby et al., 2012) and it is estimated that up to 1 million phosphosites 
concurrently exist in the mammalian proteome (Boersema et al., 2010; Lemeer and Heck, 
2009). The most commonly phosphorylated amino acids in eukaryotes are serine, threonine 
and tyrosine (Olsen et al., 2006), and less commonly histidine (Steeg et al., 2003), with the 
distribution of frequency corresponding to 88:11:1 for phosphorylated serine, threonine and 
tyrosine, respectively (Olsen et al., 2006; Villén et al., 2007). Despite the abundance of 
phosphosites reported, only fraction of them has an identified physiological function. Not 
surprisingly, functionally relevant phosphosites tend to be evolutionarily conserved, suggesting 
a way to map out useful directions of research (Levy et al., 2012).  
Phosphorylation can act as an activating modification, increasing or decreasing the protein’s 
biological activity through the addition of negative charge to the modified amino acid. This 
observation has led to the intriguing hypothesis that key aspartic and glutamic acids in enzymes 
may have been substituted with phosphorylated amino acids to allow for reversible control over 
their activity (Pearlman et al., 2011). Alternatively, protein phosphorylation can stabilise 
proteins (Chehab et al., 1999), mark them for degradation (Yada et al., 2004), disrupt or 
mediate protein-protein interactions (Pawson and Nash, 2003) or facilitate transport of proteins 
between cellular compartments (Jans and Hubner, 1996). 
1.4 Natural expansion of the genetic code: selenocysteine and 
pyrrolysine 
When first deciphered, the genetic code specified the decoding rules for the 20 canonical amino 
acids (Khorana et al., 1966). The chemical diversity of proteins and as discussed in the previous 
section amino acids can be further extended through post-translational modifications; however, 
in rare occasions living organisms use entirely new amino acids (Ambrogelly et al., 2007). 
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1.4.1 Selenocysteine 
Selenium was first discovered to be essential for activity of formate dehydrogenase in E. coli 
in 1954 (Pinsent, 1954) and the amino acid selenocysteine (Sec) was first identified in 1976 as 
the selenium moiety in glycine reductase in 1976 (Cone et al., 1976).  
Surprisingly, the codon corresponding to the position of selenocysteine was found to be the 
TGA stop codon in both E. coli formate dehydrogenase (Zinoni et al., 1986) and mouse 
glutathione peroxidase (Chambers et al., 1986), suggesting another exception to the frozen 
genetic code hypothesis by Crick et al. The subsequent discovery of a designated tRNA 
responsible for directing selenocysteine and recognizing the UGA stop codon in E. coli 
(Leinfelder et al., 1988) implied co-translational incorporation of the amino acid and led to the 
designation of selenocysteine as the 21st amino acid (Söil, 1988).  
In bacteria, the selenocysteinyl-tRNA (Sec-tRNASec) is synthesized through an intermediate 
step where the tRNASec is first aminoacylated with serine creating Ser-tRNASec, which is then 
converted to Sec-tRNASec through the action of L-seryl-tRNASec selenium transferase (SelA) 
(Forchhammer, 1991; Böck et al., 2005). In archea and eukaryotes, the Ser-tRNASec is first 
converted to phosphoseryl-tRNASec via the action of O-phosphoseryl-tRNASec kinase (PSTK) 
and the resulting phosphoseryl moiety is subsequently converted to selenocysteine by Sep-
tRNA:Sec-tRNA synthase (SepSecS) (Yuan et al., 2006). 
To discriminate between the UGA codons intended for incorporation of selenocysteine and 
UGA codons that signal translation termination, the cell uses a selenocysteine insertion 
sequence (SECIS) in the mRNA. First discovered in E. coli (Forchhammer, 1989) and 
subsequently in mammals (Berry et al., 1991) the SECIS stem-loop structure is positioned 
directly downstream (3’ side) from the UGA codon in bacteria and in the 3’ untranslated region 
in eukaryotes and archea. SECIS is bound by SELB protein in bacteria  (Baron et al., 1993) 
and SECIS-binding protein 2 (SBP2) in mammals (Copeland et al., 2000; Fletcher et al., 2001). 
These proteins are responsible for recruiting a specialised elongation factor SELB in bacteria 
(Forchhammer et al., 1989) and mSelB in eukaryotes (Fagegaltier et al., 2000; Tujebajeva et 
al., 2000) that delivers the charged Sec-tRNASec into the ribosome (Allmang and Krol, 2006). 
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Although most species do not use selenocysteine, it can be found throughout the three domains 
of life. It is virtually absent in higher plants and fungi with some minor exceptions (Hatfield et 
al., 1992; Obata and Shiraiwa, 2005). Similarly, relatively narrow range (up to quarter) of 
sequenced prokaryotes use selenocysteine (Kryukov and Gladyshev, 2004; Zhang et al., 2006). 
In humans, 25 genes code for total of 46 selenocysteine residues (Kryukov et al., 2003) mostly 
in active sites of peroxidases (Hondal et al., 2013) and reductases (Achilli et al., 2015). Of 
these, 24 are conserved in rodents (Kryukov et al., 2003). The function of selenoproteins has 
been summarised in review by Reeves and Hoffman (Reeves and Hoffmann, 2009).  
1.4.2 Pyrrolysine  
Pyrrolysine (Pyl) is the second naturally incorporated amino acid, outside the canonical set of 
20. Pyrrolysine is a lysine with a pyrroline-ring attached to the ε–amino group and was first 
discovered in the methanogen Methanosarcina barkeri based on structure of the MMA 
methyltransferase (MtmB) that has an in-frame UAG codon (Hao et al., 2002; Srinivasan et al., 
2002). In the Methanosarcina species, pyrrolysine is a critical residue in the enzymes called 
methylamine methyltrasnferases that catalyse formation of methane from methylamines 
(Krzycki, 2004). Outside of methylamine methyltransferases and transposases (Zhang et al., 
2005), pyrrolysine was also found to be incorporated in tRNAHis guanylyltransferase (Thg1), 
an enzyme that is responsible for tRNA processing, however, pyrrolysine does not participate 
in the activity of that particular enzyme and can be substituted by tryptophan (Heinemann et 
al., 2009). 
Initially it was suspected that, like in the case of selenocysteine, pyrrolysyl-tRNAPyl  (Pyl-
tRNAPyl) is formed enzymatically from Lysyl-tRNAPyl (Srinivasan et al., 2002), however, it 
was subsequently confirmed that pyrrolysine is charged directly onto the tRNAPyl through the 
action of pyrrolysyl-tRNA synthetase (PylRS) both in vitro and in vivo (Blight et al., 2004; 
Polycarpo et al., 2004) and that the amino acid is synthesized by enzymes encoded in the 
pylBCD genes (Gaston et al., 2011; Longstaff et al., 2007). 
Unlike selenocysteine, pyrrolysine has been discovered only in a very narrow range of species 
from the archea domain, mainly in the Methanosarcinaceae family, and several species in the 
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bacterial domain (Prat et al., 2012). More recently, a new order of methanogens has been 
identified (Borrel et al., 2013), including three species with pyrrolysine systems: 
Methanomethylophilus alvus (M. alvus), Methanomassiliicoccus intestinalis (M. intestinalis) 
and Methanomassiliicoccus luminyensis (M. luminyensis) (Borrel et al., 2014) (Willis and 
Chin, 2018). 
Currently, the rules for UAG decoding in the species with the pyrrolysine system are unclear 
(Zhang et al., 2005). Initial reports suggested that a pyrrolysine insertion sequence (PYLIS) 
element is present 5-6 nucleotides downstream of the UAG codon, acting in a fashion similar 
to SECIS (Namy et al., 2004) (Ibba and Söll, 2000), however, a subsequent analysis did not 
confirm this hypothesis (Zhang et al., 2005). Interestingly, some genomes in Pyl-utilising 
archea show dramatically lower-than-expected usage of the UAG codon  (< 5% of genes 
putatively terminate with UAG). In addition, readthrough of these stop codons would result in 
only low number of gene overlaps. Thereby lack of UAG candidates for the stop signal could 
lead to the hypothesis that UAG codons in Pyl containing species do not result in translation 
termination. Contrary to this hypothesis, the UAG codon is relatively frequent in the bacterium 
D. hafniense., suggesting that ambiguous decoding of the UAG codon must be present (Zhang 
et al., 2005). The experimental evidence indicates that no special mRNA element is required, 
as transformation of the pylS and pylT genes into E. coli grown in presence of pyrrolysine 
analog leads to readthrough of an in-frame UAG codon inside a reporter protein coding 
sequence (Polycarpo et al., 2006). Lastly, there is no known elongation factor associated with 
the pyrrolysine system and Lys-tRNAPyl binds EF-Tu effectively in vitro (Namy et al., 2004), 
suggesting that no other accessory protein is required for Pyl incorporation at a given UAG 
codon. 
1.5 Artificial genetic code expansion 
Expanding the set of amino acids used by living organism allows researchers to endow the 
organisms with new functionalities through designed chemical and physical properties of the 
introduced building blocks. These approaches have found many uses in probing, imaging and 
control of protein function in their native environment or production of modified proteins for 
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in vitro applications (Chin, 2017). Simultaneously, expanding the genetic code can allow 
researchers to harness the synthetic power of the cell’s translation machinery to produce 
entirely new, genetically determined unnatural polymers. These two overlapping goals – 
encoding new amino acids into proteins in cells and animals and using the cells machinery to 
synthesize unnatural polymers – fundamentally rely on re-engineering of the translation 
machinery as well as their genetic code (Chin, 2017). 
1.5.1 In vitro expansion of the genetic code 
Traditionally, peptides including non-canonical or site-specifically modified amino acids are 
prepared using solid phase peptide synthesis (SPPS) (Merrifield, 1963), a revolutionary method 
that has been widely adopted for synthesis of small amounts (< 1 g) of short peptides (< 50 
residues). The field was further advanced by invention of native chemical ligation (NCL) 
(Dawson et al., 1994), which allowed for total synthesis and study of longer proteins (reviewed 
in Bondalapati et al., 2016), of up to 203 (Torbeev and Kent, 2007) and 304 amino acids 
(Kumar et al., 2011). However, the yield of these methods as well as the length of possible 
products is limited and the amide bond synthesis has significant drawbacks including its 
expense and environmental impact (Pattabiraman and Bode, 2011). 
An alternative relies on site-specific chemical modifications of unique amino acids within the 
canonical set. Unfortunately, reactions that proceed under native conditions (aqueous solution 
at moderate temperature and neutral pH) are quite limited (Durek and Becker, 2005). The most 
widely used approach relies on the unique characteristics of the sulfhydryl group in cysteine 
residues, which can be derivatized by maledimides or methanethisulfonates, however, these 
techniques are inherently limited by the complex nature of proteins, where multiple amino 
acids within the chain exist. 
Yet another alternative to chemical protein synthesis or semi-synthesis is in vitro translation. 
In 1962 Benzer’s group first showed that cysteinyl-tRNACys could be converted to alanyl-
tRNACys using Ranley nickel and subsequently used in translation to incorporate alanine at a 
cysteine codon (Chapeville et al., 1962). A general method to aminoacylate any tRNA in vitro 
using T4 RNA ligase was subsequently developed (Hecht et al., 1978; Heckler et al., 1984) and 
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the chemically mis-aminoacylated tRNAs were shown to be translationally competent in an in 
vitro translation system (Baldini et al., 1988). This technique allowed researchers to obtain a 
tRNA aminoacylated with non-canonical amino acid and led to the first in vitro expansion of 
the genetic code. The second step to be solved was the absence of a codon to encode the non-
canonical amino acid. Inspired by nature, which uses one of the stop codons for encoding 
selenocysteine and pyrrolysine (Ambrogelly et al., 2007), Noren et al. were in a landmark 
experiment able to site-specifically incorporate a non-canonical amino acid by first mutating 
the anticodon of tRNAPhe to decode a stop codon UAG and then chemically aminoacylating 
the tRNAPheCUA with a range of non-canonical amino acids. The aminoacylated tRNA
Phe
CUA 
was used to in vitro translate a mRNA of the β-lactamase with an in-frame UAG codon (Noren 
et al., 1989). A similar experiment was performed subsequently, incorporating iodotyrosine via 
in vitro aminoacylated tRNAGlyCUA in response to the UAG stop codon in a peptide of 16 amino 
acids (Bain et al., 1989). Furhter experiments demonstrating incorporations of a variety of non-
canonical amino acids followed (reviewed in (Cornish et al., 1995)). Unfortunately, this 
approach suffers from significant drawback – the chemically aminoacylated tRNA is a limiting 
reagent and its preparation is not trivial, rendering the preparation of sufficient amount of site-
specifically modified proteins difficult. 
Despite the difficulty of preparation of significant amounts of aminoacylated in vitro tRNAs, 
this approach can be very useful for single-cell studies, where only limited amount of material 
is needed. This was first achieved by co-microinjection of amber suppression tRNACUA 
aminoacylated with tyrosine derivatives and mRNA molecule coding for alpha subunit of the 
muscle type Ach receptor (AChR) into the Xenopus oocyte (Nowak et al., 1995). The mRNA 
was translated by the endogenous cell machinery and full-length alpha subunit was produced 
AChR with site-specific insertion of the given non-canonical amino acid. A similar approach 
using transfection of aminoacylated tRNAs into mammalian cells was also demonstrated 
(Köhrer et al., 2001). 
Using microinjection or transfection of in vitro aminoacylated tRNAs, the resulting number of 
full-length proteins is approx. 1000-fold lower than the amount of injected aminoacylated 
tRNA, limiting the applicability of this method to study of proteins with detectable phenotype 
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with only a low number of molecules inside cell, such as channels, receptors and transporters 
(Dougherty and Van Arnam, 2014).  
Notably, the in vitro aminoacylation approach does not require a synthetase capable of 
aminoacylating its cognate tRNA with a given amino acid and thereby providing more 
flexibility than the classical in vivo approaches described in the next section. 
1.5.2 In vivo expansion of the genetic code 
1.5.2.1 “Surrogate amino acids” 
Initial attempts at encoding non-canonical amino acids in vivo made use of the endogenous 
aminoacyl-tRNA synthetase/tRNA (aaRS/tRNA) pairs and non-canonical amino acids 
analogous to the endogenous ones, also called “surrogate amino acids”. In one of the early 
experiments Cowie and Cohen were able to completely replace methionine with 
selenomethionine (SeMet) by supplementing it to a methionine auxotrophic strain of E. coli., 
which produced active β-galactosidase incorporating SeMet instead of methionine (Cowie and 
Cohen, 1957). Many similar studies have followed, using vaious microorganisms, including 
Staphylococcus Bacillus or Salmonella, and eukaryotic cells, including Saccharomyces, 
Tetrahymena or immortalised cell lines such as HeLa (reviewed in (Richmond, 1962)), 
incorporating variety of surrogate or modified amino acids (reviewed in Wilson and Hatfield, 
1984). The proteome wide incorporation of SeMet by the endogenous Methinoyl-tRNA 
synthetase has proven to be useful many years later for solving the phase problem in X-ray 
crystallography via multiwavelength anomalous diffraction (MAD) developed by Hendrickson 
(Hendrickson, 1991).  
Due to the fact that most amino acids outside the 20 canonical are toxic to cells, an alternative 
protocol called selective pressure incorporation (SPI) (also designated the auxotroph method 
or media-shift method) was developed (Budisa et al., 1999).  In this protocol, the target gene 
expression is kept silent during the growth phase of the cells and induced only after sufficient 
number of cells is present. The natural amino acid is then depleted from the media and the non-
canonical substitute is added. The cells serve as a factory for the protein production without 
further growth (Budisa et al., 1999). This method allows for production of labelled proteins on 
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a relatively large scale for structural studies (e.g. (Bae et al., 2001; Sykes et al., 1974)) or 
production of therapeutics (Budisa et al., 2001). 
In a first example of an engineered aaRS, Kas and Hennecke identified a point mutant of E. 
coli PheRS, which showed relaxed substrate specificity. This mutant was discovered when 
searching for Phe binding site and showed the ability to aminoacylate the tRNAPhe with p-
chlorophenylalanine (Kast and Hennecke, 1991). Later work demonstrated that the Ala294Gly 
mutant reported by Kas and Hennecke also accepts p-chlorophenylalanine and p-
bromophenylalanine as a substrate (Ibba et al., 1994)and that additional Thr251Gly mutation 
further allowed for incorporation of variety of additional amino acids, including O-
acetyltyrosine, p-iodophenylalanine, p-cyanophenylalanine or p-azidophenylalanine (Datta et 
al., 2002; Kirshenbaum et al., 2002). 
1.5.2.2 Amber suppression 
The strategies using close structural homologs of endogenous amino acids in combination with 
auxotrophic strains suffer from significant limitations. Firstly, the proteins expressed contain 
stochastically both endogenous and non-canonical amino acids; secondly, the non-canonical 
amino acid is incorporated in all positions of all proteins. As a consequence, the health of the 
organism is compromised. In order to truly expand the genetic code and have site-specific 
incorporation of non-canonical amino acids, two conditions must be met: 
1. tRNA must deliver the non-canonical amino acid in response to a unique codon and; 
2. the tRNA must not be used by any of the endogenous aaRSs present in the cell. 
 
To solve the first issue, researchers have taken inspiration from organisms with naturally 
expanded genetic code (Chapter 1.7). These organisms achieve incorporation of selenocysteine 
by suppression of one of the stop codons, specifically the UAG amber stop codon. The amber 
stop codon is the least frequent stop codon both in E. coli (314 UAG codons (Alff-Steinberger 
and Epstein, 1994; Blattner et al., 1997) and can be supressed by tRNAs with modified 
anticodon loops (Michaels et al., 1990), suggesting that amber suppression is compatible with 
the cell survival. The alternative to stop codons is the use of quandruplet codons, which are 
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used in some organisms (Riddle and Carbon, 1973; Yourno and Kohno, 1972) (the use of 
quadruplet codons is further discussed in section 1.6.2). 
The stop codon suppression approach is combined with import of a new, orthogonal aminoacyl-
tRNA synthetase/tRNA (aaRS/tRNA) pairs (Liu and Schultz, 2010) (Figure 1.4). In this 
approach, the exogenous tRNA is aminoacylated by its cognate, often engineered aaRS in vivo 
with the non-canonical amino acid either supplemented externally or made bioavailable 
through genetic engineering of the target organism (Liu and Schultz, 2010; Zhang et al., 2017) 
(Figure 1.4). 
 
 
Figure 1.4. Amber supression. (a) Amber suppression relies on import of orthogonal tRNA 
synthetase/tRNA pair with CUA anticodon. (b) Typical evolution of a new, orthogonal 
aminoacyl-tRNA/tRNA pair which is orthogonal to the endogenous pairs. Figure adapted from 
(Chin, 2014). 
 
The imported aaRS as well as the imported tRNA must be orthogonal to the endogenous tRNAs 
and aaRSs. The biological orthogonality is satisfied when the imported aaRS doesn’t 
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aminoacylate any of the endogenous tRNAs and, at the same time, does not accept any of the 
endogenous amino acids as a substrate. Siumltaneously, the imported tRNA must not be 
aminoacylated by any of the endogenous aaRSs. The first step towards creation of an 
orthogonal aaRS/tRNA pair was taken by Liu and colleagues, who have engineered the 
GlnRS/tRNAGln pair from E. coli based on the crystal structure of the aaRS:tRNA:ATP 
complex (Rould et al., 1989). In the first step, the tRNAGln anticodon was changed from CUG 
to CUA and 3 sites on the tRNAGln, selected based on their contact with the GlnRS were 
mutated to abolish recognition, creating a new mutant designated O-tRNA. The GlnRS was 
then evolved using random point mutagenesis to aminoacylate the O-tRNA, however; only to 
a level well below the aminoacylation by endogenous GlnRS (Liu et al., 1997a; Liu et al., 
1997b). Based on the observation that E. coli GlnRS does not charge yeast tRNAGln, due to 
additional domain present in the yeast homologue (Whelihan and Schimmel, 1997), Liu and 
Schultz developed a first orthogonal pair in E. coli. They were able to verify that 1. suppressor 
tRNA2
Gln
CUA(A38) is not aminoacylated by any endogenous E. coli aaRSs in vivo using amber 
mutant of β-galactosidase and 2. yeast GlnRS aminoacylates the yeast tRNAGlnCUA but not any 
of the endogenous E. coli tRNAs. However, the effort to evolve the yeast GlnRS to 
aminoacylate any non-canonical amino acids were not successful (Liu and Schultz, 1999). 
1.5.3 M. janaschii tyrosyl-tRNA synthetase/tRNA 
An alternative system based on tyrrosyl-tRNA synthetase (TyrRS) was developed by several 
groups. The TyrRS benefits from a lack of proofreading activity, which allows for an easier 
change in substrate specificity (Fersht et al., 1980; Jakubowski and Goldman, 1992). A first 
engineered TyrRS was reported by Hamano-Takaku and colleagues who used a random 
mutation library screen to isolate a Phe130Ser mutant which accepted 2-azatyrosine as a 
substrate (Hamano-Takaku et al., 2000). The first orthogonal aaRS/tRNA pair used in E. coli 
was based on Methanococcus janaschii TyrRS/tRNA, which does not aminoacylate 
endogenous E. coli tRNA to a high degree (Steer and Schimmel, 1999) but does aminoacylate 
its own amber suppressor tRNAGlyCUA (Wang et al., 2000) likely due to absence of the C-
terminal domain. In the first step, Wang et al. identified tRNA with decreased rate of 
aminoacylation by endogenous E. coli aaRSs based on a library screen with β-lactamase 
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selection. Subsequent rounds of selections from random mutagenesis library of the residues in 
the binding pocket of the M. janaschii TyrRS were then applied (Brick et al., 1989). The assay 
was based on survival conferred by chloramphenicol acetyltransferase (CAT) gene with an 
amber codon in a non-essential position Asp112 (Stemmer, 1994) in the presence of 1 mM O-
methyl-L-tyrosine. Isolating the clones that grew in the presence but not in the absence of O-
methyl-L-tyrosine led to identification of a mutant that supported expression of 2 mg/ml of O-
methyl-L-tyrosine mutant of dihydrfolate reductase (DHFR) with over 95% purity, as 
confirmed by mass spectrometry (Wang et al., 2000). While this represents drop of more than 
95% from wild-type DHFR expression (approx. 67 mg per litre of culture in rich media), this 
systems represents the first viable genetic code expansion in E. coli.  
The M. janaschii system was further evolved for incorporation of photocrosslinking amino acid 
p-benzol-L-phenylalanine, using rounds of positive and negative selection (Chin et al., 2002a). 
Positive selection based on CAT assay identified the synthetase mutants that aminoacylated 
the tRNATyrCUA based on survival in presence of the non-canonical amino acid. The positive 
selection was followed by a negative selection step, where mutants of TyrRS that 
aminoacylated the tRNATyrCUA in the absence of the non-canonical amino acid (i.e. with one of 
the canonical amino acids) led to cell death via readthrough of the amber mutant of the barnase 
gene (Chin et al., 2002a). The positive/negative selection scheme used by Chin and colleagues 
has been subsequently used to evolve the M. janaschii TyrRS/tRNATyrCUA pair for 
incorporation of a great variety of useful non-canonical amino acids, reviewed by Dumas and 
colleagues (Dumas et al., 2015). Unfortunately, the M. janachii TyrRS/tRNATyrCUA system is 
not orthogonal with respect to the eukaryotic aaRSs and therefore is limited in its scope to 
genetic expansion in proakryotes (Fechter et al., 2001; Wang et al., 2000).  
1.5.4 Methanosarcinae pyrrolysyl-tRNA synthetase/tRNA 
While a range of aaRS/tRNA pairs have been tested for in vivo genetic ode expansion, the most 
versatile system has proven to be the Methanosarcinae pyrrolysyl-synthetase/tRNA pair. This 
pair occurs as an amber suppressor in a variety of methanogens and some bacteria (discussed 
in chapter 1.7.2) and is orthogonal in both prokaryotes and eukaryotes. Initial studies focused 
on analogue of pyrrolysine, which itself is difficult to synthesise (Polycarpo et al., 2006), and 
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showed that the PylRS/tRNACUA from Methanosarcina barkeri pair is able to incorporate a 
wide variety of non-canonical amino acids (Li et al., 2009a; Li et al., 2009b; Polycarpo et al., 
2006). Over the following years, many additional amino acids were incorporated using the 
wild-type aaRS/tRNA pair. The non-canonical amino acids encoded included lysine with Boc, 
azide and alkyne groups, where the latter two allow for site specific conjugation via copper 
catalysed [3+2] cycloaddition reactions (Nguyen et al., 2009a). Fekner and colleagues encoded 
a pyrrolysine analogue with terminal alkyne functionality that allowed similar site-specific 
labelling (Fekner et al., 2009), followed by two additional analogues reported later (Lee et al., 
2013; Li et al., 2010). 
The engineering efforts have been guided by structural characterisation of the PylRS/tRNA 
complex, which was provided by Kavran et al. in 2007. The authors used a pyrrolysine 
analogue N-ε-[(cylopentyloxy)carbonyl-L-lysine (cyc) to solve the structure of PylRS-AMP-
cyc complex from M. mazei (Kavran et al., 2007). Taking advantage of the structural 
information and negative/positive selection protocol, the PylRS/tRNA pair has been evolved 
for incorporation of many different non-canonical amino acids. The first encoded amino acid 
using an engineered PylRS/tRNA was reported by Neumann and colleagues, who engineered 
PylRS mutant for incorporation of lysine bearing post-translational modification – the acetyl 
group (Neumann et al., 2008b). In their screen, Neumann et al. found a mutant of the M. Barkeri 
PylRS/tRNA with 6 mutations in the Pyl binding pocket that allowed for incorporation of N-ε-
acetyllysine and, as shown subsequently, also its alkyl analogue 2-amin-8-oxononanoic acid 
(Huang et al., 2010). The incorporation of acetyllysine has been used extensively to study its 
biological role in histones and other proteins in vitro (Arbely et al., 2011; Lammers et al., 2010; 
Neumann et al., 2009) and in vivo (Di Cerbo et al., 2014; Tropberger et al., 2013). 
The Methanosarcina PylRS/tRNA pair has been engineered for incorporation of wide variety 
of over 100 non-canonical amino acids (reviewed in (Dumas et al., 2015)). A particularly useful 
amino acids incorporated using the PylRS/tRNA pair were lysine derivatives with norbornene 
(Lang et al., 2012a), transcyclooctene and bicyclononyne (Lang et al., 2012b), which allow for 
copper-free, site-specific labelling in live cells. The system was also engineered for 
incorporation of an amino acid bearing the 2,2,5,5-tetramethyl-pyrrolin-1-oxyl spin label for 
paramagnetic distance measurements (Schmidt et al., 2014) and Virdee and colleagues 
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demonstrated incorporation of δ-thiol-L-lysine, which allowed to produce proteins with site-
specific ubiquitination (Virdee et al., 2011). 
In addition to amino acids for site-specific labelling and protein conjugation, a number of 
photocaged amino acids were incorporated using the PylRS/tRNA pair. The first photocaged 
amino acid reported was o-nitrobenzyloxycarbonyl-N-ε-L-lysine (Chen et al., 2009), followed 
by photocaged lysine used for protein location control (Gautier et al., 2010), light-activated 
transcription (Hemphill et al., 2013) and temporal dissection of MEK1 signalling (Gautier et 
al., 2011) in mammalian cells, and photocaged cysteine, used for photoactivation of TEV 
protease in mammalian cells (Nguyen et al., 2014). 
Somewhat surprisingly, the PylRS/tRNA pair has been also successfully evolved for 
incorporation of phenylalanine analogues. The first demonstration was provided by Wang and 
colleagues, who successfully evolved the PylRS binding pocket to accommodate L-
phenylalanune p-iodo-L-phenylalanine and p-bromo-L-phenylalanine (Wang et al., 2010). The 
pair was subsequently developed for incorporation of O-nitrobenzyl-O-tyrosine, a photocaged 
tyrosine derivative (Arbely et al., 2012), multiple O-substituted, meta-substituted and ortho-
substituted tyrosine derivatives (Tharp et al., 2014; Wang et al., 2012a; Wang et al., 2012b), in 
addition to meta-alkoxy- and meta-acyl-phenylalanines (Tuley et al., 2014). The already broad 
range of non-canonical amino acids incorporated by the PylRS/tRNA pair was further extended 
to histidine derivatives by Xiao et al. (Xiao et al., 2014). 
Two additional noteworthy M. mazei PylRS mutants were identified by Yanagisawa and 
colleagues through random mutagenesis library screening: Y384F and Y306A,Y384F 
(Yanagisawa et al., 2008). The Y384F mutant shows improved incorporation efficiency with 
BocK and AllocLys in E. coli (Yanagisawa et al., 2008) while the additional Y306A mutation 
allows for incorporation of a variety of non-canonical amino acids, including N-ε-
benzyloxycarbonyl-L-lysine, N-ε-(O-azidobenzyloxycarbonyl-L-lysine (Yanagisawa et al., 
2008), Se-alkylselenocysteines (Wang et al., 2012), N-e-[2-(furan-2-yl)ethoxy]carbonyl-lysine 
for light controlled protein-RNA crosslinking (Schmidt and Summerer, 2013), but also for bio-
orthogonal handles for protein labelling, such as norbornene (Plass et al., 2011), transcyclooctenes 
(Plass et al., 2012) and cyclooctene derivatives (Borrmann et al., 2012).  
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Recently, a new aaRS/tRNA pair for genetic code expansion has been discovered in the species 
Methanomethylophilus alvus (Willis and Chin, 2018). Due to the increasing number of 
sequenced genomes, Willis and Chin have been able to identify number of PylRS/tRNA pair 
candidates based on a search of homology to the C-terminal catalytic domain of M. mazei 
PylRS and the absence of N-terminal domain of Desulfobacterium hafniense, which encodes 
PylRS as two distinct coding sequences that assemble to create functional synthetase in cell 
(Herring et al., 2007). This search yielded five candidate organisms for which both the PylRS 
gene and the corresponding tRNAPyl gene were found. Of the five pairs, four were found to be 
orthogonal in E. coli and one was subsequently evolved to be orthogonal also with respect to 
the M. mazei PylRS/tRNA pair (Willis and Chin, 2018). This pair is discussed in detail in 
Chapter 4. 
1.5.5 Post-translational modifications and phosphoseryl-tRNA 
Synthetase/tRNA pair 
One of the major efforts within genetic code expansion is the efficient genetic encoding of 
amino acids bearing post-translational modifications (Chin, 2017). Access to site-specifically 
post-translationally modified proteins provides researchers a unique tool to understand the role 
of post-translational modifications, many of which play a prominent role in cell physiology 
and pathology (reviewed in section 1.3). Generally, post-translational modifications are 
installed enzymatically and are tightly regulated within cells. While it may be possible to post-
translationally modify proteins in vitro by a known enzyme, the effects are often not site-
specific and are difficult to generalise to all proteins. An alternative to phosphorylation is the 
so-called phosphomimetic mutations of the given residue to aspartate or glutamate; however, 
these amino acids are distinct and often fail to recapitulate the given phenotype (Roberts-
Galbraith et al., 2010). 
The first amino acid bearing a post-translational modification genetically encoded via the M. 
barkeri PylRS-tRNA was N-ε-acetyl-lysine (Neumann et al., 2008b). Subsequently, many 
post-translational modifications have been encoded via the PylRS/tRNA pair, including lysine 
methylation (Groff et al., 2010; Nguyen et al., 2010; Nguyen et al., 2009a; Wang et al., 2010) 
and lysine ubiquitination (Li et al., 2009b; Virdee et al., 2011; Virdee et al., 2010), as well as 
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M. janaschii TyrRS/tRNA pair, which has been successfully used for incorporation of 
Phosphotyrosine and it’s analogues (Fan et al., 2016; Hoppmann et al., 2017; Luo et al., 2017; 
Xie et al., 2007). 
Recently, the phosphoseryl-tRNA synthetase from Methanococcus mariplaudis in combination 
with tRNACys Methanocaldococcus janaschii from was adapted for the direct genetic encoding 
of phosphoserine (Park et al., 2011). In certain methanogens the tRNACys is first aminoacylated 
by phosphoserine, which is subsequently converted to cysteine via action of the SepCysS 
enzyme (Sauerwald et al., 2005). Park et al. first converted the MjtRNACys to an amber 
suppressor pair, via mutation of the anticodon and an additional mutation to improve 
aminoacylation (Hohn et al., 2006). In addition, the authors have evolved the bacterial 
elongation factor EF-Tu to improve the shuttling of the charged Sep-tRNACys to the ribosome. 
Combination of the two factors allowed for production of low levels of proteins with site-
specific phosphoserine (Park et al., 2011). 
Because SepRS recognises recognises the tRNACys anticodon (Fukunaga and Yokoyama, 
2007), this interaction is compromised by converting the anticodon into amber suppressor, 
resulting in inefficient system for incorporation of phosphoserine. Rogerson and colleagues 
managed to significantly improve the system through multiple rounds of directed evolution, 
optimising first the tRNA antiocodon stem loop and subsequently the SepRS/tRNA interface, 
identifying a pair that enabled yields of several milligrams of protein per litre of culture 
(Rogerson et al., 2015). 
In 2016, Yang and colleagues have used the SepRS/tRNA pair to incorporate phosphoserine 
into cells and subsequently removed the phosphate, converting the residue to dehydroalanine. 
Using the zinc and copper mediated addition of alkyl iodides, the authors were able to install 
several post-trasnlational modifications including various methyllysines, formyllysine and 
acetyllysine. However, this approach suffers from limited selectivity (80%) and yield (50%) 
(Yang et al., 2016). 
Zhang and colleagues have evolved the SepRS system for incorporation of phosphothreonine 
(Zhang et al., 2017). In their work, Zhang and colleagues first genetically engineered E. coli to 
produce high level of intracellular phosphothreonine by importing the pduX gene from 
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Salmonella eneterica, which codes for a kinase that converts L-threonine into 
phosphothreonine (Fan and Bobik, 2008; Fan et al., 2009). Subsequently, the tRNAv1.0CUA 
(tRNACysCUA reported by (Rogerson et al., 2015)) was evolved to improve orthogonality with 
respect to endogenous synthetases, identifying a mutant designated tRNAv2.0CUA with 4,000-
fold lower level of amber readthrough in the absence of SepRS (Zhang et al., 2017).  The 
tRNAv2.0CUA was used in a new directed evolution protocol to change the substrate specificity 
for the SepRS reported by Rogerson et al. The protocol uses parallel positive selection in 
presence and absence of non-canonical amino acid (i.e. phosphothreonine) and statistical 
comparison of surviving clones, analysed using deep sequencing (Zhang et al., 2017). The 
process led into identification of 16 clones that are selectively enriched in presence of 
phosphothreonine, one of which led to quantitative incorporation of phosphothreonine, 
designated pThrRS/tRNAv2.0CUA. This pair allowed Zhang et al. to express recombinant proteins 
for both structural and biochemical studies (Zhang et al., 2017). 
1.6 Limitations of in vivo genetic code expansion 
While great effort is directed toward making the engineered aaRS/tRNA pairs orthogonal with 
respect to the host endogenous aaRS/tRNAs, biological orthogonality cannot be absolute. The 
overall endogenous translation error rate is estimated to be approximately10-4 (Loftfield and 
Vanderjagt, 1972, Kramer and Farabaugh, 2007) and misaminoacylation of endogenous tRNAs 
by the endogenous synthetases is known to contribute to this error rate (Söll, 1990)(Söll, 1990). 
Similarly, the UAG codon is misread by endogenous tRNAs at a measureable level (Roy et al., 
2015). The reported error rates of new orthogonal pairs are less than 10-3 for optimised and 
widely used aaRS/tRNA pairs (measured either in vitro or by determining misincoporation at 
sense codons in vivo) (Liu and Schultz, 2010; Neumann et al., 2008b; Zhang et al., 2017). 
While amber codon suppression solves the problem with no available sense codons for 
incorporation of non-canonical amino acids, this solution leads to some loss of fitness caused 
by readthrough of the endogenous stop codons (Aerni et al., 2015). The Church group has 
attempted to address this issue in E. coli by removal of all of the 314 amber stop codons from 
its genome. The approach combined multiplex automated genome engineering (MAGE), which 
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relies on introduction of oligo-mediated allelic replacement through λ-red mediated 
recombination (Wang et al., 2009) with conjugation based gene transfer. First, 32 E. coli strains 
were engineered via MAGE removing the TAG codons from different sections of the genomes. 
These strains were subsequently combined together using an conjugation based hierarchical 
assembly to produce first 8 strains, each with 1/8 of their genome recoded (Isaacs et al., 2011) 
and subsequently into a single strain (Lajoie et al., 2013). The strain allowed for deletion of the 
RF1, however, additional 355 mutations were acquired in the assembly process. Ostrov and 
colleagues used this strategy to test a 57-codon recoding scheme, removing the amber stop 
codon and additional synonymous sense codons, in 55 individual segments (Ostrov et al., 
2016). An alternative strategy was developed by Wang and colleagues, who used Cas9 in 
combination with negative and positive selection markers to recode large sections of the 
genome (~ 100 kb) at a time (Wang et al., 2016). In their report, Wang and colleague 
demonstrate a feasible recoding schemes, removing subsets of sense codons from a subsection 
of the E. coli genome (Wang et al., 2016). 
1.6.1 Prokaryotic release factor engineering 
The use of amber codon as a codon for incorporation of non-canonical amino acid has intrinsic 
limitations. As discussed in previous chapter, readthrough of endogenous amber codons may 
lead to decreased cellular fitness. However, the incorporation of non-canonical amino acid via 
amber suppressor tRNACUA also leads to a competition in between the tRNACUA and RF1, 
which is recruited to the stalled ribosome whenever the target UAG codon is encountered 
(discussed in section 1.2.1), resulting in a truncated protein released from the ribosome. This 
limitation has led to efforts to either increase the intracellular tRNACUA concentration or 
engineering of the bacterial RF1. 
Due to the overlapping specificity of the bacterial release factors (RF1 terminates translation 
at UAA and UAG codons, while RF2 terminates translation at UAA and UGA), only RF1 
needs to be engineered. While an essential gene (Rydén and Isaksson, 1984), several groups 
managed to delete the prfA gene while compensating for the activity of RF1. Mukai and 
colleagues have cloned 7 essential genes (coaD, had, hemA, mreC, murF, lolA and lpxK) that 
end with TAG codon onto an artificial bacterial chromosome (BAC) and substituted the stop 
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codons for UAA and introduced an amber suppressor tRNAGlnCUA, which in combination with 
the BAC sufficed to complement for the deletion of the prfA gene (Mukai et al., 2010a). An 
alternative strategy was devised by Johnson and colleagues who have introduced two mutations 
into the prfB gene which codes for RF2. The resulting release factor was sufficient for 
termination at all stop codons, permitting the deletion of prfA gene (Johnson et al., 2011). 
1.6.2 Quadruplet codon 
An alternative to amber codon suppression is the use of quadruplet codons. Quadruplet codons 
have been first examined in the context of genetic code expansion used by Hohsaka and 
colleagues, who used tRNAs with extended anticodon loops (for incorporation of 
nitrophenylalanine through in vitro translation, proving that ribosomal decoding of quadruplet 
codon is possible (Hohsaka et al., 1996).  
The first in vivo experiments demonstrating quadruplet codon decoding were done by Moore 
et al., who have shown that tRNALeu from E. coli could be engineered to recognise UAGA by 
inserting an extra nucleotide U at position 33.5 of its anticodon loop (Moore et al., 2000). This 
effort was followed by Magliery and colleagues, who have engineered several additional 
variants of tRNA with quadruplet anticodon using the E. coli tRNASer as a base for a library 
screen (Magliery et al., 2001). 
1.6.3 Ribosome engineering 
The development of orthogonal ribosome has enabled additional significant advances in 
genetic code expansion. The difficulty of engineering an essential translational machinery is 
evident – any modification that interferes with the endogenous function very likely has a 
negative phenotype. Rackham and Chin elegantly circumvented this problem by developing a 
network of orthogonal ribosome and mRNA pairs based on altered Shine-Dalgarno sequence. 
This allowed a specific subset of orthogonal mRNA and orthogonal small ribosomal subunit to 
create a functional pair inside the cell without interaction with any of the endogenous mRNAs 
and ribosomes (Rackham and Chin, 2005). The orthogonal ribosome was subsequently evolved 
by Wang and colleagues for increased amber codon suppression through decrease in the 
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interaction between the orthogonal small ribosomal subunit and the RF1 (Wang et al., 2007a). 
Using the orthogonal ribosome first reported by Wang et al., Neumann and colleagues evolved 
the small ribosomal subunit for efficient decoding of quadruplet codons (Neumann et al., 2010) 
1.7 Expansion of the genetic code in eukaryotic cells 
Parallel to the efforts in genetic code expansion in E. coli, researchers have focused on 
expanding the genetic code of eukaryotic organisms (Chin, 2014). Similarly to expanding the 
prokaryotic code, the ability to incorporate non-canonical amino acids would allow scientists 
to probe, control and image protein function in vivo in addition to providing a route for new 
therapeutic approaches (Chin, 2017). 
Saccharomyces cerevisiae was the first organism with successfully expanded genetic code 
(Chin et al., 2003). Chin and colleagues used the E. coli tyrosyl-tRNA synthetase/tRNACUA 
pair, with the anticodon mutated to recognise the amber codon. The E. coli tyrosyl-tRNA 
synthetase is known to be orthogonal in yeast, i.e. the TyrRS aminoacylates the E. coli 
tRNATyrCUA but not any of the endogenous yeast tRNAs (Edwards et al., 1990; Edwards et al., 
1991) and similarly, the E. coli tRNATyrCUA is not aminoacylated by endogenous yeast 
synthetases (Trezeguet et al., 1991). In addition, the TyrRS does not have an editing domain 
(Fersht et al., 1980; Jakubowski and Goldman, 1992), making it an attractive candidate for 
altering the substrate specificity. The authors used the positive and negative selection cycle in 
presence and absence of the non-canonical amino acid, respectively, to select active mutants 
from library of TyrRS with 5 randomised residues. Positive selection was based on amber 
mutants of transcriptional activator GAL4 (that activated transcription of HIS3, URA3 and lacZ 
genes) and carried out in absence of uracil or in presence 3-aminotriazole and lacking histidine. 
The negative selection was subsequently carried out in presence of 5-fluorootic acid (Chin et 
al., 2003). The authors were able to encode five different non-canonical amino acids in yeast, 
including p-acetyl-L-phenylalanine, p-benzoyl-L-phenylalanine, p-azido-L-phenylalanine, O-
methyl-L-tyrosine and p-iodo-L-phenylalanine (Chin et al., 2003). This system has been 
subsequently used in photocrosslinking studies of the RNA polymerase II (Chen et al., 2007). 
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The first addition of non-canonical amino acid in mammalian cells was reported by Sakamoto 
et al., who have discovered that Bacillus stearothermophilus suppressor tRNATyrCUA 
(BstRNATyrCUA) contains an internal promoter sequence, allowing for its expression in 
mammalian cells. The authors then combined the tRNATyrCUA with E. coli TyrRS (EcTyrRS) 
mutant (expressed from tetracycline-regulated promoter), which allowed the incorporation of 
3-iodo-L-tyrosine into Ras protein (Sakamoto et al., 2002). In second example, Bacillus 
stearothermophilus tryptophanyl-tRNA (BstRNATrp) was converted to opal supressor and used 
in combination with its cognate tryptophanyl-tRNA synthetase mutated to accept 5-hydroxy-
L-tryptophan, a fluorescent probe that undergoes chemical oxidation in situ, allowing for 
protein cross-linking in mammalian cells (Zhang et al., 2004). 
In addition to being orthogonal in yeast, the BstRNATyrCUA with the EcTyrRS pair is also 
orthogonal in mammalian cells due to a high degree of conservation of the aaRS/tRNA pairs 
among eukaryotes. This was first demonstrated by Liu et al. who have combined the  
BstRNATyrCUA with the EcTyrRS mutants discovered by Chin and colleagues (Chin et al., 2003)  
and optimised their expression in mammalian cells to incorporate six different non-canonical 
amino acids in mammalian cells (Liu et al., 2007). Wang and colleagues have further 
demonstrated that the expression of exogenous suppressor tRNACUA can be driven by type-3 
pol III promoter, using the EcTyrRS/EctRNATyrCUA to incorporate different non-canonical 
amino acids into K+ channel Kv1.4 in mammalian HEK cells and neurons using transient 
transfection (Wang et al., 2007b). 
Analogous to genetic code expansion in E. coli, the imported aaRS/tRNA pair has to be 
orthogonal in the eukaryotic host. While the E. coli TyrRS/tRNA is orthogonal in eukaryotes, 
it has to be evolved directly in the eukaryotic organism due to lack of orthogonality in E. coli 
where library-screening approaches are easier to execute. This situation has limited the use of 
E. coli aaRS/tRNAs for genetic code expansion in eukaryotes. Conversely, the M. janaschii 
TyrRS/tRNATyrCUA pair has proven to be useful for incorporation of diverse set of non-
canonical amino acids in E. coli where it can be also evolved, however, the pair is not 
orthogonal in eukaryotic cells.  
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This situation has led to the adaptation of the PylRS/tRNA pair, which is orthogonal in both E. 
coli and all eukaryotic hosts tested to date. This characteristic allows researchers to evolve the 
pair PylRS/tRNA for a specific substrate in E. coli and then transfer the pair to the eukaryotic 
host. The first use of the PylRS/tRNA pair in yeast was reported by Hancock et al., who have 
incorporated a variety of non-canonical amino acids, including amino acid with an alkyne 
group, a photocaged amino acid and photo-cross-linking amino acid (Hancock et al., 2010). 
Testing out multiple possible promoter sequences, the group found that the A- and B-box 
promoters in tDNAArgUCU gene drive sufficient expression of the tRNA
Pyl
CUA gene when it is 
substituted instead of the tDNAArgUCU gene. Using this construct, the authors were able to 
successfully express in yeast cells multiple PylRS/tRNA pairs initially evolved in E. coli 
(Hancock et al., 2010). The PylRS/tRNA pair has been since then used for incorporation of 
variety of substrates including non-canonical amino acids for protein labelling (Lang et al., 
2012a; Nguyen et al., 2011, Borrmann et al., 2012; Lang et al., 2012b; Plass et al., 2012; Ramil 
et al., 2017), photocrosslinking (Chou et al., 2011; Zhang et al., 2011), and photoactivation 
(Arbely et al., 2012; Gautier et al., 2011) in mammalian cells. 
Recently, Italia and colleagues reported a new strategy for evolution of E. coli aaRS/tRNA 
pairs directly in the E. coli cell (Italia et al., 2017). The authors took advantage of previous 
efforts to replace an endogenous E. coli aaRS/tRNA pair with an evolutionarily distant pair 
(Iraha et al., 2010) and thereby liberating the given endogenous pair for directed evolution. 
Selecting the tryptophanyl-tRNA synthetase as a useful potential target, the authors first 
replaced the endogenous EcTrpRS/tRNA pair with S. cerevisiae (Sc) TrpRS/tRNA, which is 
orthogonal in E. coli (Hughes and Ellington, 2010), at the endogenous locus and then converted 
the EctRNATrp into amber suppressor. In the following step, the EcTrpRS/tRNACUA pair was 
evolved using positive and negative selection for incorporation of 5-hydroxytryptophan. In 
addition, the isolated EcTrpRS mutants were tested for incorporation of other 5-substituted 
tryptophan derivatives (Italia et al., 2017). 
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1.8 Expansion of the genetic code in animals 
Function and development of complex, multi-cellular biological structures, such as the brain, 
the nervous system and the immune system can be only studied in animals. This has motivated 
researchers to further extend the genetic code expansion into animals, where the powerful 
technology can be used to answer critical biological questions (Chin, 2014). 
The first demonstration of genetic code expansion in an animal was achieved in the nemoatode 
Caenorhabditis elegans (C. elegans) (Greiss and Chin, 2011). C. elegans is a model organism 
with several advantages which make it an ideal candidate for genetic code expansion. Firstly, 
the entire lineage of every cell in the development of this nematode has been mapped (Kimble 
and Hirsh, 1979; Sulston and Horvitz, 1977). In addition, C. elegans is transparent throughout 
its entire life cycle, allowing for very efficient use of photosensitive non-canonical amino acids. 
In addition, amber suppressor mutations have been isolated and characterised in C. elegans 
(Hodgkin, 1985; Kondo et al., 1988; Kondo et al., 1990) suggesting that amber suppression is 
not detrimental to survival of the organism. 
Greiss et al. achieved incorporation of two non-canonical amino acids: N6-(tert-
butyloxycarbonyl)-L-lysine and N6-[(2-propynyloxy)carbonyl-L-lysine; into proteins in C. 
elegans. The authors used the PylRS/tRNA pair from M. mazei, which is orthogonal in both E. 
coli, yeast and mammalian cells. The PylRS gene was expressed using a ubiquitous rps-0 
promoter while the tRNA was expressed using extragenic RNA polymerase III promoter 
(Greiss and Chin, 2011). 
Since genetic code expansion via suppression of the amber codon requires insertion of the TAG 
amber stop codon into the middle of the coding sequence, i.e. far from the 3’ mRNA end, the 
mRNA message of the target protein is subject to nonsense mediated decay pathway (NMD). 
NMD is a quality-control process that protects the organism from mRNAs with a premature 
stop codon by their degradation (Chang et al., 2007; Longman et al., 2007). To investigate 
whether NMD was a major factor, Greiss et al. created worms bearing mCherry-TAG-GFP 
reporter and crossed them with worms deficient in smg-2(e2008) worms that are deficient in 
NMD (Hodgkin et al., 1989; Page et al., 1999). The Δsmg-2 worms showed significantly higher 
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expression of the full-length product in the presence of the non-canonical amino acid, as 
measured by GFP fluorescence, suggesting that NMD can be an important factor in genetic 
code expansion in eukaryotes and animals (Greiss and Chin, 2011). A similar approach showed 
subsequently that E. coli tyrosyl- and leucyl-RS/tRNA pairs can also be converted to amber 
suppressors and used for genetic code expansion in C. elegans (Parrish et al., 2012). 
The fruit fly Drosophila melanogaster was the second model organism with expanded genetic 
code (Bianco et al., 2012). Mukai and collegues have demonstrated in 2010 that 
EcTyrRS/tRNA is orthogonal in Drosophila melanogaster Schneider 2 cells in culture and can 
be used to incorporate 4-azido-L-phenylalanine into interleukin-8 using amber suppression 
(Mukai et al., 2010b). Similarly to C. elegans, amber suppressors in the fly have been reported 
(Garza et al., 1990; Laski et al., 1989; Washburn and O'Tousa, 1992) and are therefore 
compatible with survival of all developmental stages. The authors expressed the M. mazei 
PylRS using the GAL4 upstream activating sequence and tRNAPyl by extragenic Pol III 
promoter (Bianco et al., 2012), an approach that allows for crosses with a variety of existing 
GAL4 lines that should enable expression in variety of tissues. Bianco et al. demonstrated that 
this approach can be used for incorporation of several non-canonical amino acids in tissue-
specific manner, including amino acids with norbornene and alkyne groups for site-specific 
protein labelling (Bianco et al., 2012). The genetic code expansion in D. melanogaster via the 
PylRS/tRNA pair was successfully used by Elliott and co-workers to label and image proteins 
in specific tissues and developmental stages (Elliott et al., 2014). 
The remainder of this thesis discusses several key improvements in genetic code expansion in 
mammalian cells. Chapter 2 discusses the first genetically encoded phosphorylation in 
mammalian cells, Chapter 3 presents technological progress in protein labelling technology 
and its application to novel class of microproteins and Chapter 4 introduces a new, orthogonal 
pair in mammalian cells, paving the way forward for simultaneous incorporation of multiple 
distinct non-canonical amino acids. 
 
 Chapter 2 Genetically Encoded Protein 
Phosphorylation in Mammalian Cells 
2.1 Introduction 
This chapter describes the application of the recently engineered phosphoseryl-tRNA 
synthetase/tRNA pair (SepRSv1.0/tRNAv1.0CUA) in mammalian cells for co-translational 
incorporation of phosphoserine and its non-hydrolysable phosphonate analogue.  
As introduced in section 1.4, post-translational modifications extend the chemical space of 
proteins by chemically modifying the side chains of individual amino acids or the protein 
termini. Post-translational modifications have been implicated in of almost all biological 
functions in eukaryotes (Walsh et al., 2005) and are increasingly more appreciated in bacteria 
(Grangeasse et al., 2015). The approaches to study the role of post-translational modifications 
are limited due to the fact that many of the enzymes responsible for particular modifications 
are unknown or may not modify the target protein site-specifically or completely. 
Genetic code expansion is a unique tool for investigation of post-translational modifications, 
providing researchers access to site-specifically modified proteins. To date, researchers have 
successfully encoded number of amino acids containing post-translational modification, 
including methylation (Ai et al., 2010; Nguyen et al., 2009a), acetylation (Neumann et al., 
2008b), crotonylation (Kim et al., 2012), sulphation (Liu and Schultz, 2006), nitration 
(Neumann et al., 2008a) and phosphorylation (Fan et al., 2016; Park et al., 2011; Rogerson et 
al., 2015; Zhang et al., 2017). 
The incorporation of post-translationally modified tyrosine was achieved primarily through 
directed evolution of the Methanococcus janaschii (Mj) tyrosyl-tRNA synthetase 
(TyrRS)/tRNA pair. In 2006, Liu and Schultz first reported the genetic encoding of 
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sulfotyrosine using amber suppressor MjtRNATyrCUA (Liu and Schultz, 2006). The Schultz 
group subsequently reported incorporation of phosphotyrosine analogue p-carboxymethyl-L-
phenylalanine (Xie et al., 2007), and Neumann and colleagues successfully evolved the to 
incorporate 3-nitrotyrosine into manganese superoxide dismutase (Neumann et al., 2008a). 
Lysine bearing a variety of post-translational modifications was encoded using the pyrrolysine-
tRNA synthetase (PylRS)/tRNA pairs from Methanosarcina mazei (Mm) and Methanosarcina 
barkeri (Mb). The first encoded lysine bearing post-translational modification was Nε-
acetyllysine, reported in 2008 by Neumann and colleagues (Neumann et al., 2008b). This effort 
was followed by Nguyen et al., who used the MbPylRS/tRNACUA pair to encode Nε-methyl-L-
lysine. To achieve selectivity over the endogenous lysine, which differs by only the absence of 
single methyl group, Nguyen et al. first encoded the Nε-tert-butyl-oxycarbonyl-L-lysine and 
removed the tert-butyl-oxycarbonyl group in presence of 2% trifluoroacetic acid (Nguyen et 
al., 2009a). An analogous approach was demonstrated by Ai et al., who have genetically 
encoded Nε-allyloxycarbonyl-Nε-methyl-L-lysine, which can be converted to methyl-L-lysine 
using ruthenium catalyst (Ai et al., 2010) and Wang and colleagues, who have encoded a 
photocaged Nε-methyl-L-lysine variant (Wang et al., 2010). A strategy to produce proteins 
bearing ε-N, N-dimethyl-L-lysine was subsequently reported by Nguyen and colleagues, who 
have used the incpororation of Nε-tert-butyl-oxycarbonyl-L-lysine in combination with 
protection of the all amine groups via N-(benzyloxycarbonyl)succinimide reductive 
methylation, and subsequent amine deprotection (Nguyen et al., 2010). Since this approach 
relies on denaturing conditions of the succinimide protection, Wang and colleagues have 
developed an alternative approach, encoding Nε-(4-azidobenzoxycarbonyl)-δ,ε-dehydro-L-
lysine, which is can be converted to dimethyllysine in two biocompatible reactions (Wang et 
al., 2017). 
The approaches using co-translational incorporation of amino acids bearing post-translational 
modifications are complimented by incorporation of non-canonical amino acids which can be 
used as chemical handles that allow for subsequent derviatization (reviewed in (Krall et al., 
2016; Lang and Chin, 2014)). Notably, post-translational modifications including, 
glycosylation, ubiquitination or phosphorylation were achieved using this approach. The first 
example of glycosylation was reported by Liu and colleagues who have incorporated p-acetyl-
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L-phenylalanine that was subsequently conjugated with β-linked analogue of N-
acetylglucosamine (Liu et al., 2003). The approach has been extended by incorporation of 
biochemical handles such as alkene- and alkyne-lysine for copper mediated azide-alkyne 
cycloaddition, for derivatization of lysine with multiple sugar modifications (Kaya et al., 2009). 
Similar approach using Staudinger-phosphite reaction of genetically encoded azido-
phenylalanine, resulted in an non-canonical amino acid mimicking phosphotyrosine (Serwa et 
al., 2009). 
Site-specific protein ubiquitination was achieved by incorporation of Nε-cysteinyl-L-lysine 
combined with native chemical ligation (Li et al., 2009b), however, this approach results in a 
non-native linkage, which cannot be recognised by deubiquitinases, limiting the use of this 
technique. An alternative approach termed genetically encoded orthogonal protection and 
activated ligation (GOPAL) using Nε-Boc-L-lysine combined with protection of the remaining 
lysine residues with N-(benzyloxycarbonyloxy)-succinimide and conjugation to ubiquitin 
thioester (Virdee et al., 2010), which, unlike the previously reported strategies, results in native 
ubiquitin linkage but does rely on protein refolding after denaturing conditions of the N-
(benzyloxycarbonyloxy)-succinimide protection.  A different traceless approach is based on 
incorporation of δ-thiol-Nε-(p-nitrocarbobenzyloxyl)-L-lysine, which is post-translationally 
deprotected to δ-thiol-L-lysine and the resulting sidechain can react with ubiquitin thioester 
(Virdee et al., 2011). 
Recently, significant efforts have been directed towards genetic encoding of phosphorylated 
amino acids (Chin, 2017). Incorporation of phosphotyrosine has been reported by several 
groups. Fan et al. used the MjTyrRS/tRNA pair and an evolved elongation factor Tu in an E. 
coli strain with several deleted phosphatases to incorporate phosphotyrosine into GFP reporter, 
but with only limited yield and mixture of amino acids incorporated at the target position (Fan 
et al., 2016). Using an alternative strategy, Hoppmann and colleagues developed a system for 
incorporation of phosphoramidate, which is converted to phosphotyrosine at low, denaturing 
pH (Hoppmann et al., 2017). Simultaneously, Luo et al. have reported a propeptide strategy for 
increase of cellular uptake of phosphotyrosine and 4-phosphomethyl-L-phenylalanine, a non-
hydrolyzable phosphotyrosine analogue, which allowed them to identify a MjTyrRS/tRNA pair 
with sufficient efficiency for phosphotyrosine incorporation (Luo et al., 2017). 
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In parallel to advances in genetic encoding of post-translational modifications, several groups 
pioneered the expansion of the genetic code of mammalian cells and animals (reviewed in 
sections 1.7 and 1.8). The combination of these two domains would provide researchers the 
ability to install post-translationally modified amino acids in vivo, allowing them to study their 
effect within the cellular context.  
One of the first reports of encoding Nε-acetyllysine was provided by Yokoyama groupp in 
2008 (Mukai et al., 2008), followed by Groff et al., who reported encoding of a photocaged 
version of Nε-methyl-L-lysine (Groff et al., 2010). In a more recent example, Elsasser et al. 
combined a new mammalian expression system (Schmied et al., 2014) with transposase 
mediated stable cell line selection to incorporate Nε-acetyl-L-lysine into histones in mouse 
embryonic stem cells and were able to observe the effects in gene expression (Elsässer et al., 
2016). 
The most prevalent post-translational modification – among the more than 300 known to date 
(Walsh, 2006) – is protein phosphorylation, with over 260,000 experimentally verified 
phosphorylation sites (www.phosphosite.org). The human genome contains 518 known 
kinases, amounting to approximately 1.7% of all human genes (Manning et al., 2002). Previous 
efforts to genetically encode phosphorylated amino acids, summarised in section 1.6.5, have 
resulted in an optimised system that enables high expression of proteins bearing phosphoserine 
in E. coli (Rogerson et al., 2015). This system allows researchers to purify quantitatively and 
site-specifically phosphorylated proteins for both in vitro and structural studies but does not 
allow the study of phosphorylation consequences in their native context. Following this 
development, Zhang et al. have reported a new, evolved version of the SepRS/tRNASepCUA pair 
that, together with metabolic engineering of the bacterial cell, enables the incorporation of 
phosphothreonine in proteins (Zhang et al., 2017). These advances have yielded significant 
insights into the role of protein phosphorylation, including the role of ubiquitin phosphorylation 
(Huguenin-Dezot et al., 2016) and protein folding (Mukherjee et al., 2018). 
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This chapter describes the first genetic encoding of phosphorylation in mammalian cells, 
allowing researchers to study protein phosphorylation in a site-specific manner directly in cells. 
To achieve this, we completed several steps described in the following sections: 
1. We transferred the SepRSv1.0/tRNAv1.0CUA system for site-specific installation of 
phosphorylated amino acid into expression system for mammalian cells; 
2. We engineered the eukaryotic elongation factor 1 α (EF-1α) to increase the amber 
suppression efficiency; 
3. We combined the resulting system with the engineered eukaryotic release factor 1 
(eRF1) for increased amber suppression; 
4. We increased the intracellular concentration of phosphoserine by knocking out 
phosphoserine phosphatase.  
 
All of the above steps lead to an order of magnitude increase in encoding efficiency over non-
optimised system. Because post-translational modifications are dynamic and tightly regulated 
in vivo, the genetically encoded amino acids may be subject to post-translational 
dephosphorylation by one of the endogenous protein phosphatases. To address this issue, we 
5. Engineered the cell metabolic pathway by knocking out phosphoserine 
aminotransferase to decrease the cellular concentration of phosphoserine; 
6. Demonstrate that the system incorporates a non-hydrolysable phosphonate analogue of 
phosphoserine and, lastly; 
7. Demonstrate that incorporation of phosphonate analogue into a known activation site 
in protein kinase leads to its activation. 
 
Together this chapter establishes genetic code expansion as a useful tool for studying protein 
phosphorylation in mammalian cells in a site-specific manner. In addition, the work establishes 
the SepRS/tRNASep pair as an independent orthogonal pair for genetic code expansion in 
eukaryotes. 
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 2.2 Genetically encoded protein phosphorylation in mammalian 
cells 
2.2.1 Introduction 
Protein phosphorylation is a key post-translational modification that expands the complexity 
of protein function, and regulates diverse biological processes in eukaryotic systems (Manning 
et al., 2002). Thousands of phosphorylation sites have been discovered (Olsen et al., 2006), but 
the consequences of protein phosphorylation can be hard to determine, as manipulation of the 
kinases that install phosphorylation commonly have pleiotropic effects, and so-called 
phosphomimetic mutations to aspartic acid and glutamic acid are chemically distinct (Mandell 
et al., 2007) and often fail to recapitulate the molecular and phenotypic consequences of 
phosphorylation (Roberts-Galbraith et al., 2010). 
Genetic code expansion, using orthogonal aminoacyl-tRNA synthetase/tRNACUA pairs, has 
enabled the site-specific incorporation of diverse non canonical amino acids (ncAAs) into 
proteins in cells and animals (Chin, 2014). One key application of this approach is in 
understanding the role of post-translational modifications in regulating the biological functions 
of proteins.  Directly genetically encoding ncAAs, corresponding to post-translationally 
modified versions of natural amino acids, into proteins has enabled the synthesis of 
recombinant proteins bearing defined post translational modifications, and led to numerous 
insights into how these modifications regulate protein structure and function (Davies and Chin, 
2012, Chin, 2017). 
Recently, a phosphoseryl-tRNA synthetase (SepRS)/tRNAGCA pair that directs the first step in 
a tRNA dependent cysteine biosynthesis pathway in certain methanogens (Sauerwald et al., 
2005) has been co-opted for the site-specific incorporation of phosphoserine (1) into 
recombinant proteins in E. coli. (Park et al., 2011; Rogerson et al., 2015). Since SepRS 
recognizes the anticodon of tRNAGCA, the SepRS/tRNACUA pair - in which the GCA anticodon 
was simply substituted by CUA - was a very inefficient amber suppressor. In recent work, we 
demonstrated that phosphoserine could be efficiently incorporated into proteins in E. coli using 
an evolved SepRS/tRNACUA pair (Rogerson et al., 2015). This pair, in which SepRS and the 
anticodon stem and anticodon loop of tRNACUA were evolved to function efficiently, referred 
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to herein as the SepRSv1.0/tRNAv1.0CUA pair, has been used to produce a number of site-
specifically phosphorylated proteins for structural and functional studies (Rogerson et al., 
2015; Huguenin-Dezot et al., 2016, Burgess et al., 2018, Dickson et al., 2018). We also 
demonstrated that by manipulating phosphoserine biosynthesis in E. coli a non-hydrolyzable, 
phosphonate analog of phosphoserine (2) could be incorporated into proteins using the 
SepRSv1.0/tRNAv1.0CUA pair (Rogerson et al., 2015), and that the pair can be further evolved to 
incorporate phosphothreonine in E. coli (Zhang et al., 2017). 
The ability to encode phosphoserine, and its non-hydrolyzable analogs, into defined sites in 
proteins in mammalian cells would facilitate an understanding of the molecular and cellular 
consequences of this modification.  Unlike approaches that manipulate kinases and 
phosphatases, that have many targets in the cell, orthogonal routes to installing site-specific 
phosphorylation may directly address the consequences of modifying a particular site on a 
particular protein. 
Orthogonal routes to installing other post-translational modifications have begun to emerge. 
We recently explored the genetic encoding of acetyl-lysine into chromatin (Elsässer et al., 
2016), and complementary work explored directing protein ubiquitination into chromatin via 
protein trans splicing (David et al., 2015); both these approaches modify only a small fraction 
of histones but have led to important conclusions about the consequences of these 
modifications for gene expression and cellular interactions. 
Protein phosphorylation is commonly activating and phosphoproteomics studies reveal that 
proteins are naturally regulated by sub-stoichiometric phosphorylation, with occupancies of 
less than 30% reported on the majority of phosphorylation sites (Olsen et al., 2010). Therefore, 
routes to the sub-stoichiometric installation of phosphorylated amino acids into proteins in 
mammalian cells will be useful. 
Here we demonstrate that the SepRSv1.0/tRNAv1.0CUA pair is orthogonal in mammalian cells and 
can be used, in combination with other engineered translational components, to site-specifically 
and co-translationally incorporate phosphoserine and its non-hydrolyzable phosphonate analog 
into proteins expressed in mammalian cells.  Moreover, we demonstrate the synthetic activation 
of a protein kinase in mammalian cells by encoding a phosphonate analog at a site that is 
normally phosphorylated by an upstream kinase. 
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2.2.2 Results 
2.2.2.1 Expressing SepRSv1.0/tRNAv1.0CUA in human cells 
We first demonstrated that the SepRSv1.0/tRNAv1.0CUA pair can be expressed in mammalian 
cells. We were able to detect FLAG tagged SepRSv1.0, following transfection of HEK293 cells 
with the corresponding gene, by western blot (Figure 2.1a).  Similarly, upon expressing four 
repeats of the gene encoding tRNAv1.0CUA from extragenic U6 promoters we detected 
expression of tRNAv1.0CUA by northern blot (Figure 2.1a).  These experiments demonstrate that 
SepRS and tRNAv1.0CUA can be expressed in human cells. 
 
 
Figure 2.1. The SepRSv1.0/tRNAv1.0CUA pair enables pSer incorporation in mammalian cells. 
(a) Expression of FLAG-SepRSv1.0, Myc-EF-1α-Sep, V5-eRF1(E55D) and tRNAv1.0CUA in 
HEK293 cells detected via western and northern blots. Dashed line indicates removal of 
irrelevant lanes. (b) SepRSv1.0/tRNAv1.0CUA pair directs pSer incorporation in mammalian cells, 
co-expression of eEF1-αSep, eRF1(E55D) and knockout of PSPH gene increase pSer 
incorporation. Readthrough of UAG codon is determined by ratio of GFP to mCherry 
fluorescence from the mCherry-TAG-GFP reporter. Data represent mean ± SEM for at least 
three biological replicates. (c) Recombinant SepRSv1.0 is incubated with total tRNA extracted 
from control mammalian cells (– tRNAv1.0CUA) or cells expressing tRNAv1.0CUA (+ 
tRNAv1.0CUA). The aminoacylation in each reaction is determined by measuring the AMP 
production with the AMP-Glo assay. (Data represent mean ± SEM for triplicate reactions.) 
(Data in panel a were obtained by C.D.R., data in panel b were obtained by V.B. and data in 
panel c were obtained by M.S.Z.. C.D.R. created the PSPH knockout cell line.) 
 
To assess the functionality of the SepRSv1.0/tRNAv1.0CUA pair in human cells we measured the 
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readthrough of the amber stop codon in an mCherry-TAG-GFP construct via the ratio of GFP 
and mCherry fluorescence. Expression of tRNAv1.0CUA alone led to minimal read through of the 
amber stop codon, consistent with this tRNA being minimally aminoacylated by endogenous 
synthetases. This observation suggests that tRNAv1.0CUA is orthogonal in mammalian cells 
(Figure 2.1b). Addition of SepRS led to an increase in amber suppression consistent with the 
SepRS mediated aminoacylation of tRNAv1.0CUA with phosphoserine, which is present in 
mammalian cells as a biosynthetic precursor to serine (Ichihara and Greenberg, 1957).  
In E. coli, the incorporation of phosphoserine into proteins by the SepRSv1.0/tRNAv1.0CUA pair 
can be enhanced by a mutant form of EF-Tu, named EF-Sep8, which may accommodate the 
phosphorylated amino acid.  EF-1α is the eukaryotic equivalent of EF-Tu, and delivers 
aminoacylated tRNAs to the eukaryotic ribosome (Carvalho et al., 1984). We therefore asked 
whether SepRS dependent readthrough of the amber stop codon in mammalian cells can be 
enhanced by a mutant of EF-1α.  To design a mutant of EF-1α for pSer incorporation in 
mammalian cells we aligned the EF-Tu and EF-1α sequences and identified the amino acids in 
EF-Tu that were mutated to create EF-Sep (Figures 2.2a and 2.2b).  We then created the 
corresponding mutations (L77R, Q251N, D252G, V264S, N307W) in EF-1α to create EF-1α-
Sep, and demonstrated that this mutant was expressed in mammalian cells (Figure 2.1a). Co-
expression of EF-1α-Sep with the SepRSv1.0/tRNAv1.0CUA pair led to an increase in the read 
through of the amber stop codon in mCherry-TAG-GFP (Figure 2.1b). 
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Figure 2.2. Generation of EF-1α-Sep. (a) Clustal alignment of protein sequences of EF-Tu 
(E. coli) and EF-1α (S. cerevisiae and H. sapiens). Residues mutated to create EF-Sep (Park et 
al., 2011) (H67R, E216N, D217G, F219Y, T229S, N274W) are highlighted in magenta, 
corresponding residues in EF-1α are highlighted in red (S. cerevisiae) and orange (H. sapiens). 
(b) Aligned structures of E. coli EF-Tu in complex with phenylalanyl-tRNA (PDB:1ob2; EF-
Tu in blue, Phe in green, tRNA not shown) and S. cerevisiae EF-1α (PDB:1f60; cyan, only 
structure surrounding the critical residues shown). Mutated residues are highlighted in magenta 
(E. coli) and red (S. cerevisiae). (Figure created by V.B.). 
 
We have previously shown that the efficiency of ncAA incorporation, using the 
PylRS/tRNACUA pair, in mammalian cells can be enhanced by expressing an eRF1(E55D) 
mutant of eRF1 (Schmied et al, 2014; Kolosov et al., 2005); the eukaryotic release factor that 
terminates protein synthesis at all three stop codons. eRF1(E55D) does not efficiently terminate 
protein synthesis in response to amber codons, and its expression minimizes release factor 
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competition with amber suppressor tRNAs at the amber stop codon, while maintaining 
termination on the other two stop codons.  Co-expression of eRF1(E55D) with the 
SepRSv1.0/tRNAv1.0CUA pair was confirmed by immunoblotting (Figure 2.1a) and led to a 
substantial increase in read through of the amber stop codon (Figure 2.1b). 
Next, we combined the SepRSv1.0/tRNAv1.0CUA with both EF-1α-Sep and eRF1(E55D).  This 
combination led to the greatest read through of the amber codon in the presence of SepRSv1.0 
(Figure 2.1b).  These data are consistent with a model in which SepRSv1.0, which is known to 
selectively recognize phosphoserine (Hauenstein et al., 2008), aminoacylates the orthogonal 
tRNAv1.0CUA with phosphoserine in mammalian cells, creating pSer-tRNA
v1.0
CUA.  pSer-
tRNAv1.0CUA is taken to the ribosome with the aid of EF-1α-Sep, where it is more efficiently 
decoded in response to the amber codon in the presence of eRF1(E55D).  All further 
experiments were carried out using the SepRSv1.0/tRNAv1.0CUA with EF-1α-Sep and 
eRF1(E55D). To verify that transfection of the SepRSv1.0/tRNAv1.0CUA, EF-1α-Sep and 
eRF1(E55D) does not compromise cellular fitness, we compared the cell viability with cells 
transfected with control plasmid (Figure 2.3) and saw no significant difference. We note that 
both the altered translation factors (EF-1α-Sep and eRF1(E55D)) mediate some 
SepRSv1.0/tRNAv1.0CUA pair independent readthrough of the amber stop codon; this may result 
from near-cognate decoding of the amber codon by endogenous tRNAs (Roy et al., 2015). 
 
 
Figure 2.3. CellTiter-Glo assay confirms that cell viability is not compromised by transfection 
of the genetic code expansion components when compared to transfection of a control plasmid. 
(Data measured by M.S.Z.). 
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2.2.2.2 PSPH deletion increases intracellular pSer  
Does the intracellular concentration of phosphoserine limit the efficiency of its incorporation 
using our system in mammalian cells? To address this question, we extracted metabolites from 
cells, and found that the phosphoserine levels were less than 100 μM in vivo (Figure 2.4).  
Since the Km of SepRS for phosphoserine is approximately 270 μM (Hauenstein et al., 2008) 
we reasoned that increasing the pSer concentration in cells might increase the efficiency of its 
incorporation into proteins.  In mammals, phosphoserine phosphatase (PSPH) converts 
phosphoserine to serine in the last step of serine biosynthesis (Snell, 1984) and we hypothesized 
that knocking out PSPH might lead to an increase in intracellular phosphoserine levels and 
allow us to test the effect of phosphoserine levels on SepRS mediated incorporation into 
proteins.  We performed CRISPR-Cas9 mediated knockout of PSPH in HEK293, and 
confirmed the knockout by genotyping and western blot (Figure 2.5). In the resulting cell line, 
HEK293/PSPH-KO, the intracellular pSer concentration increased by at least 400 ± 60 μM 
(SD) over HEK293 (Figure 2.6). This increase in intracellular phosphoserine led to a 
measureable increase in phosphoserine incorporation in response to the amber codon in the 
HEK293/PSPH-KO (Figure 2.1b).  We conclude that phosphoserine levels in mammalian cells 
can be increased by PSPH deletion.  Overall, the use of EF-1α-Sep, eRF1(E55D) and the PSPH 
knockout increase the efficiency of SepRSv1.0/tRNAv1.0CUA mediated amber suppression by 
more than an order of magnitude.  
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Figure 2.4. Intracellular concentration of phosphoserine in HEK293. (a) The LC-MS 
chromatograms obtained from subtracting the unspiked HEK293 lysates from each of the pSer-
spiked samples are graphed as a function of time. (b) The peak area of each pSer-spiked sample 
plotted as a function of the spiked pSer concentration. The original chromatograms were used 
for analysis rather than the difference data. The dashed, blue line represents a linear fit from 
10-80 μM pSer. The dotted orange line represents the peak area for the 5 μM pSer standard. 
The green line represents the difference between the peak area for 5 μM pSer and the projected 
peak area for a sample with no pSer spiked in, corresponding to approx. 100 μM pSer. (Data 
measured by A.D.L.). 
 
 
Figure 2.5. Characterization of HEK293/PSPH-KO. (a) Gel electrophoresis of PCR 
amplicons of PSPH exon 2 from HEK293/PSPH-KO clonal cell lines before (left) and after 
reannealing and treatment with Guide-it resolvase (right). Star denotes the final clone used in 
this study. (b) Confirmation of PSPH knockout using western blot. Star denotes the final 
clone used in this study. (Data measured by C.D.R.). 
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Figure 2.6. Intracellular concentration of phosphoserine in HEK293/PSAT-KO. The LC-MS 
chromatograms obtained from subtracting the unspiked HEK293 lysates from each of the 
HEK293/PSPH-KO lysate samples. Peak areas correspond to increase in pSer concentration of 
400 ± 60 μM (SD) over HEK293. (Data measured by A.D.L.). 
 
2.2.2.3 SepRSv1.0 is orthogonal with respect to mammalian tRNA 
Next we demonstrated that SepRSv1.0 is selective for tRNAv1.0CUA with respect to the 
mammalian tRNAs.  We isolated total tRNA from HEK293 cells (-tRNAv1.0CUA) and from 
HEK293 cells expressing tRNAv1.0CUA (+tRNA
v1.0
CUA), in which tRNA
v1.0
CUA makes up less 
than 10% of the total mammalian tRNA pool (Figure 2.7). We subjected each tRNA pool to 
in vitro aminoacylation with phosphoserine using purified SepRSv1.0. We followed the extent 
of aminoacylation as a function of total tRNA concentration by measuring AMP production 
(Mondal et al., 2017). For +tRNAv1.0CUA we observed an increase in aminoacylation with total 
tRNA concentration, while for - tRNAv1.0CUA we observed minimal aminoacylation at all tRNA 
concentrations tested (Figure 2.1c). Our results demonstrate that SepRSv1.0 does not 
substantially aminoacylate endogenous mammalian tRNAs but selectively aminoacylates 
tRNAv1.0CUA. We conclude that SepRS
v1.0 is orthogonal with respect to the tRNAs in 
mammalian cells. 
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Figure 2.7. Northern blot confirms presence of tRNAv1.0CUA in mammalian tRNA extract. 
SYBR Gold staining of RNA after denaturing PAGE (top panel). Lanes 1 to 5 contain fixed 
amounts of a chemically synthesised RNA oligo with the same sequence of tRNAv1.0CUA in the 
range from 1 to 100 ng. The last two lanes contain a total of 500 ng of RNA extract (measured 
by UV absorbance) from wild type HEK293 cells, or from cells transfected with plasmid 
containing 4x tRNAv1.0CUA gene under U6 promoter. Northern blot using a fluorescently 
labelled probe specific for tRNAv1.0CUA (bottom panel). No specific signal can be detected from 
the RNA extract of wild type cells. The signal detectable from the tRNAv1.0CUA expressing cells 
is slightly greater than the one measured from the standard containing 10 ng of RNA, but lower 
than the one from the standard containing 33 ng of RNA. (Data measured by M.S.Z). 
 
2.2.2.4 Encoded pSer is post-translationally converted to Ser 
To investigate the identity of the amino acid incorporated into proteins in response to the amber 
codon we created a streamlined expression system in which SepRS, eRF1(E55D), EF-1α-Sep 
and four copies of tRNAv1.0CUA are combined on a single plasmid. Co-transfection of this 
plasmid with a plasmid containing GFP(150TAG) and four copies of tRNAv1.0CUA into 
HEK293 cells enabled expression and purification of the resulting GFP (Figure 2.8a). 
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Figure 2.8. SepRSv1.0/tRNAv1.0CUA directs pSer into proteins, where pSer is post-translationally 
dephosphorylated. (a) Coomassie-stained SDS-PAGE gel and western blot of purified GFP 
from HEK293 cells. (b) pSer is not maintained post-translationally in GFP expressed in 
mammalian cells. The Phos-tag SDS-PAGE gel leads to a mobility shift in phosphorylated 
proteins via chelation of the phosphate in the gel. GFP and GFP(150pSer) standards were 
produced in E. coli as described previously (Rogerson et al., 2015), and define the mobility of 
phosphorylated and non phosphorylated GFP. GFP was detected by immunoblotting. (c) 
A.U.C. is the area under the curve of the extracted ion chromatograms for peptide 
LEYNFNSH[X]VYITADK in MS1 of the tryptic LC-MS/MS. Identity of the peptides was 
confirmed by MS/MS analysis (see Figure 2.9). (d) SepRSv1.0 is selective for phosphoserine 
over serine. Recombinant SepRSv1.0 was incubated with total tRNA extracted from mammalian 
cells expressing tRNAv1.0CUA. The aminoacylation in each reaction was determined by 
measuring the AMP production with AMP-Glo assay. Data represent mean ± SEM for 
reactions in four replicates. (Data in panels a, b and c measured by V.B., data in panel d 
measured by M.S.Z.). 
 
To investigate whether phosphoserine was present in GFP expressed in mammalian cells we 
prepared authentic standards of GFP bearing phosphoserine at position 150 (GFP(150pSer)), 
using a previously described E. coli expression system (Rogerson et al. 2015), and GFP bearing 
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serine at position 150 (GFP(150Ser)). We analyzed the samples on phos-tag-SDS-PAGE, a 
well-established technique in which phosphorylated proteins are resolved from non-
phosphorylated proteins and the extent of phosphorylation can be quantified (Kinoshita et al., 
2006; Kinoshita et al., 2009). 
As expected, the mobility of GFP(150pSer) was retarded with respect to that of GFP(150Ser) 
(Figure 2.8b). The majority of GFP expressed from GFP(150TAG) in mammalian cells 
migrated with the GFP150Ser standard prepared in E. coli, and we were not able to detect any 
phosphorylated GFP. This result demonstrates that the majority of the amino acid at position 
150 in GFP, expressed from GFP(150TAG) in mammalian cells, is not phosphorylated.  
To investigate the identity of amino acids incorporated in response to the amber codon in GFP 
we performed electrospray ionization tandem mass spectrometry (LC-MS/MS) on tryptic 
digests of GFP expressed in mammalian cells. The extracted ion chromatographs of peptides 
at the MS1 level reveal that serine, glutamine and traces of phosphoserine are found in GFP 
produced from GFP(150TAG) in mammalian cells containing SepRSv1.0/tRNAv1.0CUA, EF-1α-
Sep and eRF1(E55D) (Figure 2.8c).  Control experiments show that the relevant peptides 
containing pSer and Ser ionize with comparable efficiency (Figures 2.9a and 2.9b).  
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Figure 2.9. LC-MS quantification and LC-MS/MS identification of serine, phosphoserine and 
2 (Figure 2.10a) incorporation using E. coli standards. Related to Figure 2.10. Extracted ion 
chromatograms of 2+ (black line) and 3+ (red line) ions of the tryptic peptides 
LEYNFNSH[X]VYITADK where (a) [X] = serine, (b) [X] = phosphoserine and (c) [X] = 2 
when the instrument was injected with 1:1:1 mixture of GFP150Ser, GFP150pSer and 
GFP1502. Combined areas under the curves for 2+ and 3+ ions (shown in figures) demonstrate 
that the ionization of the three peptides is comparable. MS/MS spectrum confirms 
incorporation of serine (d), phosphoserine (e) and glutamine (f) at position 150 in 
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sfGFP150TAG extracted from mammalian cells. We detected no other amino acids at the 
position 150. (Data in panels measured by V.B.). 
 
We suspected that the glutamine incorporation we observe in response to the amber codon in 
mammalian cells may result from suppressor tRNA independent incorporation of glutamine 
upon expressing eRF1(E55D) in mammalian cells (Roy et al. 2015), consistent with the 
SepRSv1.0 independent readthrough of the amber codon observed with eRF1(E55D) in our 
initial system (Figure 2.1b). Protein expression in the absence of eRF1(E55D) led to a decrease 
in GFP synthesis (Figure 2.8c), as expected based on the role of this mutant in decreasing the 
efficiency of translational termination at the amber stop codon.  It also led to a substantial 
increase in the ratio of serine to glutamine at position 150 of GFP (Figure 2.8c), consistent 
with a decrease in non-cognate decoding of the TAG codon when the normal termination 
machinery is active.  In contrast, protein expression in the absence of EF-Sep led to a decrease 
in protein, and an increase in the ratio of glutamine to serine at position 150 (Figure 2.8c), 
consistent with this factor increasing the delivery of phosphoseryl-tRNAv1.0CUA to the ribosome 
and post translational dephosphorylation of phosphoserine. Finally, protein expression in the 
absence of the amber suppression machinery (-tRNAv1.0CUA) but in the presence of 
eRF1(E55D) led to a decrease in GFP, and the protein predominantly incorporated glutamine 
at position 150 (Figure 2.8c), indicating that the glutamine incorporation is not mediated by 
the SepRSv1.0/tRNAv1.0CUA pair. These observations are consistent with previous reports of 
glutamine incorporation in response to premature termination codons in eukaryotic mRNAs 
(Roy et al., 2015). 
The observed serine incorporation could formally result from either the co-translational 
incorporation of serine by SepRSv1.0/tRNAv1.0CUA or the incorporation of phosphoserine 
followed by its posttranslational dephosphorylation by phosphatases in cells. SepRS is known 
to be highly selective for phosphoserine over serine. Previous work has shown that SepRS 
selectively forms the aminoacyl-adenylate of phosphoserine over that of serine by a factor of 
104 in the first step of aminoacylation (Hauenstein et al., 2008), and the overall kinetics of 
aminoacylation of serine with this system were too low to measure; these observations suggest 
that SepRS discriminates against serine by much more than 104 fold in the overall 
aminoacylation reaction (Hauenstein et al., 2008).  Consistent with these prior observations, 
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the aminoacylation of tRNAv1.0CUA with 1mM serine by SepRS
v1.0 was negligible (Figure 
2.8d). In contrast, tRNAv1.0CUA was efficiently aminoacylated by SepRS
v1.0 in the presence of 
1 mM phosphoserine. These observations further confirm that tRNAv1.0CUA is not 
aminoacylated with serine by SepRSv1.0.  
Our observations suggest that in mammalian cells our system directs the co-translational 
incorporation of phosphoserine in response to the amber codon, and that most of the genetically 
encoded phosphorylation in GFP is post-translationally dephosphorylated to serine. As 
numerous phosphatases for serine and threonine residues are present in mammalian cells 
(Hornbeck et al., 2004) this observation is not surprising. 
2.2.2.5 Encoding a non-hydrolyzable pSer 
Next we asked whether we could increase the fraction of phosphorylated protein by encoding 
a non-hydrolyzable phosphonate analog of pSer (2) (Figure 2.10a) in cells depleted in 
phosphoserine and fed 2. We first established that 2 can enter mammalian cells and is a good 
substrate for SepRS. Supplementing the growth media with 2 mM and 10 mM 2 led to 
intracellular concentrations of 3.64 ± 0.39 mM and 12.47 ± 0.80 mM, respectively (Figure 
2.11) demonstrating that we can generate millimolar concentrations of amino acid 2 in the 
cytosol.  In vitro aminoacylation experiments confirm that SepRSv1.0 can efficiently 
aminoacylate tRNAv1.0CUA with 2 (Figure 2.12), in line with our previous observations 
incorporating the amino acid in E. coli (Rogerson et al., 2015). 
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Figure 2.10. Encoding non-hydrolyzable phosphonate analogue (2) of pSer in genetically 
engineered mammalian cells. (a) Phosphonate analogue of phosphoserine (2) used in this study. 
(b) Protein expression in the PSAT-KO.  Coomassie-stained SDS-PAGE gel and western blot 
of purified GFP from HEK293/PSAT-KO overexpressing PSPH. Amino acid 2 was used at 10 
mM (c) Separation on phos-tag SDS-PAGE gel followed by immunoblotting is consistent with 
incorporation of 2 in the HEK293/PSAT-KO cell line overexpressing PSPH. GFP, 
GFP(150pSer) and GFP(150(2)) standards were produced in E. coli as described previously 
(Rogerson et al., 2015). (d) Quantification of the relative incorporation of 2 as a result of 
increasing concentration of 2 added to the cells. Data represent mean ± SEM for three 
biological replicates. (e) Incorporation of 2 into GFP(150TAG) reporter at the genetically 
encoded site was verified by ESI-MS/MS. See also Figure 2.9. (Data measured by V.B., 
HEK293/PSAT-KO cell line was created by C.D.R.). 
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Figure 2.11. Phosphonate analogue is taken up by HEK293 cells from culture media. The LC-
MS chromatograms of lysates from wtHEK293 cultured in standard growth media (black), 
wtHEK293 supplemented with 2 mM 2 in growth media (dark blue), wtHEK293 supplemented 
with 20 mM 2 in growth media (light blue), wtHEK293 with 500 μM 2 added to the lysate 
(final concentration) (gold) and aqueous standard of 2 (grey). Peak areas correspond to 
intracellular concentration of 3.64 ± 0.39 mM and 12.47 ± 0.80 mM intracellular 2 for cells 
cultured in media supplemented with 2 mM and 20 mM 2, respectively. All values represent 
mean ± SD from three biological replicates. The insert is magnified section of the 
chromatograms. (Data measured by A.D.L.). 
 
 
Figure 2.12. 2 is a substrate for SepRSv1.0 in vitro. Recombinant SepRSv1.0 was incubated with 
total tRNA extracted from cells transfected with tRNACUADTR and the reactions were 
supplemented with phosphoserine or 2 in varying concentrations. The aminoacylation in each 
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reaction was determined by measuring the AMP production with an AMP-Glo assay. The 
luminescence of reactions was normalised by subtracting the luminescence of reaction with no 
amino acid. Data represent mean ± SEM for three replicates. (Data measured by M.S.Z.). 
 
Since pSer is biosynthesized from phosphohydroxypyruvate via the action of PSAT and 
converted to serine via the action of PSPH (Ichihara and Greenberg, 1957), we reasoned that 
phosphoserine levels resulting from this pathway could be minimized by both the deletion of 
PSAT and the overexpression of PSPH. We created a CRISPR-Cas9 mediated knockout cell 
line, HEK293/PSAT-KO, and confirmed this knockout by genotyping and western blot 
(Figure 2.13). pSer levels were already below the detection limit of our LC-MS assay in 
HEK293 cell metabolite extractions, and we could not measure these levels in the 
HEK293/PSAT-KO strain. We found that the effect of the PSAT knockout and PSPH 
overexpression on serine levels was modest, reducing them from 362 ± 52 μM in HEK293 cells 
to 201 ± 22 μM and 215 ± 14 μM (all errors are SD) for the PSAT knockout and PSAT knockout 
with PSPH overexpression, respectively (Figure 2.14). 
 
 
Figure 2.13. Characterization of HEK293/PSPH-KO and HEK293/PSAT-KO cell lines. (a) 
Gel electrophoresis of PCR amplicons of PSAT exon 1 from HEK293/PSAT-KO clonal cell 
lines before (top) and after reannealing and treatment with Guide-it resolvase (bottom). Star 
denotes the clone used in this study. Dashed line indicates unrelated lanes that were removed 
for clarity. (b) Confirmation of PSAT knockout using western blot. Star denotes the clone used 
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in this study. (Both cell lines created by C.D.R. Data measured by C.D.R.). 
 
 
Figure 2.14. The LC-MS chromatograms of lysates from wtHEK293 (black), HEK293/PSAT-
KO (dark blue), HEK293/PSAT-KO with overexpressed PSPH (orange), wtHEK293 with 
spiked 50 μM Serine (final concentration) (green) and aqueous standard for Serine (grey). Peak 
areas correspond to intracellular Serine concentration of 362 ± 52 μM, 201 ± 22 μM, 215 ± 14 
μM for wtHEK293, HEK293/PSAT-KO and HEK293/PSAT-KO with PSPH overexpression, 
respectively. All values represent mean ± SD from three biological replicates. The insert is 
magnified section of the chromatograms. (Data measured by A.D.L.). 
 
We co-transfected HEK293/PSAT-KO cells with two plasmids: one encoding SepRSv1.0, EF-
1α-Sep, eRF1(E55D), PSPH and four copies of tRNAv1.0CUA, and one encoding GFP(150TAG) 
and four copies of tRNAv1.0CUA.  GFP was expressed from these cells via read-through of the 
amber codon. Protein production in these cells was comparable in the presence and absence of 
2 (Figure 2.10b).  
To investigate whether our system enables 2 to compete with phosphoserine for SepRSv1.0 
mediated incorporation into proteins in mammalian cells we took advantage of our ability to 
prepare proteins that site-specifically incorporate either phosphoserine or 2 in E. coli.9 We 
produced authentic standards of GFP incorporating pSer at position 150 (GFP(150pSer)) and 
GFP incorporating 2 at position 150 (GFP(1502)) in  E. coli (Figure S2a-c), and subjected these 
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(along with GFP encoding serine at position 150 (GFP(150Ser))) to phos-tag-SDS-PAGE 
(Figure 2.10c).  
We discovered that the phosphonate in 2 leads to a dramatic decrease in mobility of GFP(1502), 
with respect to both GFP and GFP(150pSer), in phos-tag-SDS-PAGE (we ran these gels under 
conditions where GFP150Ser and GFP150pSer are not resolved, as longer runs led to diffuse 
bands of GFP1502). This result demonstrates that GFP incorporating 2 can be resolved by its 
mobility in phos-tag-SDS-PAGE (Figure 2.10c).  GFP expressed from GFP(150TAG) in 
mammalian cells deleted for PSAT, and expressing PSPH, SepRSv1.0,  EF-1α-Sep, 
eRF1(E55D) and tRNAv1.0CUA , and provided with 2 led to two bands on phos-tag-SDS-PAGE; 
one band co-migrated with the authentic standard for GFP(1502) and the other with the 
authentic standards for GFP(150Ser) and GFP150pSer (Figure 2.10c, top panel). Standard 
SDS-PAGE analysis of the same sample produced single band for each sample, confirming 
that the slower migration of the upper band in phos-tag SDS-PAGE is due to a different 
interaction of 2 with the phos-tag gel matrix (Figure 2.10c). The GFP(1502) fraction of the 
total GFP produced increased with the concentration of 2 in the growth media and reached 49 
± 11% (SEM) for 25 mM 2. Mass spectrometry (Figure 2.10e and Figure 2.15) revealed that 
the GFP produced contained either glutamine or 2; this suggests that 2 can outcompete pSer at 
the active site of SepRS (control experiments demonstrate that the relevant peptides containing 
pSer and 2 ionize comparably (see Figure 2.9)), but that the amber suppressor tRNA does not 
entirely outcompete glutamine incorporation in the presence of eRF1(E55D). We note that the 
ratio of 2 to glutamine in these experiments is lower than the ratio of serine to glutamine when 
phophoserine is incorporated (Figure 2.8c); this may be a result of the different genetic 
backgrounds used for the two experiments.  
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Figure 2.15. Identification of amino acid incorporated in response to amber codon in 
sfGFP150TAG. (a) LC-MS counts of tryptic peptides containing serine, glutamine or 2 at 
position 150 in sfGFP (no other amino acids were detected). Data are represented as mean ± 
SEM, where relevant. MS/MS spectrum confirms incorporation of serine (b), 2 (c) and 
glutamine (d) at position 150. No other amino acids were detected. (Data measured by V.B.). 
 
Since phosphorylation is often an activating, dominant modification and glutamine 
incorporation in place of serine is very unlikely to have phenotypic consequences (and these 
can be explicitly ruled out by testing the phenotype of an Ser to Gln mutation).  Moreover, 
since proteomics studies suggest that the majority of proteins are naturally regulated by sub-
stoichiometric phosphorylation (<30%) (Olsen et al., 2010), the sub-stoichiometric genetic 
encoding of phosphorylated amino acids in mammalian cells should not substantively limit the 
utility of our system for studies in mammalian cells. 
2.2.2.6 Kinase activation by genetically encoded phosphorylation 
Next we explicitly demonstrated that genetically encoding 2 at a biologically relevant site of 
serine phosphorylation enables synthetic activation of a protein kinase (MEK1) in mammalian 
cells.  It is well established that phosphorylation at serine 218 and serine 222 of MEK1, upon 
stimulation of upstream kinases by growth factors, leads to activation of MEK1 and 
phosphorylation of its substrates, notably ERK1/2 (Shaul and Seger, 2007).  Serine to aspartic 
acid substitutions at positions 218 and 222 can activate MEK1 (Huang and Erikson, 1994).  
MEK1 is also phosphorylated at several other sites (Hornbeck et al., 2004) and the native 
protein from unstimulated cells runs as two bands in a phostag gel (Figure 2.16), reflecting the 
phosphorylation state of un-activated MEK1 in mammalian cells. 
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Figure 2.16. Activation of Mek by incorporation of 2. (a) Phos-tag SDS PAGE analysis is 
consistent with incorporation of 2 at position 218 in Mek1/2 (top panel). SDS-PAGE analysis 
(bottom panel) shows single band, confirming that the slower migration of upper band is due 
to chelation of phosphate group in the gel. (b) Expression of MEK1(2182) and 
MEK1(2182222D) results in phosphorylation of Erk in SepRSv1.0 dependent manner, as 
confirmed by phosphospecific antibody (top panel). The loading control was performed with 
standard Erk antibody (bottom panel). (Data measured by V.B.). 
 
We introduced plasmids expressing MEK1(218TAG) or MEK1(218TAG222Asp), along with 
an (ERK)-GFP fusion, SepRSv1.0,  EF-1α-Sep, eRF1(E55D), tRNAv1.0CUA and PSPH into 
HEK293/PSAT-KO cells.  As expected, based on the GFP expression experiments, addition of 
2 led to stably phosphorylated MEK variants, which were retarded in Phos-tag SDS PAGE 
(Figure 4a) with respect to the bands characteristic of unactivated MEK. 
Incorporation of 2 at position 218 of MEK led to phosphorylation of ERK-GFP (Figure 4b), 
consistent with reports that a serine to aspartic acid mutation at this position can stimulate some 
kinase activity (Huang et al., 1995). We observed a more dramatic increase in ERK-GFP 
phosphorylation by MEK(2182222D), consistent with maximal activity of MEK requiring both 
phosphorylations (Huang et al., 1995). Control experiments in which either SepRSv1.0 or 2 are 
omitted substantially decreased levels of ERK-GFP phosphorylation, further confirming that 
the activation we observe results from the genetically encoded incorporation of 2. 
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2.2.3 Discussion 
We have demonstrated that the SepRSv1.0/tRNAv1.0CUA pair is orthogonal in mammalian cells.  
We have developed an EF-1α mutant that facilitates the incorporation of phosphoserine, and 
combined this with engineered eRF1 and manipulations of phosphoserine biosynthesis to 
increase the efficiency of phosphoserine incorporation. By minimizing the intracellular pool of 
phosphoserine and feeding the cell a non-hydrolyzable analog of phosphoserine we have been 
able to genetically encode a constitutive phosphorylation in mammalian cells.  We anticipate 
that the first generation system we have reported herein may be further optimized by directed 
evolution of the translational components in mammalian cells. In this regard we note that the 
current PylRS/tRNACUA systems are orders of magnitude more efficient than the original 
systems (Schmied et al., 2014). 
The demonstration that the SepRSv1.0/tRNAv1.0CUA pair is orthogonal in mammalian cells and 
can be combined with other factors for the incorporation of pSer in mammalian cells, along 
with our recent demonstration that the SepRSv1.0/tRNAv1.0CUA can be evolved in E. coli to 
recognize ncAAs that are not natural substrates of SepRS (Zhang et al., 2017) opens up many 
new opportunities. We note that it may be possible to evolve the SepRSv1.0/tRNAv1.0CUA to 
incorporate ncAAs in E. coli and to use the evolved SepRSv1.0 variants to incorporate diverse 
ncAAs into proteins in mammalian cells.  
We used our approach to activate MEK1 by co-translationally encoding a phosphorylated 
amino acid at genetically targeted sites in vivo. We anticipate that extensions of this approach 
may provide a route to deciphering the consequences of specific phosphorylations, both 
through synthetically manipulating cellular signaling pathways, as demonstrated here, and as a 
basis for capturing phospho-protein interaction partners in cells.  
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2.2.5 METHODS 
2.2.5.1 EXPERIMENTAL MODEL AND SUBJECT DETAILS 
HEK293 cells (epithelial human embryonic kidney, female)(ATCC) were cultivated in DMEM 
(Gibco) supplemented with 10% fetal bovine serum (Gibco) in humifdified incubator at 37°C, 
5% CO2. For passaging, cells were washed with phosphate buffered saline, detached using 
trypsin/EDTA-solution, resuspended in fresh growth medium and seeded into cell culture 
flasks. The cells were routinely tested for mycoplasma contamination. 
2.2.5.2 METHOD DETAILS 
2.2.5.2.1 Plasmid Generation 
tRNAv1.0CUA (B4 variant (Rogerson et al., 2015)) repeats containing the human U6 promoter, 
followed by the tRNAv1.0CUA with no CCA tail, and a terminator were synthesized with unique 
homology arms on each side, allowing for cloning of four repeats by Gibson into a minimal 
backbone derived from pUC19. The resulting sequence of one repeat is as following: 
Human U6 promoter :: tRNAv1.0CUA :: terminator 
CCTAGTTGGGCAGGAAGAGGGCCTATTTCCCATGATTCCTTCATATTTGCATATA
CGATACAAGGCTGTTAGAGAGATAATTAGAATTAATTTGACTGTAAACACAAAG
ATATTAGTACAAAATACGTGACGTAGAAAGTAATAATTTCTTGGGTAGTTTGCAG
TTTTAAAATTATGTTTTAAAATGGACTATCATATGCTTACCGTAACTTGAAAGTAT
TTCGATTTCTTGGCTTTATATATCTTGTGGAAAGGACGAAACACCGCCGGGGTAG
TCTAGGGGTTAGGCAGCAGTCTCTAAAATTGCCTTACGTGGGTTCAAATCCCACC
CCCGGCTGACAAGTGCGGTTTTT 
The structure of EF-1α was aligned with EF-Sep, and the engineered mutations were 
transferred over (see Figures S1a and S1b).  The mutations (L77R, Q251N, D252G, V264S, 
N307W) were introduced via QuickChange site-directed mutagenesis and the resulting EF-1α-
Sep was cloned into pcDNA3.4 via Gibson.  SepRSv1.0 was cloned into pcDNA3.4 via Gibson 
from previously published plasmids (Rogerson et al., 2015). 
2.2 Genetically encoded protein phosphorylation in mammalian cells 71 
 
Plasmids containing four copies of tRNAv1.0CUA, protein of interest (SepRS
v1.0, EF-1α-Sep, or 
multiple cloning site (MCS)) under EF1A promoter were cloned by Gibson assembly from the 
above described plasmids and previously published plasmids (Schmied et al, 2014). The 
resulting constructs are designated pPB_FLAG-SepRSv1.0_4xU6-tRNAv1.0CUA, pPB_Myc-EF-
1α-SepRS_4xU6-tRNAv1.0CUA and pPB_MCS_4xU6-tRNAv1.0CUA. Fluorescence reporter 
constructs pPB_GFP(150TAG)_4xU6-tRNAv1.0CUA (GFP refers to sfGFP variant (Pédelacq et 
al., 2006)) with C-terminal His6 tag) and pPB_mCherry-TAG-GFP_4xU6-tRNA
v1.0
CUA were 
assembled from previously reported plasmids (Elsässer et al., 2016) via restriction cloning into 
pPB_MCS_4xU6-tRNAv1.0CUA. pPB_V5-eRF1(E55D)_4xU6-tRNA
v1.0
CUA was similarly 
cloned via restriction cloning into pPB_MCS_4xU6-tRNAv1.0CUA. Control plasmids with no 
tRNAv1.0CUA (pPB_MCS and pPB_mCherry-TAG-GFP) were cloned using Gibson assembly 
from the plasmids described above. pPB_FLAG-SepRS_Myc-EF1a_V5-eRF1(E55D)_4xU6-
tRNAv1.0CUA and pPB_FLAG-SepRS_Myc-EF1a_V5-eRF1(E55D)_V5-PSPH_4xU6-
tRNAv1.0CUA were enzymatically assembled via Gibson from plasmids described above with 
individual coding DNA sequences joined via cleavable P2A peptides. 
pPB_MEK1(218TAG)_4xU6-tRNAv1.0CUA and pPB_MEK1(218TAG222Asp)_4xU6-
tRNAv1.0CUA were cloned by gibson assembly from previously reported plasmids (Tsai et al., 
2015). 
2.2.5.2.2 Phosphoserine Incorporation 
HEK293 cells were seeded into poly-L-lysine coated 24 well plates (1.4 × 105 cells per well). 
Upon reaching 70%-80% confluency cells were transfected with combinations of pPB_FLAG-
SepRSv1.0_4xU6-tRNAv1.0CUA, pPB_Myc-EF-1α-Sep _4xU6-tRNAv1.0CUA, pPB_V5-
eRF1(E55D)_4xU6-tRNAv1.0CUA and pPB_mCherry-TAG-GFP_4xU6-tRNA
v1.0
CUA. For data 
in Figure 1, we transfected 125 ng of each plasmid per well, keeping the total amount of 
transfected DNA at 500 ng by addition of pPB_MCS_4xU6-tRNAv1.0CUA or pPB_MCS. The 
DNA was transfected using 2 µL of 1 mg/ml solution of polyethylenimine MW 40,000 (PEI; 
Polysciences) per well. For subsequent experiments, the cells were transfected with 
combination of pPB_FLAG-SepRS_Myc-EF1a_V5-eRF1(E55D)_V5-PSPH_4xU6-
tRNAv1.0CUA or SepRS_Myc-EF1a_V5-eRF1(E55D)_V5-PSPH_4xU6-tRNA
v1.0
CUA and 
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pPB_GFP(150TAG)_4xU6-tRNAv1.0CUA using 1000 ng of DNA/well. DNA and PEI were 
diluted in Opti-MEM and incubated for 15 minutes at room temperature. Cells were washed 
once with Opti-MEM before adding the transfection mix to the cells. The transfection medium 
was exchanged for fresh growth medium after 4 hours. The medium was exchanged again two 
days after the transfection. Cells were harvested and analyzed after 3 to 4 days of expression. 
Cell viability was measured using CellTiter-Glo 2.0 assay (Promega) according to the 
manufacturer’s instructions. 
Flow Cytometry 
The cells were washed with PBS, detached using trypsin/EDTA solution, resuspended in 
growth medium, pelleted and resuspended in PBS. The cells were analyzed using Becton 
Dickinson LSRII SORP (488 nm coherent sapphire laser for GFP excitation, 561 coherent 
compass laser for mCherry excitation). The data was analyzed in FlowJo software (FlowJo, 
LLC). 
Western Blotting 
For lysis HEK293 cells were washed with PBS and lysed in RIPA buffer containing HALT 
Protease and Phosphatase Inhibitor Cocktail (Thermo) and incubated at 4°C for 5 minutes. 
Samples were centrifuged for 10 minutes at 20000 rcf. Protein concentration of the supernatant 
was determined via BCA assay (ThermoFisher) according to manufacturer's instructions. The 
sample was transferred to SDS sample buffer (62.5 mM Tris-HCl (pH 7.4), 12.6% glycerol, 
2% SDS, 100 mM DTT, 0.01% bromophenol blue) and boiled at 95°C for 5 minutes. Proteins 
were separated via SDS-PAGE using 4-12% Bis-Tris gels (Novex) and transferred to 
nitrocellulose membranes using the iBlot2 Dry Blotting System (ThermoFisher) according to 
manufacturer's instructions. 
The membrane was blocked with 5% milk in tris-buffered saline with 0.1% Tween 20 (TBS-
T) for 1 h and incubated with the primary antibody α-GFP (Roche (13.1 and 7.1)), α-FLAG 
(Sigma-Aldrich (F1804)), α-Myc (Cell Signaling (9B11)), α-V5 (Invitrogen (2F11F7)), α-actin 
(Sigma-Aldrich (A3853)), α-HA (Roche (3F10)), α-Erk (Cell Signalling (L34F12)), α-pErk 
(Cell Signalling (D13.14.4E)) at 4 °C overnight. The membrane was washed several times with 
TBS-T and incubated with corresponding secondary antibody conjugated to HRP (Santa Cruz 
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Biotechnology or Cell Signalling) for 1 h at room temperature. The blot was washed with TBS-
T and developed using SuperSignal West Pico or Femto Chemiluminescent Substrate 
(ThermoFisher) according to manufacturer's instructions. Images were acquired using a 
ChemiDoc system (Bio-Rad). 
Northern Blotting 
RNA was isolated from HEK293 cells using the QIAzol Lysis Reagent (QIAGEN) according 
to manufacturers instructions. The samples were analyzed using the NorthernMax-Gly 
procedure (Thermo Fisher). Sep-tRNA was detected using a biotin labeled probe 
(AACCCACGTAAGGCAATTTTAGAGACTGCTGCCTAACC-CCT), which was 
hybridized at 37 °C overnight in Ambion ULTRAhyb Ultrasensitive Hypridization Buffer 
(ThermoFisher). Blots were washed with low stringency wash buffer (2x saline-sodium citrate, 
0.1% sodium dodecyl sulfate), incubated with horseradish peroxidase conjugated streptavidin 
and developed using enhanced chemiluminescence solution (both ThermoFisher). 
2.2.5.2.3 Cell Line Generation 
To knock out PSPH in HEK293 cells a guide RNA targeting exon 2 of PSPH was designed 
using to previously reported software (Hsu et al., 2013) and cloned into the pSpCas9(BB)-2A-
GFP plasmid using a previously reported protocol (Ran et al., 2013) (top strand: 
CACCGCACACCTGACCCCCGGCATA; bottom strand: 
AAACTATGCCGGGGGTCAGGTGTGC). HEK293 cells were transfected with the plasmid 
using PEI and grown in DMEM containing 10% FBS and 1 mM serine for 3 days before they 
were sorted to single cells via fluorescence activated cell sorting based on GFP fluorescence. 
Subsequently, single cell colonies were screened for indel formation using the Guide-it 
mutation detection kit (Clontech laboratories) and a complete PSPH knock out was confirmed 
by western blot analysis using α-PSPH antibody (ThermoFisher). The PSAT knockout 
HEK293 cell line (HEK293/PSAT-KO) was created analogously using guide RNA targeting 
exon 1 of PSAT (top strand: CACCGCCAGGCAGGTGGTCAACTTT; bottom strand: 
AAACAAAGTTGACCACCTGCCTGGC). The primers used for genotyping via the Guide-it 
mutation detection kit were: CAGCCTGTTAATGTTATTTTCAAGC (PSPH exon 2 forward 
primer), ACGCTGTAGTAAGCCATGATTATAC (PSPH exon 2 reverse primer), 
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AAACAGTAAACGCGAGGAGG (PSAT exon 1 forward primer), 
CTCATTCACACTATGTCCATTCATGC (PSAT exon 1 reverse primer). 
2.2.5.2.4 In Vitro Experiments 
SepRS Purification 
The gene fragment coding for SepRS was cloned into a pET-20b vector to give 
pET20b_SepRS. BL21(DE3) cells transformed with pET20b_SepRS were used to inoculate 2-
litre 2xTY culture. At OD600 = 0.5, 0.1 mM IPTG was added and the culture was incubated at 
24 °C for 16hrs before being pelleted. The cell pellet was resuspended in lysis buffer (50 mM 
Tris-HCl, pH = 8.0, 300 mM NaCl, 20 mM imidazole, 1 mM beta-mercaptoethanol). After 
sonication, the lysates were heated to 70°C for 20 min and centrifuged at 20 000g for 30 min. 
The supernatant was loaded onto a HisTrap column which was eluted by a linear gradient 
between 20 mM to 500 mM imidazole. The fractions with SepRS were pooled and incubated 
with 3C protease at 4 °C for 24hrs to remove the tag. Then, proteins were further loaded to 
HiTrap Q column and eluted with a gradient from 50 mM to 1 M NaCl. The fractions with 
SepRS were pooled, concentrated, and snap frozen in liquid nitrogen and stored at -80°C. 
tRNA Extraction and Purification 
HEK293 cells were transfected as described above with plasmid containing 4xU6-tRNAv1.0CUA 
cultured for 2 days and harvested by pipetting into ice cold PBS. 500 µl of cell pellet are 
resuspended in 6 ml of tRNA Buffer (50 mM NaOAc pH 5, 150 mM NaCl, 10 mM MgCl2, 
0.1 mM EDTA) and aliquoted into 5x2 ml vial. The cells are centrifuged again (5 min, 500 
rcf), the supernatant removed and 950 µl of fresh tRNA buffer are added. To lyse the cells, 50 
µl of liquefied phenol (P9346, Sigma Aldrich) are added and the tubes put in mild head-over-
tail shaking (10 rpm) for 15 min. The vials are then centrifuged for 25 min at 4 °C at 21,000 
rcf, then the supernatant containing the tRNAs is recovered and transferred to a new vial, where 
1 volume of chloroform is added. After thorough mixing using a vortex, the emulsion is 
separated in a centrifuge (1 min, 21,000 rcf) and the acqueous phase recovered. To deacylate 
the purified tRNAs, 40 µl of NaOH 300 mM are added to 680 µl of aqueous phase. The reaction 
is incubated for 1 h at 42 °C, then the solution is neutralised using 40 µl of NaOAc 3 M pH 5. 
The deacylated tRNAs are ethanol precipitated for 1 h at 10 °C by adding 2.33 volumes of 
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absolute ethanol to the recovered aqueous phase. After 30 min centrifugation at 21,000 rcf at 4 
°C the supernatant is removed and the precipitated RNAs resuspended in water. 
In Vitro Aminoacylation Assay 
The aminoacylation by SepRS was measured with AMP-Glo assay (Promega). 25 nM 
recombinant SepRS was mixed with 0, 3.3, 10, or 30 μg extracted tRNA in aminoacylation 
buffer (50 mM Tris pH = 7.4, 20 mM KCl, 2 mM DTT, 10 mM MgCl2) supplemented with 
0.1 mM ATP, 1 mM phosphoserine, and 0.1 mg/ml BSA. Reactions were assembled to 25 μl 
and were incubated at 37 °C for 2 hrs. The AMP generated by the reaction was then measured 
with AMP-Glo assay by following the instruction from the manufacturer. 
2.2.5.2.5 Quantitative Northern Blot Analysis 
500 ng of the RNAs purified from wild type cells or cell transfected with a plasmid containing 
the tRNAv1.0CUA are run alongside linear dilutions of RNA standard on a 10% acrylamide gel 
under denaturing conditions (7 M urea, 1xTBE buffer) for 70 min at 200 V using the BioRad 
Mini-proean apparatus. The gel is then stained using SYBR Gold and imaged under blue light 
to visualise total RNA, then the RNA is transferred on positively charged nylon membrane 
using iBolt transfer system and crosslinked to the membrane under UV light. The membrane 
was pre-hypridised using the ULTRAhyb®-Oligo Buffer for 30 min at 37°C, then 2 µg of 
infrared fluorescent probe [5'-/5IDR800/GTG GGA TTT GAA CCC ACG TAA GGC AAT 
TTT -3', Integrated DNA Technologies] were added. The hybridisation was carried out at 37°C 
overnight. The excess probe was washed using 2xSSC buffer containing 0.1% SDS four times, 
then the membrane imaged using the Amersham Typhoon 5 (785 nm laser). 
2.2.5.2.6 LC-MS Analysis of Intracellular Amino Acids 
HEK293, HEK293/PSPH-KO and HEK293/PSAT-KO cells were cultured and transfected as 
described above. Cells were detached using trypsin and washed three times with PBS before 
analysis. Concentration was measured using Countess II cell counter (ThermoFisher) prior to 
last pelleting of the cells. The frozen cell pellets were thawed at room temperature and 
resuspended in methanol-water (40:60) to 500 µl. The suspension was transferred to a 1.5-ml 
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eppendorf tube. The cells were lysed by six freeze-thaw cycles (liquid nitrogen and room 
temperature). The resulting lysate was centrifuged at 21,000 g for 1 h at 4 ˚C. The supernatant 
was pipetted into a 3K MWCO amicon centrifugal filter. The samples were centrifuged at 
14,000 g for 30 min at 4 ˚C. The flow-throw was analysed by LC-MS analysis. From the flow-
through, 50 µl aliquots were pipetted into 250-µl glass inserts (Agilent). To prepare a 
calibration curve, 50-µl aliquots of the control sample were spiked with serine, pSer, or 2 to a 
final concentration of 5, 10, 20, 40, or 80 µM. For comparison, analogous calibration curves 
were also prepared in a methanol-water mixture (40:60). 
An Agilent 1260 Infinity equipped with an Agilent 6130 Quadrupole LC-MS unit was used for 
analysis of all samples. From each sample, 10 µl was injected onto a Zorbax SB C18 column, 
4.6 x 150 mm equipped with a guard column (Agilent). Each sample was eluted from the 
column using a mobile phase gradient from 0.5 % to 95 % acetonitrile containing 0.02 % formic 
acid. The mass spectrometer was set to selected ion monitoring (SIM) mode. For pSer, the ions 
measured were 186 M/z in the positive mode and 184 M/z in the negative mode. For Ser, the 
ions measured were 106 M/z in the positive mode and 104 M/z in the negative mode. Lastly, 
for 2, the ions measured were 184 M/z in the positive mode and 182 M/z in the negative mode. 
The peaks for phosphoserine and serine overlapped with background peaks. Thus difference 
spectra were prepared for analysis by subtracting the chromatogram of the control with the 
chromatograms from each calibration standard. The resulting traces were integrated to derive 
a calibration curve. For the pSer lysate samples, the chromatograms from the HEK293 samples 
were subtracted from the chromatograms of the HEK293/PSPH-KO cell line. From the 
difference chromatograms, the unobscured peak for phosphoserine was integrated. A linear fit 
of the calibration curve from 10-80 µM was used to determine the concentration of serine, 
phosphoserine, and 2 in each of the lysates. 
Using the following equation, the intracellular concentration was determined from the lysate 
concentration and the cell number measurements for each sample. [IC] = (lysate concentration 
× lysate volume) / (total number of cells × cell volume). The lysate volumes were 500 µl for 
all experiments. An approximate value was used for the cell volume, 2 pL. The intracellular 
concentration of phosphoserine in the control HEK cells was roughly estimated by 
extrapolation of the calibration curve and comparison with the 5 µM calibration point. 
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2.2.5.2.7 Purification of GFP from Mammalian Cells 
HEK293 or HEK23/PSAT-KO cells were seeded into T-75 flasks  (5.25 × 106 per flask) 24 
hours before transfection with 18.75 μg of DNA (75 μL PEI). The medium was changed after 
4 hours to medium with or without 10 mM 2, neutralized with NaOH. Cells were harvested, 
lysed and GFP was purified via GFP pull-down using GFP-Trap_MA beads (ChromoTek 
GmbH) according to manufacturer's instructions 3 days after transfection. Proteins were eluted 
by addition of SDS-sample buffer and boiling at 95 °C for 10 minutes. Alternatively, proteins 
were eluted using 200 mM glycine buffer (pH 2), which was neutralized by addition of Tris 
HCl (pH 10.4). The proteins were separated via SDS-PAGE, stained using InstantBlue 
(Expedeon). 
2.2.5.2.8 Phos-tag SDS-PAGE Electrophoresis 
Cells were cultured and transfected as described above. Before harvesting, cells were washed 
twice with TBS and detached using pipette or cell scraper. The cells were lysed in RIPA buffer 
supplemented with HALT protease and phosphatase inhibitors (ThermoFischer). Protein 
concentration was measured using BCA assay (ThermoFischer) according to manufacturer’s 
instructions. 8% Phos-tag SDS-PAGE gels (Wako) were run according to manufacturer’s 
instructions (25 mA, 100-120 minutes) and the proteins were transferred onto PVDF membrane 
using iBlot2 system (ThermoFischer). The membrane was immunostained and developed as 
described above. GFP, GFP150pSer and GFP150(2) standards were expressed in E. Coli as 
described previously (Rogerson et al., 2015). Quantitative analysis was done using ImageJ. 
2.2.5.2.9 LC-MS/MS Analysis of Amino Acid Incorporation 
The tandem mass spectrometry was carried out as described previously (Rogerson et al., 2015). 
Briefly, bands of interest (1–2 mm) were cut from polyacrylamide gel. The gel slices were 
destained with 50% v/v acetonitrile and 50 mM ammonium bicarbonate, reduced with 10 mM 
DTT and alkylated with 55 mM iodoacetamide in 96-well plate. The proteins were digested 
overnight at 37 °C using 6 ng/μl trypsin solution (Promega) and the resulting peptides were 
extracted with 2% v/v formic acid, 2% v/v acetonitrile. The peptides were analyzed by 
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nanoscale capillary LC-MS/MS using Ultimate U3000 HPLC (ThermoScientific  Dionex) 
under 300 nl/min flow. Before separation, the peptides were trapped on a C18 Acclaim 
PepMap100 3 μm, 75 μm × 150 mm nanoViper (ThermoScientfic Dionex) and subsequently 
eluted with acetonitrile gradient into a modified nanoflow ESI source with a hybrid dual 
pressure linear ion trap mass spectrometer (Orbitrap Velos, ThermoScientific). Analysis was 
carried out using a resolution of 30,000 for the full MS spectrum followed by ten MS/MS 
spectra in the linear ion trap using 35 as threshold energy of for collision-induced dissociation.  
For the targeted analysis of the GFP tryptic peptide LEYNFNSH[X]VYITADK, where 
X=glutamine, serine, phosphoserine or 2, the theoretical masses were determined to 4 
significant figures for all relevant charge states and the raw data searched with a m/z range of  
±0.15 Da. The resulting extracted ion chromatograms were integrated and the area-under-the-
curve (AUC) was used for relative quantitation. 
The collected LC-MS/MS data were searched using the Mascot search engine (Matrix Science) 
against database containing Swiss-Prot and the GFP construct with all amino acids and post-
translational modifications allowed at position 150. Precursor tolerance of 5 p.p.m. and a 
fragment ion mass tolerance of 0.8 Da were used for the search, allowing two missed enzyme 
cleavages and variable modifications for oxidized methionine, carbamidomethyl cysteine, 
pyroglutamic acid and phosphorylated serine, threonine and tyrosine.  MS/MS data were 
subsequently validated using the Scaffold program (Proteome Software Inc.) and interrogated 
manually. 
2.2.5.2.10 MEK1 Expression 
HEK293/PSAT-KO cells were seeded and transfected as described above with combination of  
pPB_FLAG-SepRS_Myc-EF1a_V5-eRF1(E55D)_V5-PSPH_4xU6-tRNAv1.0CUA, Erk-GFP 
reporter and pPB_MEK1(218TAG)_4xU6-tRNAv1.0CUA or 
pPB_MEK1(218TAG222Asp)_4xU6-tRNAv1.0CUA. The cells were incubated in DMEM 
supplemented with 10% FBS and 10 mM 2, lysed and analysed by phos-tag-SDS-PAGE or 
SDS-PAGE and western blotting, as described above. 
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2.2.5.3 QUANTIFICATION AND STATISTICAL ANALYSIS 
Quantification of western blots was carried out using ImageJ. Details of all statistical datasets 
are included in the corresponding figure legends. 
 Chapter 3 Genetic Code Expansion for Site-
specific Live-cell Protein Labelling 
Genetic code expansion has emerged as a unique tool to label proteins in live cells. This chapter 
provides an overview of genetic code expansion in the context of protein labelling and imaging 
and describes two major advances in protein labelling in mammalian cells.  
First, we leverage recent developments in genetic code expansion in mammalian cells to 
densely label proteins with bright and photostable organic dyes and image them using super-
resolution microscopy. 
In the second section, we identify the readthrough of endogenous amber codons, resulting in 
aberrantly extended proteins bearing the non-canonical amino acid, as the primary source of 
non-specific labelling. We minimise this off-target labelling through optimisation of the 
transfection protocol for multiple distinct proteins. We then demonstrate that the resulting 
protocol allows live-cell imaging of low levels of proteins with signal-to-noise comparable to 
immunofluorescence. 
In the last section, we demonstrate the efficiency of the new protocol for live-cell imaging, 
describing the dynamic behaviour of a recently discovered microprotein NoBody in live cells.  
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3.1 Introduction 
Visualization of biomolecules by fluorescent microscopy has transformed our understanding 
of biological systems (Tsien, 1998). The use of fluorescence, in which the imaged object itself 
emits light after absorbing it, allows for better image quality as the emitted light can be 
spectrally separated due to the Stokes shift that results as vibrational relaxation of the excited 
state before the photon is emitted. When coupled with the right labelling technique 
fluorescence imaging provides molecular specificity to the otherwise very complex biological 
samples. 
Fluorescent imaging has been useful across several orders of magnitude of both space and time: 
from morphogenesis of tissues and organs in entire organisms such as the fruit fly (McMahon 
et al., 2008), nematode (Liu et al., 2009), zebrafish (Keller et al., 2008) or mouse embryos 
(Keller, 2013; Trichas et al., 2012) over many days down to structural insights on the 
nanometre scale (with most recent super-resolution methods) and nanosecond time resolution 
(Elangovan et al., 2002; St-Pierre et al., 2014). 
3.1.1 Super-resolution imaging 
The advent of super-resolution microscopy has enabled researchers to observe biological 
processes occurring on a scale below the diffraction limit (Betzig et al., 2006; Klar et al., 2000; 
Rust et al., 2006). In aggregate the two main approaches single-molecule localization 
microscopy (which includes photoactivated localization microscopy (Betzig et al., 2006) and 
stochastic optical reconstruction microscopy (Rust et al., 2006)) and stimulated emission 
depletion microscopy (STED) (Klar et al., 2000) use photophysical properties of the 
fluorescent dyes to break the diffraction barrier, first described by Abbe in 1873 (Abbe, 1873). 
Patterned illumination approaches also allow improvement in resolution by expanding the 
optical transfer function of the microscope ((Gustafsson, 2005)), however, the resolution 
improvement is limited to a factor of 2 (in all 3 simensions).  
Specifically, the methods rely on turning majority of the fluorescent molecules to an OFF state. 
STED achieves this by stimulated emission in a structured ‘donut’ pattern around the focal 
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point (Hell and Wichmann, 1994), which allows for saturable depletion outside of the focal 
point. The donut pattern is achieved by insertion of phase mask into the stimulated emission 
beam which itself is superimposed on the excitation beam. As a result fluorophores positioned 
anywhere outside of the very centre of the ‘donut’ beam are forced into ground state via the 
stimulated emission. Subsequently, the fluorescence from the subdiffraction area inside the 
donut is detected (Hell and Wichmann, 1994; Klar et al., 2000). The single-molecule 
localisation microscopy approaches illuminate the entire sample using a widefield microscope 
but use special conditions where only small subset of fluorophores emit at any given time 
(Huang et al., 2009). In PALM or fluorescence PALM (fPALM) (Hess et al., 2006) molecules 
are stochastically converted by low-power activating beam into active state, where they are 
imaged and immediately photobleached back into non-fluorescent state (Betzig et al., 2006). 
This is possible due to the discovery of several variants of green fluorescent protein (GFP) that 
can be activated or change colour by high-frequency (~ 405 nm) light  (Ando et al., 2002; 
Patterson and Lippincott-Schwartz, 2002; Wiedenmann et al., 2004). In STORM, majority of 
the molecules are excited but subsequently transition into the dark triplet state in the presence 
of thiols (usually mercapthoethylamine or β-mercaptoethanol) (Dempsey et al., 2011). 
The photophysical properties are critical for the performance of super-resolution methods.  
Main parameters are photon emission, the duty cycle (ratio of time spent in dark state vs. active 
state), photostability and number of switching cycles before bleaching (Dempsey et al., 2011). 
This demand has created an urgent need for efficient, specific, and non-perturbative methods 
to label molecules in living cells with bright and photostable fluorophores. 
3.1.2 Fluorescent proteins 
Historically, fluorescent labelling of organisms relied on antibody labelling (Coons, 1942), 
which requires sample fixation and, for imaging of intracellular proteins, membrane 
permeabilisation. Inherently, cell fixation does not provide information on cellular dynamics, 
which can be obtained through either direct imaging or alternative techniques such as 
fluorescence recovery after photobleaching (FRAP), fluorescence correlation spectroscopy 
(FCS), fluorescence cross-correlation spectroscopy (FCCS), single-particle tracking (SPT), or 
Förster resonance energy transfer (FRET) experiments. In addition, fixation of cells for 
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microscopy may lead to significant artifacts and distortions of cellular features (Schnell et al., 
2012). 
Since 1990s the green fluorescent protein (Chalfie et al., 1994; Prasher et al., 1992) and its 
spectral variants (Heim and Tsien, 1996) have ignited a revolution in live-cell imaging (Tsien, 
1998), thanks to the ability to encode the fluorescent protein tag genetically as a fusion to the 
protein of interest. This development has allowed scientists to study protein localisation using 
fusion tags, use GFP as a reporter gene, in FRET exepriments, for metabolite indicators, pH 
indicators and many others (Zimmer, 2002). Despite many developments, the nature of the 
fluorophore formation in fluorescent proteins (FP) inherently limits their photophysical 
properties (Wang et al., 2014). 
3.1.3 Organic fluorophores 
Organic fluorophores provide an attractive alternative to fluorescent protein due to their 
virtually unconstrained chemical structure. Dye synthesis is a traditional field of organic 
chemistry and the majority of fluorescent dyes such as coumarins, fluoresceins, rhodamines 
phenoxazines and cyanines were synthesized in the late 19th or early 20th century (Lavis, 2017). 
To improve the dye properties various functionalities were introduced, such as sulfonation to 
increase solubility or structural motifs to rigidify the structure to increase photostability and 
brightness. The resulting lines of dyes, including the dyes known as ‘Alexa Fluor’ (Panchuk-
Voloshina et al., 1999) and ‘CyDyes’ (Mujumdar et al., 1993), are still commonly used today 
and have been modified for various uses including staining of various organelles, or as ion 
indicators (Lavis and Raines, 2008). 
The recent advances in super-resolution microscopy with its high demand on the ‘photon 
budget’ have spurred new developments in organic dyes. Most notably, silicon-substituted 
rhodamine (SiR) has emerged as a particularly useful, far-red dye for super-resolution imaging 
(Lukinavičius et al., 2013). Besides its  excellent spectroscopic properties, SiR exists in 
equilibrium between open, zwitterionic and closed forms, which is nonfluorescent. The free 
dye in solution adopts the closed form, but shifts the equilibrium when bound to a polar protein 
surface. This renders the SiR a ‘fluorogenic’ dye and leads to minimal background originating 
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from an unbound dye, reducing the necessity for sample washes (Lukinavičius et al., 2013). 
SiR has since been engineered for, among other uses, labelling of cytoskeletal proteins 
(Lukinavičius et al., 2014) and DNA (Lukinavičius et al., 2015) and further developed to a 
further red-shifted version SiR700 (Lukinavičius et al., 2016). An alternative to SiR derivatives 
have been developed by the Lavis group, who have used Pd-catalyzeed cross-coupling 
chemistry to introduce azetidine ring into tetramethyl-rhodamine, significantly increasing its 
brightness and photostability (Grimm et al., 2015), an approach that could be further extended 
to other dyes spanning the visible spectrum (Grimm et al., 2015; Grimm et al., 2017). 
3.1.4 Current protein labelling strategies 
Currently, the approaches for specific protein labelling with organic dyes rely on genetically 
encoded tag expressed as part of the protein, which directs the fluorophore to the protein. The 
commonly used protein tags include SNAP-tag/CLIP-tag (Gautier et al., 2008), HaloTag (Los 
et al., 2008), FlAsH (Martin et al., 2005), and PRIME (Uttamapinant et al., 2010). All of these 
methods rely on attachment of protein or peptide appendages to the target molecules, which 
are known to perturb their function, localisation and dynamics. In addition, these methods are 
limited to the protein termini and, in some cases, flexible loop domains, which renders many 
important targets impossible to visualise in live cell context either without major perturbations 
or completely. 
An alternative to protein fusion is to use a small molecule binder. In an example of this 
approach, Lukinavicius and colleagues fused the silicon-rhodamine dye to paclitaxel (Taxol) 
and phalloidin, known microtubule and actin binding molecules (Lukinavičius et al., 2014). 
The resulting molecules allowed them to study the cell cytoskeleton using super-resolution 
microscopy without any genetic modification. While simple to use, the small molecule binders 
must be membrane permeable and not actively exported from the cell interior, which is not 
trivial (Lukinavičius et al., 2014). Similarly, this approach is not easily transferrable to other 
protein targets for which a strong and specific small molecule binder may not be available. 
Lastly, the targeting moiety must not interfere with the target protein function. 
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3.1.5 Bioorthogonal chemistry and genetic code expansion 
Genetic code expansion has recently emerged as a unique method to label proteins in live cells 
with organic fluorophores. This development was enabled by the advance in bio-orthogonal 
chemistry, a group of chemical reactions that:  
(1) are selective under physiological conditions and with respect to the cellular environment; 
(2) produce stable covalent linkage that is not metabolically or thermodynamically broken and; 
(3) produces no toxic byproducts and require no toxic catalysts (Lang and Chin, 2014).  
In the live-cell labelling context, these reactions should also have high second-order rate 
constant k2 (labelling reactions normally follow second-order kinetics) such that quantitative 
labelling can be achieved on a reasonable timescale without necessity to provide an excess of 
labelling reagent. Among the most widely used reactions for cellular labelling are azide-alkyne 
reactions ([3 + 2 cycloadditions) (Himo et al., 2005). To proceed at physiological conditions, 
the cycloaddition requires the use of copper(I) salts  (Tornøe et al., 2002; Wang et al., 2003), 
which can be toxic to cells (Wolbers et al., 2006). An attractive alternative are the strained 
alkene/alkyne-tetrazine reactions ([4 + 2 Diels-Alder cycloadditions) (Boger, 1986), which 
proceed at much higher rate than strain-promoted click reactions. 
As reviewed in section 1.6, genetic code expansion uses a new, orthogonal aminoacyl-tRNA 
synthetase/tRNA pair to incorporate non-canonical amino acid into proteins, generally in 
response to the amber stop codon. Pioneered by the Schultz group, several amino acids bearing 
bio-orthogonal handles, such as azides, alkynes, alkenes or ketones have been incorporated 
(Chin et al., 2003; Chin et al., 2002b; Deiters et al., 2003; Mehl et al., 2003; Nguyen et al., 
2009b; Wang et al., 2003; Zhang et al., 2002). More recently, strained alkenes, such as 
norbornenes and trans-cyclooctenes (Lang et al., 2012a) and bicycle[6.1.0nonynes (Lang et 
al., 2012b) have been incorporated and used to site-specifically label proteins in E. coli and 
mammalian cells with tetrazine-dye conjugates. In many instances the use of tetrazine 
conjugated dyes exhibit weak fluorescence when in solution but become strongly fluorescent 
upon attachment (Lang et al., 2012b). This fluorogenic behaviour further helps to increase the 
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specificity of the labelling approach by supressing the background and limiting the need for 
sample washes. 
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3.2 Genetic code expansion enables live-cell and super-
resolution imaging of site-specifically labeled cellular proteins 
3.2.1 Introduction 
The rise of super-resolution microscopy led to a renewed interest in protein labelling 
technologies. As introduced in chapter 3.1, super-resolution microscopy relies on a bright and 
photostable fluorophores that provide large ‘photon budget’, allowing imaging with high 
spatial and temporal resolution whilst maintaining low phototoxicity (Liu et al., 2015). Due to 
the very high spatial resolution of the imaging methods, the size of the fluorescent probe itself 
can play important role. The current experimental limits of approx. ~10 nm in X and Y (Strauss 
et al., 2018) are on the same range as the size of fluorescence proteins (~ 4.2 x 2.4 nm) and 
significantly below the size of commonly used antibodies (10 – 15 nm for single antibody and 
up to 30 nm when using secondary antibodies). Thereby, labelling proteins directly with 
organic fluorophores, which are small, bright and very photostable, offers a significant 
advantage for super-resolution imaging.  
Super-resolution microscopy may be used to determine the sub molecular structure of protein 
assemblies through particle averaging (Szymborska et al., 2013). To achieve this, multiple sites 
on the target protein or protein assembly need to be labelled and thereby specific antibodies 
against various epitopes need to be raised. The genetic code expansion, which allows site-
specific labelling, is ideally suited to this approach, extending its applicability to virtually any 
proteins or protein assemblies. 
Simultaneously, the high image resolution requires a dense labelling of the ultrastructures to 
achieve sufficient spatial resolution (Nieuwenhuizen et al., 2013). Previously, genetic code 
expansion in mammalian cells suffered from poor yields, making high level of protein 
expression and labelling difficult. Recently, Schmied et al. have developed a new mammalian 
expression system, which provided high expression thanks to high level of the amber 
suppressor tRNAPylCUA. This system expressed 129% of full length GFP containing a single 
non-canonical amino acid (Nε-Boc-L-lysine) when compared to a wild-type GFP expressed 
from cytomegalovirus (CMV) promoter (Schmied et al., 2014) 
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3.2.2 Super-resolution imaging of mammalian cytoskeleton 
Using the mammalian expression system developed by Schmied and colleagues, Uttamapinant 
et al. were able to densely label and cytoskeletal proteins actin and vimentin as well as the 
epidermal growth factor (EGFR) and image them using multiple super-resolution techniques 
(Uttamapinant et al., 2015). Both actin and vimentin were labelled by incorporating the 
bicyclo[6.1.0nonyne-lysine (BCNK) via the BCNKRS/tRNAPylCUA pair (Lang et al., 2012b). 
Once expressed, the proteins were labelled in live cells with 4-(1.2.4.5-tetrazin-3-
yl)benzylamino derivative of silicon rhodamine (SiR-tetrazine) (Lukinavičius et al., 2013), via 
the inverse-electron-demand Diels-Alder cycloaddition (Figure 3.1). 
 
 
a
b
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Figure 3.1. Super-resolution imaging of mammalian cytoskeleton via genetic code expansion. 
(a) Protein labelling via incorporation of BCNK using the BCNKRS/tRNAPylCUA pair (Lang et 
al., 2012) and subsequent derivatization with tetrazine-dye conjugate. (b) Representative image 
of actin(K118BCNK) using widefield (left panels) and STORM microscopy (right panels). 
Adapted from (Uttamapinant et al., 2015). 
 
3.2.3 tRNAPylCUA-dependent labelling background 
When imaging the cytoskeletal protein vimentin, we observed an occasional fluorescent signal 
in the nucleus of some cells. Because vimentin is an exclusively cytosolic protein, we 
hypothesized that the signal may be originating from aminoacylated tRNAPylCUA trapped in the 
nucleus where it is not available for translation. To verify this, we carried out fluorescence in 
situ hybridisation (FISH) experiments, to see whether the background signal co-localises with 
the tRNAPylCUA. We transfected HEK293 cells with plasmids containing the BCNKRS, 
tRNAPylCUA and Myc-vimentin(N116TAG) and incubated them in presence of 1 mM BCNK 
for 48 hours. The cells were washed and labelled with 400 nM carboxyfluorescein diacetate 
(CFDA) tetrazine conjugate and fixed. The cells were then stained with Alexa Fluor 647 
labelled oligonucleotide targeting the tRNAPylCUA  and anti-Myc antibody to verify the 
localization of vimentin. We observed that indeed the tRNAPylCUA  signal co-localised with the 
nuclear CFDA signal but not with the anti-Myc signal, confirming that the source of the non-
specific signal is the aminoacylated tRNAPylCUA (Figure 3.2). While this problem may be 
remedied by longer washout periods, allowing the aminoacylated tRNA to be turned over, this 
situation posses a challenge for proteins with high turnover or protein synthesized at a low 
level. 
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Figure 3.2. tRNAPylCUA-dependent labelling background. HEK293 cells transfected with 
plasmids bearing BCNKRS, tRNAPylCUA and Myc-vimentin(N116TAG) were cultured in 
presence of 1 mM BCNK and labelled with tetrazine-CFDA (centre panels), oligonucleotide 
targeting the tRNAPylCUA (right panels) and anti-Myc antibody, targeting the product of Myc-
vimentin(N116TAG) gene (left panels). White arrows highlig1ht the nuclear background co-
localizing with tRNAPylCUA signal but not anti-Myc staining. (Figure taken from (Uttamapinant 
et al., 2015))  
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3.3 Optimizing live-cell labelling signal-to-noise ratio 
3.3.1 Optimization of labelling in mammalian cells 
In previous experiments we (Uttamapinant et al., 2015) and others (Peng and Hang, 2016) have 
observed low level of background labelling of the mammalian proteome when mammalian 
cells were transfected with one of the evolved variants of pyrrolysyl-tRNA synthetase 
(PylRS)/pyrrolysyl-tRNACUA (tRNA
Pyl
CUA) pair from Methanosarcina species (MbBCNKRS 
(Lang et al., 2012b) or MmPylRS-AF mutant (Yanagisawa et al., 2008)) in combination with 
an amber mutant of a protein of interest. 
Because this non-specific labelling is dependent on the presence of the non-canonical amino 
acid with bioorthogonal reactive group and manifested as several discrete bands on fluorescent 
scans of SDS-PAGE gels, we hypothesised that the non-specific background originates from 
aberrant readthrough of endogenous amber codons rather than non-specific attachment of dye 
molecules to cell proteome. While aberrantly extended proteins are degraded by the cell over 
time (Arribere et al., 2016), this background can lead to decrease in signal-to-noise ratio for in 
vivo imaging applications, especially on shorter timescales. 
Two recent advances in protein labelling using non-canonical amino acids focus on decreasing 
the labelling of the charged MmPyl-tRNAPylCUA or the MmPylRS/tRNA
Pyl
CUA pair complex. 
The first approach relies on simple decrease of the tRNAPylCUA expression (Aloush et al., 2018), 
the latter approach relies on observation that the PylRS from Methanosarcina mazei (Mm) 
locates to the nucleus when expressed in mammalian cells and consequent trapping of the 
charged tRNAPylCUA, which is labelled by the tetrazine-dye conjugate (Nikić et al., 2016). The 
solution presented was the addition of nuclear export sequence (NES) to the coding sequence 
of the PylRS, that resulted in up to 15-fold increase in amber suppression efficiency along with 
marked decrease of labelling background. 
We tested this approach using the amino acid BCNK, which permits significantly more 
efficient labelling of the expressed proteins and comparable expression rate (Peng and Hang, 
2016), while preventing chemical elimination of the functional group of the amino acid (Ge et 
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al., 2016). Unfortunately, under the condition we tested (5 and 50 µM BCNK) the several 
different N and C-terminal fusions of NES did not show improved amber suppression 
efficiency compared to that of the wild type MmPylRS-AF (Figure 3.3 and 3.4). 
Next we checked for the presence of nuclear aggregation using the MmPylRS-AF mutant. We 
overexpressed FLAG tagged versions of the MmPylRS-AF and NES-MmPylRS-AF in 
combination with tRNAPylCUA in HEK293 cells. The cells were grown in the presence of 50 
µM BCNK and labelled using SiR-tetrazine. The cells were subsequently fixed, permeabilised, 
immunostained with anti-FLAG antibody and imaged using confocal microscope. Similarly to 
our previous observations (Figure 3.2) and previous studies (Nikić et al., 2016) we detected 
discernable nuclear aggregation of the MmPylRS-AF in the form of puncta (Figure 3.3). Some 
of the nuclear aggregates co-localised with labelling in the SiR channel, suggesting that 
nuclear-trapped BCNK-tRNAPylCUA can be labelled by the tetrazine-dye conjugate (Figure 
3.3). When using the NES-MmPylRS-AF we did not observe any nuclear aggregates of NES-
MmPylRS-AF supporting this hypothesis, however, the major fraction of the non-specific 
labelling persisted (Figure 3.3). This observation is consistent with the hypothesis that majority 
of the labelling originates from the aberrantly extended endogenous proteins. We note that we 
observed nuclear puncta only when we overexpressed the MmPylRS-AF (Figure 3.5) and 
under the conditions of our labelling experiments we did not see significant aggregation and 
labelling of tRNAPylCUA in the cell nuclei (Figure 2, S3, S6, S7). 
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Figure 3.3. Effect of nuclear export of MmPylRS-AF on cellular localization and nuclear 
labelling background. HEK293 cells transfected with MmPylRS-AF (top panels) and NES-
MmPylRS-AF (FLAG-NS2-MmPylRS-AF, see Figure S2) (bottom panles).The cells were 
cultured in presence of BCNK for 24 hours, washed and labelled with SiR-tetrazine. Nuclear 
aggregates observed when MmPylRS is overexpressed are highlighted with white arrows. Scale 
bar represents 20 µm. 
 
Similarly, we checked for the presence of nuclear aggregation and observed that under the 
conditions used in our study, we did not see significant aggregation of ncAA labelling in the 
cell nuclei but rather a diffuse signal present throughout the cell (Figures 3.5, 3.8, 3.9 and 
SiR Channel
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3.3 Optimizing live-cell labelling signal-to-noise ratio 95 
 
3.10). When we overexpressed the MmPylRS-AF we did observe occasional aggregation in the 
cell nucleus. Under these conditions, the labelling on the tRNAPylCUA may make a appreciable 
contribution to the non-specific background, and may be prevented by the use of NES.  
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Figure 3.4. Effect of nuclear export of MmPylRS-AF on amber suppression at 50 µM BCNK. 
(a) Nuclear export sequences (NES) tested: PKI = LALKLAGLDIG and NS2 = 
MTKKFGTLTI. (b) Amber suppression efficiency measured by flow cytometry and expressed 
as a ratio of mCherry and GFP fluorescence resulting from co-transfection of mCherry-TAG-
GFP reporter alongisde the PylRS-AF/tRNAPylCUA transgenes. (c) Raw data used to calculate 
amber suppression efficiency in panel b.  
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Figure 3.5. Effect of nuclear export of MmPylRS-AF on amber suppression at 5 µM BCNK. 
(a) Nuclear export sequences (NES) tested: PKI = LALKLAGLDIG and NS2 = 
MTKKFGTLTI. (b) Amber suppression efficiency measured by flow cytometry and expressed 
as a ratio of mCherry and GFP fluorescence resulting from co-transfection of mCherry-TAG-
GFP reporter alongisde the PylRS-AF/ tRNAPylCUA transgenes. (c) Raw data used to calculate 
amber suppression efficiency in panel b.  
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Figure 3.6. Nuclear background caused by aggregation of PylRS-AF in nucleus. HEK293 cells 
were transfected with 50 ng of vimentin(N116TAG) and variable amount of PylRS-AF 
plasmid, controlling for total amount of tRNAPylCUA gene transfected and incubated in presence 
of 50 µM BCNK. Sub-nuclear puncta originating from PylRS-AF aggregation (white arrows) 
are apparent only in few cells and at high level of expression, while most of the background is 
diffuse throughout the nucleus. Scalebar 30 µm.  
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To improve the signal-to-noise ratio (SNR) we therefore sought to increase the specific signal, 
i.e. labelling of the protein of interest, while minimizing non-specific labelling of aberrantly 
extended proteins expressed by readthrough of endogenous amber codons. We hypothesized 
that increasing the level of mRNA of the target protein would lead to increase in specific signal 
as more of the charged tRNAPylCUA is will be directed to ribosomes translating the transgene 
mRNA compared to readthrough of the endogenous amber codons. To test this hypothesis, we 
transfected HEK293 cells with increasing amount of sfGFP(150TAG) plasmid, maintaining 
constant amount of the MmPylRS-AF and tRNAPylCUA transgenes, controlling for the total 
amount of transfected DNA. After overnight expression in the presence of bicycle[6.1.0]non-
4-yn-9-ylmethanol lysine (BCNK), the cells were washed and labelled for 20 minutes in vivo 
with 4-(1.2.4.5-tetrazin-3-yl)benzylamino derivative of silicon rhodamine (SiR-tetrazine). 
After additional washing step to remove the free dye, the cells were lysed and analysed by 
SDS-PAGE. Fluorescent scans of the gels (Figure 3.7) showed a dose-dependent increase of 
specific fluorescent labelling, corresponding to increase in expression of sfGFP(150BCNK), 
further confirmed by α-GFP western blot (bottom panel). Importantly, the increase in specific 
labelling was concurrent with decrease in background labelling of the proteome, consistent 
with the hypothesis that bigger fraction of the aminoacylated tRNAPylCUA gets directed to 
translation of the sfGFP(150TAG) mRNA compared to the endogenous amber codons. 
Quantification of the signal confirmed 3-fold increase in SNR as a result of increased amount 
of sfGFP(150TAG) plasmid transfected (Figure 3.7b and 3.8).  
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Figure 3.7. Optimization of protein labelling via genetic code expansion. (a) Fluorescent scan 
of SDS-PAGE gel of lysates of HEK293 cells transfected with increasing amount of 
sfGFP(150TAG) plasmid, incubated overnight in presence of 50 uM BCNK and labelled in 
vivo with SiR-tetrazine (top). α-GFP and α-tubulin western blot of the SDS-PAGE gel gel 
(bottom). The fluorescence contrast was enhanced through use of heat colormap (shown left) 
(see Figure 3.8 for grayscale image fluorescent traces). (b) Quantification of signal-to-noise 
ratio based on fluorescence intensity of the GFP150BCNK band and the rest of the proteome. 
Data represent mean +/- SD from three biological replicates. (c) Fluorescent scan of SDS-
PAGE gel of lysates of HEK293 cells transfected with 1900 ng of sfGFP(150TAG) plasmid, 
incubated overnight with varying amount of BCNK in the culture media and labelled in vivo 
with SiR-tetrazine (top). α-GFP western blot of the SDS-PAGE gel gel (bottom). The 
fluorescence contrast was enhanced through use of heat colormap (see Figure 3.8 for grayscale 
image fluorescent traces). (d) Quantification of signal-to-noise ratio based on fluorescence 
intensity of the GFP150BCNK band and the rest of the proteome. Data represent mean +/- SD 
from three biological replicates.   
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Figure 3.8. Grayscale versions of in-gel fluorescence scans and coresponding fluorescent 
traces. (a) Figure 3.7a in gray scale. (b) Fluorescent intensity traces of lanes in panel a. (c) 
Figure 3.7c in gray scale. (d) Fluorescence intensity traces of lanes in panel c.  
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Increasing the amount of transfected exogenous DNA may result in overexpression of the target 
protein. We hypothesized that decreasing the BCNK concentration will lead to decrease in both 
the expression and labelling of the protein of interest as well as aberrantly extended proteins 
with endogenous amber codons, resulting in constant SNR. We tested this hypothesis by 
transfecting HEK293 cells with sfGFP(150TAG) DNA and plasmid containing the MmPylRS-
AF and tRNAPylCUA transgenes, varying the concentration of BCNK. As expected, both 
expression (Figure 3.7c bottom) and labelling (Figure 3.7c top) of sfGFP150BCNK was 
strongly dependent on the amount of supplied BCNK.  Similarly, the labelling of the proteome 
decreased with the decreasing concentration of BCNK, consistent with lower readthrough of 
amber codons by the aminoacylated tRNAPylCUA. Consistent with our hypothesis, we observed 
a relatively constant SNR across the various concentrations of BCNK, with the exception of 1 
µM BCNK, where other source of non-specific labelling may come into play (Figure 3.7c top). 
Importantly, this data suggests that lowering the concentration of BCNK can precisely regulate 
the level of target protein expression without compromising the SNR of the target labelling. 
3.3.2 Verification for in situ labelling in mammalian cells 
To confirm these results for in situ imaging, we took advantage of our observation that after 
transfecting cells with only MmPylRS-AF and tRNAPylCUA most of the fluorescent labelling 
resulting from aberrantly extended proteins in cells was located in the cell nucleus (Figure 
3.6). We reasoned that transfecting and labelling an exclusively cytosolic protein would allow 
us to separate true signal located in the cytosol and the non-specific labelling in the nucleus 
and thereby quantitatively assess the SNR for in situ imaging. To this aim, we used previously 
reported Myc-vimentin(N116TAG) construct (Uttamapinant et al., 2015). We transfected 
HEK293 cells with increasing amount of Myc-vimentin(N116TAG) gene, keeping the amount 
of PylRS and tRNAPylCUA genes as well as the total amount of transfected DNA constant. The 
cells were labelled with SiR-tetrazine, fixed and stained with α-Myc antibody, immunostaining 
only the exogenously expressed Myc-vimentin(N116BCNK) protein. We imaged the cells 
using confocal microscope, manually segmented the cells into nuclear and cytosolic parts and 
quantified the mean fluorescent signal originating from the two cellular compartments (Figure 
3.9a, 3.9b, 3.10a and 3.11a). For immunofluorescence, the SNR, calculated as a ratio of 
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cytosolic to nuclear signal, increased approximately 2-fold with increasing amount of DNA 
transfected, as expected from the increase in amount of Myc-vimentin(N116BCNK) expressed. 
For BCNK labelling, however, the SNR increased more than 8-fold between lowest and highest 
amount of Myc-vimentin(N116TAG) transfected (Figure 3.9b), with SNR comparable to 
immunostaining for transfection of 950 ng of Myc-vimentin(N116TAG) plasmid. We 
confirmed the imaging assay using SDS-PAGE analysis (Figure 3.12) with results in exact 
agreement with our in situ imaging assay. 
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Figure 3.9. In situ quantification of signal-to-noise ratio for protein labelling via genetic code 
expansion. (a) Representative images of HEK293 cells expressing Myc-vimentin(116BCNK) 
labelled using α-Myc antibody (left) and SiR-tetrazine (right) after transfection of varying 
amount of the Myc-vimentin(116TAG) plasmid (for full scale images see Figure 3.10) (b) 
Signal-to-noise (SNR) calculated as ratio of mean cytosolic and nuclear signal (mean values ± 
SEM, n > 100 cells per condition). (c) Representative images of HEK293 cells expressing Myc-
vimentin(116BCNK) labelled using anti-Myc antibody (left) and SiR-tetrazine (right) after 
incubation in presence of varying amount BCNK (for full scale images see Figure 3.11) (d) 
Signal-to-noise (SNR) calculated as ratio of mean cytosolic and nuclear signal (mean values ± 
SEM, n > 100 cells per condition).  
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Figure 3.10. Reresentative full-size images shown in Figure 3.9a and used to generate data in 
Figure 3.9b. (a) HEK293 cells were transfected with progressively increasing amount of 
vimentin(N116TAG) DNA plasmid, keeping the amount of PylRS-AF and tRNAPylCUA genes 
constant. The vimentin(116BCNK) was labellied in vivo by SiR-tetrazine (SiR channel) and 
post fixation and permeabilisation by anti-Myc antibody (IF (α-Myc)). Scalebar 50 µm. (b) 
Cells were manually segmented into nuclear and cytoplasmic regions and the signal in both 
BCNK and IF channel was quantified. Values shown are mean ± SEM. Each bar represents 
over 100 cells analysed.  
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Figure 3.11. Reresentative full-size images shown in Figure 3.9c and used to generate data in 
Figure 3.9d. (a) HEK293 cells were transfected with constant amount of vimentin(N116TAG), 
PylRS-AF and tRNAPylCUA genes and incubated in presence of varying amount of BCNK. The 
vimentin(116BCNK) was labellied in vivo by SiR-tetrazine (SiR channel) and post fixation 
and permeabilisation by anti-Myc antibody (IF (α-Myc)). Scalebar 50 µm. (b) Cells were 
manually segmented into nuclear and cytoplasmic regions and the signal in both BCNK and IF 
channel was quantified. Values shown are mean ± SEM. Each bar represents over 100 cells 
analysed.  
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Figure 3.12. In-gel quantification of signal-to-noise ratio for in vivo labelling of vimentin via 
genetic code expansion. (a) Grayscale (left) and colourmap (right) fluorescent scans of SDS-
PAGE gel of lysates of HEK293 cells transfected with increasing amount of Myc-
Vimentin(116TAG) plasmid, incubated overnight in presence of 50 uM BCNK and labelled in 
vivo with SiR-tetrazine. (b) Fluorescent intensity traces corresponding to lanes in panel a. (c) 
Quantification of signal-to-noise ratio based on fluorescence intensity of the Myc-
Vimentin(116BCNK) band and the rest of the proteome. (d) Grayscale (left) and colourmap 
(right) fluorescent scans of SDS-PAGE gel of lysates of HEK293 cells transfected with 1900 
ng of Myc-Vimentin(116TAG) plasmid, incubated overnight in presence of varying 
concentrations of BCNK and labelled in vivo with SiR-tetrazine. (e) Fluorescent intensity 
traces corresponding to lanes in panel d. (f) Quantification of signal-to-noise ratio based on 
fluorescence intensity of the Myc-Vimentin(116BCNK) band and the rest of the proteome.  
a d
e fb c
kDa
250
150
100
75
50
25
15
10
37
20
Vimentin(116TAG) DNA (ng)
Vimentin(116TAG) DNA (ng)
Grayscale Colormap
10
0
40
0
90
0
14
00
19
00
0 10
0
40
0
90
0
14
00
19
00
0
0 1 2 3 4
0
10000
20000
30000
40000
F
lu
o
re
s
c
e
n
c
e
 (
a
.u
.)
0 ng
100 ng
400 ng
900 ng
1400 ng
1900 ng
10
0 
ng
40
0 
ng
90
0 
ng
14
00
 n
g
19
00
 n
g
Grayscale Colormap
BCNK (µM)
1 5 10 20 500 1 5 10 20 500kDa
250
150
100
75
50
25
15
10
37
20
0 1 2 3 4
0
10000
20000
30000
40000
F
lu
o
re
s
c
e
n
c
e
 (
a
.u
.)
0 uM
1 uM
5 uM
10uM
20 uM
50 uM
0.0
0.5
1.0
1.5
2.0
2.5
S
N
R
1 
uM
5 
uM
10
uM
20
 u
M
50
 u
M
0
1
2
3
S
N
R
108 Genetic Code Expansion for Site-specific Live-cell Protein Labelling 
 
Next we wanted to confirm that decreasing the BCNK concentration provides control over 
expression levels of Myc-vimentin(N116BCNK) while maintaining SNR. As expected, we 
observed similar SNR for immunofluorescence labelling and BCNK labelling across different 
BCNK concentrations (Figure 3.9c-d). Interestingly, the cytosolic signal from SiR-tetrazine 
decreased correspondingly to the decreasing BCNK concentration, while immunostaining level 
remained relatively constant (Figure 3.11b). This result suggests that labelling proteins via 
unnatural amino acids allows quantitative analysis of protein levels via fluorescence imaging, 
overcoming the issue of low antibody penetration after fixation.  
We conclude that the DNA concentration of the amber mutant transgene controls the SNR of 
the labelling method and that the observed SNR for the optimized conditions matches that of 
immunofluorescence, a widely used and accepted standard for fluorescent protein imaging 
(Stadler et al., 2013). In addition, the concentration of BCNK allows for direct control of the 
level of transgene expression without significantly compromising the SNR for fluorescent 
imaging. 
3.4 The microprotein NoBody is rapidly exchanging component 
of P bodies 
3.4.1 Small open reading frames 
A group of proteins not amenable to standard labelling techniques altogether, are the recently 
discovered short open reading frame (sORF) encoded polypeptides (SEPs). sORFs are 
translated from traditionally designated untranslated regions or from splice variants of known 
protein coding sequences. Majority of sORFs contain less than 100 codons, coding for peptides 
with molecular weight below 10 kDa. To date, proteomic screens have reported hundreds of 
putative sORFs (Andrews and Rothnagel, 2014; Slavoff et al., 2013), a few of which have been 
confirmed to encode functional polypeptides (D'Lima et al., 2017). However, the functions of 
almost all SEPs in cells remain largely unknown, in part because it is difficult to tag individual 
SEPs for isolation, co-immunoprecipitation or live-cell imaging with traditional tagging tools, 
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while the use of peptide epitope tags limits tagging sites to protein termini, and cannot be 
extended to live-cell imaging. 
3.4.2 Expression and site specific labelling of microprotein nobody 
To demonstrate the advantage of the optimised protocol for genetic code expansion as a 
minimally perturbative method for live-cell imaging, we sought to describe the dynamic 
behaviour of a recently discovered microprotein NoBody (D'Lima et al., 2017). NoBody is a 
7-kDa polypeptide that interacts with proteins involved in removal of 5’cap of mRNAs. 
Similarly to many proteins involved in the 5’-to-3’ decay, NoBody localizes to cytosolic RNA-
protein granules called P-bodies and its expression level is inversely correlated with number of 
P-bodies in cells (D'Lima et al., 2017), however, the information on its dynamics in living cells 
is missing. 
When we transfected cells with increasing amount of Myc-NoBody(48TAG) gene, we 
observed strong increase in specific labelling and decrease of non-specific labelling of the 
proteome with increasing amount of transfected plasmid (Figure 3.13). In agreement with our 
previous experiments, expression of Myc-NoBody(48BCNK) showed a strong dependence on 
BCNK concentration, demonstrating the site specific incorporation of BCNK and allowing 
control over the expression level of NoBody by decreasing the BCNK concentration to minimal 
levels (Figure 3.12). We further confirmed the specificity of our labelling method in situ using 
immunofluorescence against Myc tag (Figure 3.13a).  
110 Genetic Code Expansion for Site-specific Live-cell Protein Labelling 
 
 
 
Figure 3.13. In-gel quantification of signal-to-noise ratio for in vivo labelling of NoBody via 
genetic code expansion. (a) Grayscale (left) and colourmap (right) fluorescent scans of SDS-
PAGE gel of lysates of HEK293 cells transfected with increasing amount of Myc-
NoBody(48TAG) plasmid, incubated overnight in presence of 50 uM BCNK and labelled in 
vivo with SiR-tetrazine. (b) Fluorescent intensity traces corresponding to lanes in panel a. (c) 
Quantification of signal-to-noise ratio based on fluorescence intensity of the Myc-
NoBody(48BCNK) band and the rest of the proteome. (d) Grayscale (left) and colourmap 
(right) fluorescent scans of SDS-PAGE gel of lysates of HEK293 cells transfected with 400 ng 
of Myc-NoBody(48TAG) plasmid, incubated overnight in presence of varying concentrations 
of BCNK and labelled in vivo with SiR-tetrazine. (e) Fluorescent intensity traces corresponding 
to lanes in panel d. (f) Quantification of signal-to-noise ratio based on fluorescence intensity 
of the Myc-NoBody(48BCNK) band and the rest of the proteome.  
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Figure 3.14. NoBody is a dynamic component of P-bodies. (a) Fluorescent images of fixed 
HEK293 cells transfected with Myc-NoBody(48TAG), MmPylRS-AF and PylT transgenes. 
Myc-NoBodyL48BCNK was labelled via α-Myc immunostaining (green) and SiR-tetrazine 
derivatization (red). Endogenous Dcp2 was labelled via immunostaining (magenta). (b) 
Representative curves of FRAP of Myc-NoBodyL48BCNK and Dcp2-GFP in P-body and in 
cytosol in live cells.  
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3.4.3 Live-cell dynamics of NoBody 
Similarly to previous report, we found that only a small subset of cells expressing 
NoBody(48BCNK) contained P-bodies (Figure 3.14a and Figure 3.15), consistent with its 
role as a negative regulator of P-bodies. To limit overexpression, we used 5 µM BCNK – a 
concentration allowing us to observe some P-bodies in a subset of transfected cells – for all 
subsequent experiments. 
 
Figure 3.15. Multiple large-field-of-view images of fixed cells shown in Figure 3.14. Scalebar 
20 µm 
 
For live cell imaging of NoBody and its localisation to P-bodies, we used a GFP fusion of 
Dcp2, a core component of P-bodies (Franks et al., Mol Cell, 2009), as a P-body marker. We 
transfected HEK293 cells with MmPylRS-AF, tRNAPylCUA and NoBody(48TAG) transgenes, 
followed by transduction with lentivirus containing Dcp2-GFP fusion gene. To allow for easier 
observation of larger number of P-bodies, we stimulated cells with 0.3 mM sodium arsenite, 
inducing P-body assembly through oxidative stress (Kedersha et al., 2005). 1 hour after the 
sodium arsenite treatment, we were able to observe a large number of dynamic P-bodies cells, 
with all P-bodies enriched in the NoBody peptide (Figure 3.16)..  
3.4 The microprotein NoBody is rapidly exchanging component of P bodies 113 
 
 
Figure 3.16. HEK 293 cells transduced with lentivirus containing Myc-NoBody transgene and 
stimulated with 0.3 mM sodium arsenite. Unstimulated cells show very low amount of P-
bodies, especially in cells expressing Myc-NoBody. Scalebar 30 µm. 
 
Finally, we wanted to examine whether NoBody is a stable component of P-bodies. Using 
Dcp2-GFP protein as a P-body marker, we measured fluorescence recovery after 
photobleaching (FRAP) to determine the rate of exchange of the two components to and from 
P-bodies. We observed that NoBody, unlike Dcp2, is rapidly exchanging with the cytosol, 
reaching complete recovery in less than 1 s, suggesting very transient interaction with 
components in the RNP granules (Fig. 3.11b). 
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3.5 Chapter discussion 
The genetic code expansion in combination with bio-orthogonal chemistry provides a unique 
tool for protein labelling and imaging. The method allows for site-specific protein labelling in 
live cells with small, bright and photostable fluorophores but – despite the unique aspects of 
this approach – few key limits of the method exist. In this chapter we have identified and 
addressed these concerns. 
We have demonstrated that by leveraging the recent developments in genetic code expansion 
in mammalian cells, we were able to achieve sufficient labelling to obtain super-resolved 
images of the mammalian cytoskeleton. This development should facilitate more precise 
imaging experiments due to the minimal size of the label and the linkage, taking full advantage 
of the spatial resolution of the imaging methods. 
We further optimised the signal-to-noise ration of the labelling method by optimisation of the 
transfection protocol. The presence of endogenous amber codons poses a challenge to genetic 
code expansion via amber suppression. While the cell preferentially degrades most aberrantly 
extended proteins (Arribere et al., 2016) some do persist and are subsequently labelled by the 
fluorescent dye (Figure 3.7). To address this, we sought to shift the balance of amber codon 
readthrough towards the target protein by increasing the intracellular availability of the target 
mRNA. This approach led to over 5-fold increase in signal-to-noise ratio to a level comparable 
with immunofluorescence (Figure 3.9). 
We used these improvements to image a small, 7 kDa polypeptide NoBody, leveraging the 
minimal perturbation caused by our labelling approach. Our results identify NoBody as a 
rapidly exchanging, dynamic component of P-bodies. The exact mechanism of P-body 
downregulation via P-body remains unclear (D’Lima et al., 2016). Our study suggests that 
direct structural perturbation is unlikely, given the transient nature of NoBody interaction. We 
note that this is a preliminary result and further experiments under varying conditions need to 
be carried out to confirm this hypothesis. 
Combined together, the advances presented in this chapter provide a significant advancement 
in use of genetic code expansion for live-cell protein labelling. The minimal background seen 
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in our approach should allow for imaging of low abundance proteins in live cells. The imaging 
approach can be expanded to non-dividing primary cells, such as neurons and whole tissues 
when combined with the adeno-associated virus (AAVs) transduction system developed in our 
group (Ernst et al., 2016). This approach could be of particular interest for imaging neural 
micropeptides and microproteins (Makarewich and Olson, 2017), thanks to the minimal 
perturbation to target protein caused by genetic code expansion. Thanks to the mostly 
unrestrained position of the label within the polypeptide chain, this approach should allow for 
structural insights into macromolecular protein assemblies using particle averaging 
(Szymborska et al., 2013) and allow for development of novel FRET sensors (Baumdick et al., 
2015). 
  
116 Genetic Code Expansion for Site-specific Live-cell Protein Labelling 
 
3.6 Methods 
3.6.1 Plasmid assembly 
NoBody gene was cloned into previously reported plasmids for genetic code expansion in 
mammalian cells (Schmied et al., JACS 2014), using restriction cloning, introducing the amber 
codon at position 48 via quickchange to create pPB_NoBody48TAG_4xPylT. The second 
plasmid, pPB_MmPylRS-AF_4xPylT was cloned from previously reported plasmids using 
Gibson assembly (Uttamapinant et al., 2015). 
3.6.2 Tissue culture 
HEK293 cells (ATCC) were cultured in DMEM (ThermoFisher) media supplemented with 
10% fetal bovine serum (FBS; ThermoFisher). Cells were passaged after reaching 80 – 90% 
confluence, by washing cells with PBS and trypsinization. 
3.6.3 Flow cytometry  
The HEK293 cells were transfected with appropriate plasmids using polyethyleneimine (MW 
~40,000; Polysciences) in ratio 1 ug DNA to 4 ul of PEI (1 mg/ml solution in PBS). The cells 
were incubated for 1-2 days in presence or absence of the non-canonical amino acid. The 
cells were then trypsinized and analysed on FACS LSR-II (BD Biosciences) flow cytometer 
using the appropriate filter settings. The transfected cells (based on mCherry fluorescence 
threshold) were analysed, using mean GFP/mean mCherry ratio as the amber  codon 
readthrough. 
3.6.4 Lentivirus production 
HEK293T cells (ATCC) were seeded into 10 cm dishes day prior. The cells were transfected 
at 90% confluence with combination of ENV plasmid, Packaging plasmid (pMDLg/p RRE) 
and pRSV-REV plasmid (Addgene 12251, 8454, 12253, respecively) and Dcp2-GFP 
plasmid using Lipfectamine 2000 mix (ThermoFisher). After 5 hours and 16 hours, the media 
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was exchanged for fresh media, starting the collection of the lentivirus. The media was 
collected 48 hours after transfection and again 72 hours post transfection, replacing with fresh 
media after first collection. The collected media was filtered using 0.45 µm filter to remove 
cellular debris.  The media was centrifuged at 50,000 RCF for 150 minutes at 4C and the virus 
pellet was resuspended in ice cold PBS. For titration, HEK293 cells were transduced with serial 
dilution of the lentivirus and analyzed 2 days later by FACS. 
3.6.5 Live cell labelling 
HEK293 cells were seeded into poly-L-lysine coated 24-well plates of fibronectin (Merck) 
coated glass chambers. Upon reaching ~ 80% confluence, the media was exchanged for 
Optimem (Thermo Fischer) and transfection mixture of DNA and polyethyleneimine (MW 
~40,000; Polysciences) in ratio 1 ug DNA to 4 ul of PEI (1 mg/ml solution in PBS) was added 
to the cells. After incubation for 4 hours at 37C, the media was exchanged for DMEM 
supplemented with 10% FBS and BCNK (Synnafix; solubilized in DMEM, adjusting pH by 
NaOH) of corresponding concentration. For live-cell imaging, cells were transduced with the 
appropriate lentivirus. Cells were grown for in presence of amino acid for 1-2 days. Before 
labelling, the cells were washed 2-3 times by DMEM media with 10% FBS to remove the 
excess BCNK. The cells were labelled for 20 minutes and labeled with 400 nM SiR-tetrazine 
(Spirochrome) and subsequently washed again with DMEM with 10% FBS. The imaging was 
carried out under 5% CO2 atmosphere at 37C. 
3.6.6 SDS-PAGE analysis 
The cell media was removed by aspiration and cells were lysed with ice-cold RIPA buffer (25 
mM Tris (pH 7.4), 150 mM NaCl, 0.1% SDS, 0.5% sodium deoxycholate, 1% Triton X-100) 
supplemented with cOmplete protease inhibitors (Sigma-Aldrich). Cells were lysed on ice for 
20 minutes and the lysates were cleared by centrifugation at 20,000 g at 4C. The supernatants 
were collected and protein concentration normalized using BCA assay (ThermoFisher). The 
lysates were analysed on 4-12% Bis-Tris gels (Novex) in LDS buffer supplemented with 5% 
-mercaptoethanol. The gels were run at 200V for 35 – 45 minutes and subsequently analysed 
using Amersham Typhoon scanner (GE Life Sciences) with appropriate laser and filter settings. 
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3.6.7 Western blotting 
For western blotting, the proteins were transferred onto PVDF membranes using the iBlot2 
system, following the manufacturer’s instructions. The membrane was blocked with 5% milk 
in TBS-T (20 mM Tris, 150 mM NaCl, 0.1 % Tween 20) for 1 hour at room temperature and 
then overnight at 4C with primary antibody α-GFP (Roche (13.1 and 7.1)), α-Myc (Cell 
Signaling (9B11)) or α-actin (Sigma-Aldrich (A3853)), using concentrations recommended by 
the manufacturer. The membrane was washed several times with TBS-T and incubated with 
corresponding HRP-conjugated secondary antibody (Cell Signalling) for 1 hour at room 
temperature. The membrane was washed few times with TBS-T and developed using 
SuperSignal West Pico Chemiluminescent Substrate (Thermo Fisher) according to 
manufacturer's instructions. Membrane images were acquired using a ChemiDoc system (Bio-
Rad). 
3.6.8 Live cell and fixed cell imaging 
After labelling, the cells were imaged live or fixed using 4% paraformaldehyde in PBS for 10 
mins at room temperature. The fixed cells were permeabilised using Triton X-100 and blocked 
using 3% bovine serum albumin (BSA) solution in PBS for 1 hour at room temperature. The 
cells were subsequently immunostained with primary antibodies α-Myc (Cell Signaling 
(9B11)) or α-Dcp2 (Abcam (ab28658)) for 1 hour at room temperature, washed 3 times with 
PBS and immunostained with fluorescently labeled secondary antibodies (Thermo Fisher). The 
cells were imaged using Leica SP8 or Leica STED confocal microscopes with appropriate laser 
and filter settings. 
3.6.9 Fluorescence in situ hybridisation 
HEK293T cells were transfected with the following plasmids: (U6- PylTU25C)4/EF1α-
BCNKRS and (U6-PylTU25C)4/EF1α-vimentinN116TAG and incubated in the presence of 1 
mM BCNK for 36-48 hours. The cells were subsequently washed and labelled with 400 nm 
tet1-CFDA. After washing of the excess dye, the cells were fixed using 4% formaldehyde in 
DPBS for 1 hr at room temperature and washed several times with DPBS. For in situ 
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hybridization, the cells were washed twice with 2X saline-sodium citrate (SSC) buffer with 
50% v/v formamide (Ambion) and incubated for 30 minutes at 37°C in FISH buffer (10% 
dextran (Sigma), 2 mM vanadyl ribonucleoside complex (Sigma), 0.02% RNAse-free BSA 
(Life Technologies) and 1 µg/µl E. coli tRNA (Sigma) in 2X SSC, 50% formamide). 
Subsequently, 1.33 µg/µl of a DNA oligo probe (5’- 
GGAAACCCCGGGAATCTAACCCGGCTGAACGGATTTAGAG-3’) with 5’ terminal 
Alexa Fluor 647 was mixed to the buffer and hybridized overnight at 37°C. Before imaging, 
the cells were washed twice in 2X SSC, 50% v/v formamide for 30 minutes at 37°C and once 
with DPBS. 
 Chapter 4 An Evolved M. alvus pyrrolysyl-tRNA 
synthetase/tRNA pair is highly active and 
orthogonal in mammalian cells. 
4.1 Chapter Introduction 
The efforts to incorporate non-canonical amino acids into proteins in mammalian cells rely on 
the availability of new orthogonal aaRS/tRNA pairs. To date, only a limited number of 
orthogonal aaRS/tRNA pairs in mammalian cells have been reported (Italia et al., 2017). With 
the exception of the Methanococcus mazei (Mm) and barkeri pyrrolysine-tRNA 
synthetase/tRNA pairs, the majority are orthogonal in eukaryotes but not in E. coli. This chapter 
demonstrates that the recently engineered PylRS/tRNAPyl(6)CUA pair from 
Methanomethylophilus alvus (Ma) is highly active and orthogonal in mammalian cells, making 
it only second pair orthogonal in both eukaryotes and wild-type E. coli. In addition, we 
demonstrate the MaPylRS/tRNAPyl(6)CUA pair is orthogonal to the widely used 
MmPylRS/tRNAPylCUA pair and that these two pairs can be used together to site-specifically 
incorporate two distinct non-canonical amino acids into a single protein. This development 
paves a way for an efficient incorporation of multiple distinct amino acids into proteins in 
mammalian cells. 
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 4.2 An evolved M. alvus pyrrolysyl-tRNA synthetase/tRNA pair 
is highly active and orthogonal in mammalian cells. 
Genetically encoding the site-specific co-translational incorporation of non-canonical amino 
acids into proteins in eukaryotic cells and animals has provided numerous strategies for 
imaging and controlling the functions of proteins in their native environment (Chin, 2014). 
Extensions of these approaches have enabled the tagging and labelling of cell-specific 
proteomes via stochastic orthogonal recoding of translation (SORT) (Elliott et al., 2016; Elliott 
et al., 2014; Hoffmann et al., 2018; Krogager et al., 2018). 
The incorporation of ncAAs into proteins relies on the development of orthogonal aminoacyl-
tRNA synthetase (aaRS)/tRNA pairs: the orthogonal aaRS selectively recognizes its cognate 
orthogonal tRNA over endogenous tRNAs and the orthogonal tRNA is a substrate for the 
orthogonal aaRS, but a poor substrate for endogenous synthetases.  Since the sets of 
endogenous synthetases and tRNAs differ between organisms, aaRS pairs that are orthogonal 
in one system are commonly not orthogonal in another (Chin, 2014). For example, the 
Methanocaldococcus janaschii (Mj) TyrRS pair that has been extensively used for genetic code 
expansion in E. coli (Ec) cannot be used for genetic code expansion in eukaryotic cells because 
it is not orthogonal with respect to endogenous eukaryotic aaRS/tRNA pairs. 
The EcTyrRS/TyrtRNA (Chin et al., 2003; Sakamoto et al., 2002) pair and EcLeuRS/LeutRNA 
pair(Wu et al., 2004) are orthogonal in eukaryotic cells and variants of these pairs have been 
discovered, primarily by directed evolution in yeast or subsequent screening, that enable the 
incorporation of a range of ncAAs in eukaryotic systems. The PylRS/PyltRNA pair from Mm is 
commonly considered an ideal pair for genetic code expansion because it is orthogonal in both 
E. coli and eukaryotic cells and animals (Chin, 2014). This has facilitated the discovery and 
characterization of MmPylRS variants that incorporate ncAAs in E. coli and the transfer of 
these variant to eukaryotic systems, thereby facilitating genetic code expansion in eukaryotic 
cells and animals. Recent work has demonstrated that SepRS/SeptRNACUA pair that has been 
evolved for efficient incorporation of phosphoserine and its nonhydrolyzable analog (Rogerson 
et al., 2015), can be further evolved to incorporate phosphothreonine in E. coli (Zhang et al., 
2017) and is also orthogonal in mammalian cells (Beranek et al., 2018). The ability to 
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incorporate ncAAs into proteins in mammalian cells has been further expanded by strategies 
that replace the genomically encoded EcTrpRS/TrptRNA pair in E. coli with the Sacchromyces 
cerevisiae (Sc) TrpRS/TrptRNA pair (Hughes and Ellington, 2010; Iraha et al., 2010; Italia et 
al., 2017). Since the ScTrpRS/TrptRNA is orthogonal in E. coli, suppressor derivatives of the 
EcTrpRS/TrptRNA pair can be introduced into the resulting E. coli strains and evolved for ncAA 
incorporation.  The resulting EcTrpRS/TrptRNA pairs can then be used for genetic code 
expansion in mammalian cells, where they are orthogonal. Recent work has extended this 
strategy to the EcTyrRS/ TyrtRNA pair (Italia et al., 2018). In several cases, aaRS/tRNA pairs 
that are active and orthogonal with respect to the endogenous aaRSs and tRNAs in mammalian 
cells have also been shown to be orthogonal with respect to other orthogonal pairs; creating 
'mutually orthogonal’ pairs in mammalian cells (Xiao et al., 2013; Zheng et al., 2017a; Zheng 
et al., 2017b). 
Willis and Chin recently discovered that a new class of PylRS/PyltRNA pairs from 
Methanomassiliicocales are active and orthogonal in E. coli.(Borrel et al., 2014; Willis and 
Chin, 2018) These pairs, unlike the MmPylRS/MmPyltRNA pair, lack the N-terminal domain 
of PylRS, which was previously thought to be essential for tRNA recognition and 
aminoacylation (Herring et al., 2007; Jiang and Krzycki, 2012). We showed that certain 
orthogonal pairs from this class are naturally mutually orthogonal to the MmPylRS (Willis and 
Chin, 2018); this surprising result demonstrated that there is sufficient divergence between 
archeal PylRS/PyltRNA pairs to generate mutually orthogonal pairs for the same amino acid 
within a domain of life.  We developed a number of exceptionally active and orthogonal pairs, 
including the MaPylRS/MaPyltRNA(6) pair, that are mutually orthogonal to the 
MmPylRS/MmPyltRNA pair by virtue of mutations introduced into the body of MaPyltRNA 
(Willis and Chin, 2018). Moreover, we showed that, since the active sites of MmPylRS and 
MaPylRS share common substrate recognition determinants, we could transplant mutations 
that direct the selective incorporation of specific ncAAs from the MmPylRS active site to the 
MaPylRS active site to reprogram its substrate specificity (Willis and Chin, 2018). Finally, we 
showed that by diverging the active sites of MaPylRS and MmPylRS to selectively recognize 
distinct substrates and altering the anticodons of MaPyltRNA(6) and MmPyltRNA to decode 
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distinct codons in orthogonal translation we could use these pairs in the same cell to direct the 
incorporation of two distinct ncAAs into a single polypeptide (Willis and Chin, 2018). Here 
we show that the MaPylRS/MaPyltRNA(6) is highly active and orthogonal in mammalian cells, 
where it is also mutually orthogonal to the MmPylRS/MmPyltRNA (Figure 4.1), and that 
derivatives of the two pairs can be used to incorporate distinct amino acids into a protein in 
mammalian cells. 
 
 
Figure 4.1. The evolved MaPylRS/MaPyltRNA(6) is orthogonal with respect to the endogenous 
E. coli aaRS/tRNA pairs as well as mutually orthogonal to the MmPylRS/MmPyltRNA(6) pair. 
Here we ask if this pair is also orthogonal and mutually orthogonal in mammalian cells. NTD 
is N-terminal domain. 
 
We first demonstrated that the MaPylRS/MaPyltRNA(6)CUA pair is active in mammalian cells, 
and that both  MaPylRS and MaPyltRNA(6)CUA are orthogonal with respect to the endogenous 
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tRNAs and the aaRSs in human cells. To this aim, we cloned coding sequences of MaPylRS 
and MaPyltRNA(6)CUA into a vector for mammalian expression;(Schmied et al., 2014) we 
cloned MaPylRS under the EF1a promoter and four copies of the MaPyltRNA(6)CUA under the 
human U6 promoter into the same vector. We transiently co-transfected HEK293 cells with the 
MaPylRS/MaPyltRNA(6)CUA vector and an  mCherry-TAG-GFP reporter (Beranek et al., 2018) 
and cultured the resulting cells in presence or absence of Nε–((tert-butoxy)carbonyl)-L-lysine 
(BocK), a known substrate for this pair.(Willis and Chin, 2018) We measured the ratio of 
GFP/mCherry fluorescence by flow cytometry (Figure 4.2a, Figure 4.3) and fluorescence 
microscopy (Figure 4.4), and performed control experiments with the well-characterised 
MmPylRS/PyltRNACUA pair. 
 
 
Figure 4.2. MaPylRS/MaPyltRNA(6)CUA is active and orthogonal in mammalian cells. (a) 
MaPylRS and MmPylRS show comparable, BocK dependent, readthrough of the amber stop 
codon with their cognate tRNAs. Data represent mean +/- SD from two biological replicates. 
(b) ESI-MS of purified sfGFP confirms quantitative incorporation of BocK via the 
MmPylRS/MmPyltRNACUA pair. (c) ESI-MS of purified sfGFP confirms quantitative 
incorporation of BocK via the MaPylRS/MaPyltRNA(6)CUA pair. 
 
We observed minimal readthrough of the amber codon by the MaPylRS/MaPyltRNA(6)CUA pair 
in the absence of BocK (Figure 4.2a). This demonstrates that MaPyltRNA(6)CUA is orthogonal 
with respect to the aminoacyl-tRNA synthetases that are endogenous in human cells. Upon 
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addition of 0.5 mM and 1 mM BocK, we observed substantial readthrough of the TAG codon 
by the MaPylRS/MaPyltRNA(6)CUA pair. The level of amber codon readthrough mediated by 
the MaPylRS/MaPyltRNA(6)CUA pair is comparable to that  mediated by the highly active 
MmPylRS/MmPyltRNACUA pair (Figure 4.2a); this demonstrates that the 
MaPylRS/MaPyltRNA(6)CUA pair is highly active in mammalian cells. 
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Figure 4.3. MaPylRS/MaPyltRNA(6)CUA is active and orthogonal in mammalian cells and 
mutually orthogonal to MmPylRS/MmPyltRNACUA. (a) Flow cytometry data summarised in 
Figures 4.2 and 4.5. MaPylRS and MmPylRS show comparable, BocK dependent readthrough 
of the amber stop codon with their cognate tRNAs but not the non-cognate tRNAs. 
Readthrough control (b) and untransfected cells (c) are shown.  
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Figure 4.4. MaPylRS/MaPyltRNA(6)CUA is active and orthogonal in mammalian cells and 
mutually orthogonal to MmPylRS/MmtRNAPylCUA. Fluorescence microscopy data summarised 
in Figures 4.2 and 4.5. MaPylRS and MmPylRS show comparable, BocK dependent 
readthrough of the amber stop codon with their cognate tRNAs but not the non-cognate tRNAs. 
 
To demonstrate that MaPylRS is functionally orthogonal in human cells we co-transfected 
plasmids encoding the MaPylRS/MaPyltRNA(6)CUA pair and GFP(150TAG)His6 and cultured  
the cells in the presence of 1 mM BocK. ESI-MS  of the resulting GFP has the expected mass 
(Figure 4.2b) and is indistinguishable from a control in which we used the 
MmPylRS/MmPyltRNACUA pair to incorporate BocK in to GFP(150TAG)His6 (Figure 4.2c). 
Taken together our experiments reveal that the MaPylRS/MaPyltRNA(6)CUA pair is a highly 
active and orthogonal pair in mammalian cells. 
GFPmCherry GFPmCherry
No BocK 1 mM BocK
MaPyltRNA(6)
CUA
MmPylRS
MmPyltRNA
CUA
MmPylRS
MaPyltRNA(6)
CUA
MaPylRS
MmPyltRNA
CUA
MaPylRS
132 An Evolved M. alvus pyrrolysyl-tRNA synthetase/tRNA pair is highly active and 
orthogonal in mammalian cells. 
 
Next, we aimed to demonstrate that the MmPylRS/MmPyltRNACUA pair and 
MaPylRS/MaPyltRNA(6)CUA pair are mutually orthogonal in their aminoacylation specificity 
when expressed in mammalian cells. We swapped the 4x U6-tRNA cassette between the Mm 
and Ma expression vectors producing a plasmid containing MmPylRS/MaPyltRNA(6)CUA pair 
and a plasmid containing MaPylRS/MmPyltRNACUA pair. We co-transfected the mCherry-
TAG-GFP reporter with each of the two and cultured the cells in presence and absence of 
BocK. We compared the readthrough of the amber stop codon by these non-cognate pairs to 
that mediated by the Mm and Ma derived cognate pairs (Figure 4.5).  Our data show that the 
non-cognate MmPylRS/MaPyltRNA(6)CUA and MaPylRS/Mm
PyltRNACUA pairs lead to minimal 
read through of the amber stop codon (Figure 4.5), while the cognate pairs lead to efficient 
amber suppression (Figure 4.2). This demonstrates that these two PylRS/PyltRNACUA pairs are 
mutually orthogonal in mammalian cells. 
 
 
Figure 4.5. MaPylRS/MaPyltRNA(6)CUA is mutually orthogonal to MmPylRS/MmPyltRNACUA 
pair in mammalian cells. MaPylRS and MmPylRS show comparable, BocK dependent 
aminoacylation of their cognate tRNA and minimal cross-aminoacylation of the non-cognate 
PyltRNACUA. Data represent mean +/- SD from two biological replicates. 
 
Next we differentiated the active sites of MaPylRS and MmPylRS such that they selectively 
recognize distinct substrates. By screening a collection of MaPylRS mutants for non-natural 
substrate specificity in E. coli, we discovered  a variant of MaPylRS, MaPylRS(mut) that 
incorporates 3-methyl-L-histidine (Me-His) but not BocK, this synthetase contains the 
Reporter: GFP-TAG-mCherry
BocK (mM) 0 0.5 10 0.5 10 0.5 10 0.5 1
G
F
P
/m
C
h
e
rr
y
0.0
0.2
0.4
0.6
0.8
1.0
1.2
PylRS
PyltRNA
CUA
M. mazei
M. alvus(6)
M. mazei
M. mazei
M. alvus
M. mazel
M. alvus
M. alvus(6)
4.2 An evolved M. alvus pyrrolysyl-tRNA synthetase/tRNA pair is highly active 
and orthogonal in mammalian cells. 
133 
 
mutations L121M, L125I, Y126F, M129A and V168F. And we find that MmPylRS directs the 
incorporation of BocK but not Me-His, these specificities are maintained in mammalian cells 
(Figure 4.6a). Finally we performed a double incorporation of BocK and Me-His into 
GFP(101TGA,150TAG) using the MmPylRS/MmPyltRNACAU and 
MaPylRS/MaPyltRNA(6)CUA pairs. Production of full-length protein was dependent on addition 
of both ncAAs (Figure 4.6b), consistent with the site-specific incorporation of both amino 
acids into GFP in mammalian cells. 
 
 
Figure 4.6. (a) MmPylRS/MmPyltRNACUA and MaPylRS(mut)/Ma
PyltRNA(6)CUA pairs 
selectively incorporate BocK and Me-His in response to amber stop codon. Data represent 
mean +/- SD from three biological replicates. All ncAAs were used at 1 mM. (b) Double 
incorporation of Me-His and BocK into GFP(101TGA,150TAG) using the 
MmPylRS/MmPyltRNACAU and MaPylRS/Ma
PyltRNA(6)CUA pairs. Data represent mean +/- SD 
from three biological replicates. All amino acids were used at 1 mM. 
 
We have demonstrated that the MaPylRS/MaPyltRNA(6)CUA pair is orthogonal with respect to 
the synthetases and tRNAs present in mammalian cells, and is highly active in mammalian 
cells. As the MaPylRS/MaPyltRNA(6)CUA pair is also orthogonal in E. coli, and we have 
demonstrated that mutations discovered in the active site of MmPylRS or MbPylRS can be 
transplanted into MaPylRS to reprogram its substrate specificity (Willis and Chin, 2018), it 
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will be possible to rapidly expand the substrate scope of the MaPylRS/MaPyltRNA(6)CUA pair.  
Moreover, as the MaPylRS is a single domain protein that lacks the poorly soluble N-terminal 
domain of MmPylRS it may be even more amenable to directed evolution in E. coli than the 
MmPylRS system. Our results demonstrate that MaPylRS mutants discovered and 
characterized in E. coli will be of direct utility in mammalian cells. 
Finally we have confirmed that the mutual orthogonality of the MmPylRS/MmPyltRNA pair and 
MaPylRS/MaPyltRNA(6) pair, that we have characterized in E. coli, is maintained in 
mammalian cells and shown that these pairs can be used together for (un-optimized) double 
incorporation. These are therefore the first mutually orthogonal pairs in which each pair is itself 
orthogonal in both E. coli and eukaryotic systems.  We anticipate that this foundational advance 
will facilitate multiplexed proteome labelling (Elliott et al., 2016; Elliott et al., 2014; Hoffmann 
et al., 2018; Krogager et al., 2018). Combinations of the advances reported herein, together 
with strategies for creating additional blank codons and increasing the efficiency of multi-site 
ncAA incorporation in mammalian cells may facilitate the site-specific incorporation of 
diverse, and currently inaccessible, combinations of ncAAs into proteins in mammalian cells 
(Xiao et al., 2013; Zheng et al., 2017a; Zheng et al., 2017b). 
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4.4 Methods 
4.4.1 Plasmid assembly 
MaPylRS coding sequence was synthesised as double stranded DNA fragment (Integrated 
DNA Technologies) and introduced into the previously reported plasmid for mammalian 
expression(Schmied et al., 2014) via restriction cloning, creating the pPB_MaPylRS_4xU6-
MmPyltRNACUA plasmid. The Ma
PyltRNA(6)CUA gene under the U6 promoter and followed by 
terminator was synthesized as double stranded DNA fragment (Integrated DNA Technologies) 
with the following sequence (MaPyltRNA(6)CUA gene underlined): 
CCTAGTTGGGCAGGAAGAGGGCCTATTTCCCATGATTCCTTCATATTTGCATATA
CGATACAAGGCTGTTAGAGAGATAATTAGAATTAATTTGACTGTAAACACAAAG
ATATTAGTACAAAATACGTGACGTAGAAAGTAATAATTTCTTGGGTAGTTTGCAG
TTTTAAAATTATGTTTTAAAATGGACTATCATATGCTTACCGTAACTTGAAAGTAT
TTCGATTTCTTGGCTTTATATATCTTGTGGAAAGGACGAAACACCGGGGGACGGT
CCGGCGACCAGCGGGTCTCTAAAACCTAGCATAGCGGGGTTCGACACCCCGGTC
TCTCGGACAAGTGCGGTTTTT 
This fragment was PCR amplified in four reactions with 4 pairs of mutually overlapping 
primers and assembled via Gibson assembly with the backbone of pPB_MaPylRS_4xU6-
MmPyltRNACUA plasmid digested with StuI and AsiSI restriction enzymes, replacing the 4xU6-
MmPyltRNACUA cassette and creating the pPB_MaPylRS_4xU6-Ma
PyltRNACUA plasmid. The 
plasmid pPB_MaPylRS_4xU6-MaPyltRNACAU and pPB_MmPylRS_4xU6-Mm
PyltRNACAU 
were constructed analogously.   
The pPB_MmPylRS_4xU6-MaPyltRNACUA and pPB_GFP150TAG_4xU6-Ma
PyltRNACUA 
plasmids were created by restriction cloning from the previously reported 
pPB_MmPylRS_4xU6-MmPyltRNACUA and pPB_GFP150TAG_4xU6-Mm
PyltRNACUA(Schmied 
et al., 2014), using the StuI and AsiSI restriction sites. Lastly, the pPB_ GFP(101TGA,150TAG) 
and pPB_MaPylRS(mut)_4xU6-MaPyltRNACUA, were created using Gibson cloning from the 
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above described plasmids. The GFP150TAG encodes all of the 20 canonical amino acids, using 
the following codons: 
Phe (TTC(12)), Leu (CTC(2), CTG(18)), Ile (ATC (11)), Met (ATG (5)), Val (GTG (19)), Ser 
(TCT (1), TCC (1), AGC (9)), Pro (CCT (2), CCC (8)), Thr (ACC (16), ACA (2)), Ala (GCT 
(1), GCC (7)), Tyr (TAG (1)), His (CAT (4), CAC (12)), Gln (CAG (7)), Asn (AAT (1), ACC 
(11)), Lys (AAA (1), AAG (19)), Asp (GAT (4), GAC (14)), Glu (GAA (7), GAG (9)), Cys 
(TGC (2)), Trp (TGG (1)), Arg (CGG (6), AGA (2)), Gly (GGC (21), GAA (2)) 
4.4.2 Tissue culture 
HEK293 (female human embryonic kidney) cells (ATCC) were cultured in Dulbecco’s 
Modifid Eagle Medium (DMEM) (Gibco) supplemented with 10% fetal bovine serum (FBS) 
(Gibco) at 37°C and 5% CO2 in humidified incubator. The cells were regularly passaged by 
detaching with trypsin/EDTA solution, followed by resuspension in DMEM with 10% FBS 
and seeding into cell culture flasks. 
4.4.3 Transfections and incorporation of non-canonical amino acids 
HEK293 cells were seeded onto poly-l-lysine (Sigma) coated 24-well plates day prior to 
transfection. The media was exchanged for Optimem media (Gibco) and transfection mixture 
of 1 μg DNA  and 4 μl of 1 mg.ml polyethyleneimine MW 40,000 (PEI; Polysciences) in 
Optimem was added to each well. After 4 hours, the media was exchanged for DMEM 
(supplemented with 10% FBS) with or without Nε–((tert-butoxy)carbonyl)-L-lysine (BocK; 
Bachem) or 3-methyl-L-histidine (Me-His; Bachem). 
4.4.4 Flow cytometry 
24 hours after transfection, the cells were detached using trypsin/EDTA solution and analysed 
on Becton Dickinson LSRII SORP flow cytometer (BD Biosciences) with the appropriate filter 
settings (488 nm coherent sapphire laser for GFP excitation and 561 nm compass laser for 
mCherry excitation). The front scatter and side scatter was used to identify intact cells and 
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mean background fluorescence from untransfected cells was subtracted from the measured 
signal. FlowJo software (FlowJo) was used to analyse the data. 
4.4.5 Fluorescence microscopy 
The cells were imaged after 24 hours post transfection using Leica DM IL LED inverted 
fluorescence microscope with QCapture Suite PLUS software. 
4.4.6 LC-MS analysis 
HEK293 cells were seeded into 75 ml cell culture flasks. After reaching ~ 80% confluency, the 
media was exchanged for fresh media and the cells were transfected using transfection mixture 
of 20 μg DNA and 80 μl of 1 mg/ml PEI solution. BocK was added to final concentration of 1 
mM and the cells were cultured for 48 hours. The cells were harvested using PBS and lysed in 
ice cold RIPA buffer supplemented with HALT protease and phosphatase inhibitor cocktail 
(Sigma). The cells were spun down at 4°C at 16,000 g for 20 minutes, collecting the 
supernatant. The GFP was purified from the supernatant using GFP-Trap_MA beads 
(ChromoTek), following the manufacturer’s instructions. The GFP was eluted from the beads 
in 200 mM glycine (pH 2.5) and immediately neutralized by adding 1M Tris base (pH 10.4). 
The purified GFP was analysed on Agilent 1200 LC-MS with Quadrupole spectrometer 
(Agilent) using 0.2% formic acid in water and 0.2% formic acid in acetonitrile as buffer A and 
B, respectively. The samples were run through Phenomenex Jupiter C4 column (150 x 2 mm, 
5 μm) into the mass spectrometer. The data was collected in positive mode. The spectra was 
analysed and deconvoluted in OpenLAB CDS Chemstation software (Agilent). The expected 
mass was calculated using online tool (http://web.expasy.org/protparam) and corrected for 
molecular weight of BocK, N-terminal methinone cleavage and N-terminal acetylation. 
 Chapter 5 Discussion 
This thesis presents several advances in the field of genetic code expansion in mammalian cells. 
Mammalian cells present an attractive model organism for genetic code expansion for several 
reasons. Firstly, biological insights gained from studies in human cell lines are of great 
relevance to understanding of human physiology and pathology. In this regard, genetic code 
expansion is a unique tool, which allows biologists to study of processes inside living cells 
with precision on the single amino acid level. Secondly, production of certain biological 
therapeutics, such as antibody-drug conjugates via genetic code expansion (Oller-Salvia et al., 
2018), can only be carried out in eukaryotic cells. Overall, the capabilities of this technology 
depend both on its efficiency (i.e. how well and how specifically are ncAA incorporated into 
target proteins) and the variety of ncAA that can be efficiently incorporated. 
This thesis addresses both improvements of efficiency in incorporation of ncAAs and the 
incorporation of new ncAA. Overall, it reports two new orthogonal aaRS-tRNA pairs in 
mammalian cells (SepRSv1.0/tRNAv1.0CUA and MaPylRS/tRNA
Pyl(6)CUA) and the incorporation 
of two new ncAAs: phosphoserine and its phosphonate analogue. It further provides a method 
to significantly decrease off-target incorporation of ncAAs at endogenous amber codon sites, 
further improving the specificity of the method. 
In Chapter 2, we demonstrate the incorporation of phosphoserine via the 
SepRSv1.0/tRNAv1.0CUA pair and then increase its efficiency via an engineered version of the 
eukaryotic elongation factor alpha – EF-1α-Sep. We subsequently demonstrate incorporation 
of non-hydrolysable analague of phosphoserine and use it to synthetically activate a protein 
kinase Mek1. We note that the approach of using an evolved EF-1α variant could be extended 
to other ncAA in mammalian cells. The currently used the version of EF-Tu evolved in bacteria, 
could be further extended using directed evolution in mammalian cells may yield even better 
variants (Kelemen et al., 2018). Further, the SepRSv1.0/tRNAv1.0CUA pair can be evolved to 
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incorporate amino acids other than phosphoserine (Zhang et al., 2017) and therefore paves the 
way for genetic encoding of other phosphorylated and non-phosphorylated amino acids in 
mammalian cells. 
In Chater 3, we develop an approach to minimise the off-target incorporation of ncAA in 
response to the endogenous amber stop codons. We use this approach to improve the signal-
to-noise ratio of protein labelling via bio-orthogonal chemistry and subsequently image a 
microprotein at low expression levels. This approach can be adapted in any applications where 
the incorporation at endogenous amber codons may be detrimental to the cell health or may 
interfere with the observed phenomena. 
Lastly, in Chapter 4, we report a new orthogonal pair in mammalian cells, the 
MaPylRS/tRNAPyl(6)CUA. The MaPylRS lacks N-terminal domain found in the majority of 
PylRS variants and therefore has the potential to be a more versatile synthetase compared to 
the commonly used PylRS from M mazei or M. barkeri. We use this pair for simultaneous 
incorporation of multiple distinct amino acids into a single reporter protein. When paired with 
appropriate mutually orthogonal chemistries, this approach could be used for multi-probe 
labelling of proteins inside live cells for imaging and proteomic studies or used in protein cross-
linking, leveraging the approaches developed in Chapter 2. 
In aggregate, this thesis presents distinct advances in the scope (through two, new orthogonal 
aaRS/tRNA pairs and two newly encoded ncAA) and efficiency (through minimalisation of off 
target ncAA incorporation) of genetic code expansion in mammalian cells and should serve as 
a basis for further improvements in and applications of this technology. 
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